[
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2001",
        "submitter_treatment_id": "TREATMENT_8001",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2002",
        "submitter_treatment_id": "TREATMENT_8002",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2003",
        "submitter_treatment_id": "TREATMENT_8003",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2004",
        "submitter_treatment_id": "TREATMENT_8004",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2005",
        "submitter_treatment_id": "TREATMENT_8005",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2006",
        "submitter_treatment_id": "TREATMENT_8006",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2007",
        "submitter_treatment_id": "TREATMENT_8007",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2008",
        "submitter_treatment_id": "TREATMENT_8008",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2009",
        "submitter_treatment_id": "TREATMENT_8009",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2010",
        "submitter_treatment_id": "TREATMENT_8010",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2011",
        "submitter_treatment_id": "TREATMENT_8011",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2012",
        "submitter_treatment_id": "TREATMENT_8012",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2013",
        "submitter_treatment_id": "TREATMENT_8013",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2014",
        "submitter_treatment_id": "TREATMENT_8014",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2015",
        "submitter_treatment_id": "TREATMENT_8015",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2016",
        "submitter_treatment_id": "TREATMENT_8016",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2017",
        "submitter_treatment_id": "TREATMENT_8017",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2018",
        "submitter_treatment_id": "TREATMENT_8018",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2019",
        "submitter_treatment_id": "TREATMENT_8019",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2020",
        "submitter_treatment_id": "TREATMENT_8020",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2021",
        "submitter_treatment_id": "TREATMENT_8021",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2022",
        "submitter_treatment_id": "TREATMENT_8022",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2023",
        "submitter_treatment_id": "TREATMENT_8023",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2024",
        "submitter_treatment_id": "TREATMENT_8024",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2025",
        "submitter_treatment_id": "TREATMENT_8025",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2026",
        "submitter_treatment_id": "TREATMENT_8026",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2027",
        "submitter_treatment_id": "TREATMENT_8027",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2028",
        "submitter_treatment_id": "TREATMENT_8028",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2029",
        "submitter_treatment_id": "TREATMENT_8029",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2030",
        "submitter_treatment_id": "TREATMENT_8030",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2031",
        "submitter_treatment_id": "TREATMENT_8031",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2032",
        "submitter_treatment_id": "TREATMENT_8032",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2033",
        "submitter_treatment_id": "TREATMENT_8033",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2034",
        "submitter_treatment_id": "TREATMENT_8034",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2035",
        "submitter_treatment_id": "TREATMENT_8035",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2036",
        "submitter_treatment_id": "TREATMENT_8036",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2037",
        "submitter_treatment_id": "TREATMENT_8037",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2038",
        "submitter_treatment_id": "TREATMENT_8038",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2039",
        "submitter_treatment_id": "TREATMENT_8039",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2040",
        "submitter_treatment_id": "TREATMENT_8040",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2041",
        "submitter_treatment_id": "TREATMENT_8041",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2042",
        "submitter_treatment_id": "TREATMENT_8042",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2043",
        "submitter_treatment_id": "TREATMENT_8043",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2044",
        "submitter_treatment_id": "TREATMENT_8044",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2045",
        "submitter_treatment_id": "TREATMENT_8045",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2046",
        "submitter_treatment_id": "TREATMENT_8046",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2047",
        "submitter_treatment_id": "TREATMENT_8047",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2048",
        "submitter_treatment_id": "TREATMENT_8048",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2049",
        "submitter_treatment_id": "TREATMENT_8049",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2050",
        "submitter_treatment_id": "TREATMENT_8050",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2051",
        "submitter_treatment_id": "TREATMENT_8051",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2052",
        "submitter_treatment_id": "TREATMENT_8052",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2053",
        "submitter_treatment_id": "TREATMENT_8053",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2054",
        "submitter_treatment_id": "TREATMENT_8054",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2055",
        "submitter_treatment_id": "TREATMENT_8055",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2056",
        "submitter_treatment_id": "TREATMENT_8056",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2057",
        "submitter_treatment_id": "TREATMENT_8057",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2058",
        "submitter_treatment_id": "TREATMENT_8058",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2059",
        "submitter_treatment_id": "TREATMENT_8059",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2060",
        "submitter_treatment_id": "TREATMENT_8060",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2061",
        "submitter_treatment_id": "TREATMENT_8061",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2062",
        "submitter_treatment_id": "TREATMENT_8062",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2063",
        "submitter_treatment_id": "TREATMENT_8063",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2064",
        "submitter_treatment_id": "TREATMENT_8064",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2065",
        "submitter_treatment_id": "TREATMENT_8065",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2066",
        "submitter_treatment_id": "TREATMENT_8066",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2067",
        "submitter_treatment_id": "TREATMENT_8067",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2068",
        "submitter_treatment_id": "TREATMENT_8068",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2069",
        "submitter_treatment_id": "TREATMENT_8069",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2070",
        "submitter_treatment_id": "TREATMENT_8070",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2071",
        "submitter_treatment_id": "TREATMENT_8071",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2072",
        "submitter_treatment_id": "TREATMENT_8072",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2073",
        "submitter_treatment_id": "TREATMENT_8073",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2074",
        "submitter_treatment_id": "TREATMENT_8074",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2075",
        "submitter_treatment_id": "TREATMENT_8075",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2076",
        "submitter_treatment_id": "TREATMENT_8076",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2077",
        "submitter_treatment_id": "TREATMENT_8077",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2078",
        "submitter_treatment_id": "TREATMENT_8078",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2079",
        "submitter_treatment_id": "TREATMENT_8079",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2080",
        "submitter_treatment_id": "TREATMENT_8080",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2081",
        "submitter_treatment_id": "TREATMENT_8081",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2082",
        "submitter_treatment_id": "TREATMENT_8082",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2083",
        "submitter_treatment_id": "TREATMENT_8083",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2084",
        "submitter_treatment_id": "TREATMENT_8084",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2085",
        "submitter_treatment_id": "TREATMENT_8085",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2086",
        "submitter_treatment_id": "TREATMENT_8086",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2087",
        "submitter_treatment_id": "TREATMENT_8087",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2088",
        "submitter_treatment_id": "TREATMENT_8088",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2089",
        "submitter_treatment_id": "TREATMENT_8089",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2090",
        "submitter_treatment_id": "TREATMENT_8090",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2091",
        "submitter_treatment_id": "TREATMENT_8091",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2092",
        "submitter_treatment_id": "TREATMENT_8092",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2093",
        "submitter_treatment_id": "TREATMENT_8093",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2094",
        "submitter_treatment_id": "TREATMENT_8094",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2095",
        "submitter_treatment_id": "TREATMENT_8095",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2096",
        "submitter_treatment_id": "TREATMENT_8096",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2097",
        "submitter_treatment_id": "TREATMENT_8097",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2098",
        "submitter_treatment_id": "TREATMENT_8098",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2099",
        "submitter_treatment_id": "TREATMENT_8099",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2100",
        "submitter_treatment_id": "TREATMENT_8100",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2101",
        "submitter_treatment_id": "TREATMENT_8101",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2102",
        "submitter_treatment_id": "TREATMENT_8102",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2103",
        "submitter_treatment_id": "TREATMENT_8103",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2104",
        "submitter_treatment_id": "TREATMENT_8104",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2105",
        "submitter_treatment_id": "TREATMENT_8105",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2106",
        "submitter_treatment_id": "TREATMENT_8106",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2107",
        "submitter_treatment_id": "TREATMENT_8107",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2108",
        "submitter_treatment_id": "TREATMENT_8108",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2109",
        "submitter_treatment_id": "TREATMENT_8109",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2110",
        "submitter_treatment_id": "TREATMENT_8110",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2111",
        "submitter_treatment_id": "TREATMENT_8111",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2112",
        "submitter_treatment_id": "TREATMENT_8112",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2113",
        "submitter_treatment_id": "TREATMENT_8113",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2114",
        "submitter_treatment_id": "TREATMENT_8114",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2115",
        "submitter_treatment_id": "TREATMENT_8115",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2116",
        "submitter_treatment_id": "TREATMENT_8116",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2117",
        "submitter_treatment_id": "TREATMENT_8117",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2118",
        "submitter_treatment_id": "TREATMENT_8118",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2119",
        "submitter_treatment_id": "TREATMENT_8119",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2120",
        "submitter_treatment_id": "TREATMENT_8120",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2121",
        "submitter_treatment_id": "TREATMENT_8121",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2122",
        "submitter_treatment_id": "TREATMENT_8122",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2123",
        "submitter_treatment_id": "TREATMENT_8123",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2124",
        "submitter_treatment_id": "TREATMENT_8124",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2125",
        "submitter_treatment_id": "TREATMENT_8125",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2126",
        "submitter_treatment_id": "TREATMENT_8126",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2127",
        "submitter_treatment_id": "TREATMENT_8127",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2128",
        "submitter_treatment_id": "TREATMENT_8128",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2129",
        "submitter_treatment_id": "TREATMENT_8129",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2130",
        "submitter_treatment_id": "TREATMENT_8130",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2131",
        "submitter_treatment_id": "TREATMENT_8131",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2132",
        "submitter_treatment_id": "TREATMENT_8132",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2133",
        "submitter_treatment_id": "TREATMENT_8133",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2134",
        "submitter_treatment_id": "TREATMENT_8134",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2135",
        "submitter_treatment_id": "TREATMENT_8135",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2136",
        "submitter_treatment_id": "TREATMENT_8136",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2137",
        "submitter_treatment_id": "TREATMENT_8137",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2138",
        "submitter_treatment_id": "TREATMENT_8138",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2139",
        "submitter_treatment_id": "TREATMENT_8139",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2140",
        "submitter_treatment_id": "TREATMENT_8140",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2141",
        "submitter_treatment_id": "TREATMENT_8141",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2142",
        "submitter_treatment_id": "TREATMENT_8142",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2143",
        "submitter_treatment_id": "TREATMENT_8143",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2144",
        "submitter_treatment_id": "TREATMENT_8144",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2145",
        "submitter_treatment_id": "TREATMENT_8145",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2146",
        "submitter_treatment_id": "TREATMENT_8146",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2147",
        "submitter_treatment_id": "TREATMENT_8147",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2148",
        "submitter_treatment_id": "TREATMENT_8148",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2149",
        "submitter_treatment_id": "TREATMENT_8149",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2150",
        "submitter_treatment_id": "TREATMENT_8150",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2151",
        "submitter_treatment_id": "TREATMENT_8151",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2152",
        "submitter_treatment_id": "TREATMENT_8152",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2153",
        "submitter_treatment_id": "TREATMENT_8153",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2154",
        "submitter_treatment_id": "TREATMENT_8154",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2155",
        "submitter_treatment_id": "TREATMENT_8155",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2156",
        "submitter_treatment_id": "TREATMENT_8156",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2157",
        "submitter_treatment_id": "TREATMENT_8157",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2158",
        "submitter_treatment_id": "TREATMENT_8158",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2159",
        "submitter_treatment_id": "TREATMENT_8159",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2160",
        "submitter_treatment_id": "TREATMENT_8160",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2161",
        "submitter_treatment_id": "TREATMENT_8161",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2162",
        "submitter_treatment_id": "TREATMENT_8162",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2163",
        "submitter_treatment_id": "TREATMENT_8163",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2164",
        "submitter_treatment_id": "TREATMENT_8164",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2165",
        "submitter_treatment_id": "TREATMENT_8165",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2166",
        "submitter_treatment_id": "TREATMENT_8166",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2167",
        "submitter_treatment_id": "TREATMENT_8167",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2168",
        "submitter_treatment_id": "TREATMENT_8168",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2169",
        "submitter_treatment_id": "TREATMENT_8169",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2170",
        "submitter_treatment_id": "TREATMENT_8170",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2171",
        "submitter_treatment_id": "TREATMENT_8171",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2172",
        "submitter_treatment_id": "TREATMENT_8172",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2173",
        "submitter_treatment_id": "TREATMENT_8173",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2174",
        "submitter_treatment_id": "TREATMENT_8174",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2175",
        "submitter_treatment_id": "TREATMENT_8175",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2176",
        "submitter_treatment_id": "TREATMENT_8176",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2177",
        "submitter_treatment_id": "TREATMENT_8177",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2178",
        "submitter_treatment_id": "TREATMENT_8178",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2179",
        "submitter_treatment_id": "TREATMENT_8179",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2180",
        "submitter_treatment_id": "TREATMENT_8180",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2181",
        "submitter_treatment_id": "TREATMENT_8181",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2182",
        "submitter_treatment_id": "TREATMENT_8182",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2183",
        "submitter_treatment_id": "TREATMENT_8183",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2184",
        "submitter_treatment_id": "TREATMENT_8184",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2185",
        "submitter_treatment_id": "TREATMENT_8185",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2186",
        "submitter_treatment_id": "TREATMENT_8186",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2187",
        "submitter_treatment_id": "TREATMENT_8187",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2188",
        "submitter_treatment_id": "TREATMENT_8188",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2189",
        "submitter_treatment_id": "TREATMENT_8189",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2190",
        "submitter_treatment_id": "TREATMENT_8190",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2191",
        "submitter_treatment_id": "TREATMENT_8191",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2192",
        "submitter_treatment_id": "TREATMENT_8192",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2193",
        "submitter_treatment_id": "TREATMENT_8193",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2194",
        "submitter_treatment_id": "TREATMENT_8194",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2195",
        "submitter_treatment_id": "TREATMENT_8195",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2196",
        "submitter_treatment_id": "TREATMENT_8196",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2197",
        "submitter_treatment_id": "TREATMENT_8197",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2198",
        "submitter_treatment_id": "TREATMENT_8198",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2199",
        "submitter_treatment_id": "TREATMENT_8199",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2200",
        "submitter_treatment_id": "TREATMENT_8200",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2201",
        "submitter_treatment_id": "TREATMENT_8201",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2202",
        "submitter_treatment_id": "TREATMENT_8202",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2203",
        "submitter_treatment_id": "TREATMENT_8203",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2204",
        "submitter_treatment_id": "TREATMENT_8204",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2205",
        "submitter_treatment_id": "TREATMENT_8205",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2206",
        "submitter_treatment_id": "TREATMENT_8206",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2207",
        "submitter_treatment_id": "TREATMENT_8207",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2208",
        "submitter_treatment_id": "TREATMENT_8208",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2209",
        "submitter_treatment_id": "TREATMENT_8209",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2210",
        "submitter_treatment_id": "TREATMENT_8210",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2211",
        "submitter_treatment_id": "TREATMENT_8211",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2212",
        "submitter_treatment_id": "TREATMENT_8212",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2213",
        "submitter_treatment_id": "TREATMENT_8213",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2214",
        "submitter_treatment_id": "TREATMENT_8214",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2215",
        "submitter_treatment_id": "TREATMENT_8215",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2216",
        "submitter_treatment_id": "TREATMENT_8216",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2217",
        "submitter_treatment_id": "TREATMENT_8217",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2218",
        "submitter_treatment_id": "TREATMENT_8218",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2219",
        "submitter_treatment_id": "TREATMENT_8219",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2220",
        "submitter_treatment_id": "TREATMENT_8220",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2221",
        "submitter_treatment_id": "TREATMENT_8221",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2222",
        "submitter_treatment_id": "TREATMENT_8222",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2223",
        "submitter_treatment_id": "TREATMENT_8223",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2224",
        "submitter_treatment_id": "TREATMENT_8224",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2225",
        "submitter_treatment_id": "TREATMENT_8225",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2226",
        "submitter_treatment_id": "TREATMENT_8226",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2227",
        "submitter_treatment_id": "TREATMENT_8227",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2228",
        "submitter_treatment_id": "TREATMENT_8228",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2229",
        "submitter_treatment_id": "TREATMENT_8229",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2230",
        "submitter_treatment_id": "TREATMENT_8230",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2231",
        "submitter_treatment_id": "TREATMENT_8231",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2232",
        "submitter_treatment_id": "TREATMENT_8232",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2233",
        "submitter_treatment_id": "TREATMENT_8233",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2234",
        "submitter_treatment_id": "TREATMENT_8234",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2235",
        "submitter_treatment_id": "TREATMENT_8235",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2236",
        "submitter_treatment_id": "TREATMENT_8236",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2237",
        "submitter_treatment_id": "TREATMENT_8237",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2238",
        "submitter_treatment_id": "TREATMENT_8238",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2239",
        "submitter_treatment_id": "TREATMENT_8239",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2240",
        "submitter_treatment_id": "TREATMENT_8240",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2241",
        "submitter_treatment_id": "TREATMENT_8241",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2242",
        "submitter_treatment_id": "TREATMENT_8242",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2243",
        "submitter_treatment_id": "TREATMENT_8243",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2244",
        "submitter_treatment_id": "TREATMENT_8244",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2245",
        "submitter_treatment_id": "TREATMENT_8245",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2246",
        "submitter_treatment_id": "TREATMENT_8246",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2247",
        "submitter_treatment_id": "TREATMENT_8247",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2248",
        "submitter_treatment_id": "TREATMENT_8248",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2249",
        "submitter_treatment_id": "TREATMENT_8249",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2250",
        "submitter_treatment_id": "TREATMENT_8250",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2251",
        "submitter_treatment_id": "TREATMENT_8251",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2252",
        "submitter_treatment_id": "TREATMENT_8252",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2253",
        "submitter_treatment_id": "TREATMENT_8253",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2254",
        "submitter_treatment_id": "TREATMENT_8254",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2255",
        "submitter_treatment_id": "TREATMENT_8255",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2256",
        "submitter_treatment_id": "TREATMENT_8256",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2257",
        "submitter_treatment_id": "TREATMENT_8257",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2258",
        "submitter_treatment_id": "TREATMENT_8258",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2259",
        "submitter_treatment_id": "TREATMENT_8259",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2260",
        "submitter_treatment_id": "TREATMENT_8260",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2261",
        "submitter_treatment_id": "TREATMENT_8261",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2262",
        "submitter_treatment_id": "TREATMENT_8262",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2263",
        "submitter_treatment_id": "TREATMENT_8263",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2264",
        "submitter_treatment_id": "TREATMENT_8264",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2265",
        "submitter_treatment_id": "TREATMENT_8265",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2266",
        "submitter_treatment_id": "TREATMENT_8266",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2267",
        "submitter_treatment_id": "TREATMENT_8267",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2268",
        "submitter_treatment_id": "TREATMENT_8268",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2269",
        "submitter_treatment_id": "TREATMENT_8269",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2270",
        "submitter_treatment_id": "TREATMENT_8270",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2271",
        "submitter_treatment_id": "TREATMENT_8271",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2272",
        "submitter_treatment_id": "TREATMENT_8272",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2273",
        "submitter_treatment_id": "TREATMENT_8273",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2274",
        "submitter_treatment_id": "TREATMENT_8274",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2275",
        "submitter_treatment_id": "TREATMENT_8275",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2276",
        "submitter_treatment_id": "TREATMENT_8276",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2277",
        "submitter_treatment_id": "TREATMENT_8277",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2278",
        "submitter_treatment_id": "TREATMENT_8278",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2279",
        "submitter_treatment_id": "TREATMENT_8279",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2280",
        "submitter_treatment_id": "TREATMENT_8280",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2281",
        "submitter_treatment_id": "TREATMENT_8281",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2282",
        "submitter_treatment_id": "TREATMENT_8282",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2283",
        "submitter_treatment_id": "TREATMENT_8283",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2284",
        "submitter_treatment_id": "TREATMENT_8284",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2285",
        "submitter_treatment_id": "TREATMENT_8285",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2286",
        "submitter_treatment_id": "TREATMENT_8286",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2287",
        "submitter_treatment_id": "TREATMENT_8287",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2288",
        "submitter_treatment_id": "TREATMENT_8288",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2289",
        "submitter_treatment_id": "TREATMENT_8289",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2290",
        "submitter_treatment_id": "TREATMENT_8290",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2291",
        "submitter_treatment_id": "TREATMENT_8291",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2292",
        "submitter_treatment_id": "TREATMENT_8292",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2293",
        "submitter_treatment_id": "TREATMENT_8293",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2294",
        "submitter_treatment_id": "TREATMENT_8294",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2295",
        "submitter_treatment_id": "TREATMENT_8295",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2296",
        "submitter_treatment_id": "TREATMENT_8296",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2297",
        "submitter_treatment_id": "TREATMENT_8297",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2298",
        "submitter_treatment_id": "TREATMENT_8298",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2299",
        "submitter_treatment_id": "TREATMENT_8299",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2300",
        "submitter_treatment_id": "TREATMENT_8300",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2301",
        "submitter_treatment_id": "TREATMENT_8301",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2302",
        "submitter_treatment_id": "TREATMENT_8302",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2303",
        "submitter_treatment_id": "TREATMENT_8303",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2304",
        "submitter_treatment_id": "TREATMENT_8304",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2305",
        "submitter_treatment_id": "TREATMENT_8305",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2306",
        "submitter_treatment_id": "TREATMENT_8306",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2307",
        "submitter_treatment_id": "TREATMENT_8307",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2308",
        "submitter_treatment_id": "TREATMENT_8308",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2309",
        "submitter_treatment_id": "TREATMENT_8309",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2310",
        "submitter_treatment_id": "TREATMENT_8310",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2311",
        "submitter_treatment_id": "TREATMENT_8311",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2312",
        "submitter_treatment_id": "TREATMENT_8312",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2313",
        "submitter_treatment_id": "TREATMENT_8313",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2314",
        "submitter_treatment_id": "TREATMENT_8314",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2315",
        "submitter_treatment_id": "TREATMENT_8315",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2316",
        "submitter_treatment_id": "TREATMENT_8316",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2317",
        "submitter_treatment_id": "TREATMENT_8317",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2318",
        "submitter_treatment_id": "TREATMENT_8318",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2319",
        "submitter_treatment_id": "TREATMENT_8319",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2320",
        "submitter_treatment_id": "TREATMENT_8320",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2321",
        "submitter_treatment_id": "TREATMENT_8321",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2322",
        "submitter_treatment_id": "TREATMENT_8322",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2323",
        "submitter_treatment_id": "TREATMENT_8323",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2324",
        "submitter_treatment_id": "TREATMENT_8324",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2325",
        "submitter_treatment_id": "TREATMENT_8325",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2326",
        "submitter_treatment_id": "TREATMENT_8326",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2327",
        "submitter_treatment_id": "TREATMENT_8327",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2328",
        "submitter_treatment_id": "TREATMENT_8328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2329",
        "submitter_treatment_id": "TREATMENT_8329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2330",
        "submitter_treatment_id": "TREATMENT_8330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2331",
        "submitter_treatment_id": "TREATMENT_8331",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2332",
        "submitter_treatment_id": "TREATMENT_8332",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2333",
        "submitter_treatment_id": "TREATMENT_8333",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2334",
        "submitter_treatment_id": "TREATMENT_8334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2335",
        "submitter_treatment_id": "TREATMENT_8335",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2336",
        "submitter_treatment_id": "TREATMENT_8336",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2337",
        "submitter_treatment_id": "TREATMENT_8337",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2338",
        "submitter_treatment_id": "TREATMENT_8338",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2339",
        "submitter_treatment_id": "TREATMENT_8339",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2340",
        "submitter_treatment_id": "TREATMENT_8340",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2341",
        "submitter_treatment_id": "TREATMENT_8341",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2342",
        "submitter_treatment_id": "TREATMENT_8342",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2343",
        "submitter_treatment_id": "TREATMENT_8343",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2344",
        "submitter_treatment_id": "TREATMENT_8344",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2345",
        "submitter_treatment_id": "TREATMENT_8345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2346",
        "submitter_treatment_id": "TREATMENT_8346",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2347",
        "submitter_treatment_id": "TREATMENT_8347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2348",
        "submitter_treatment_id": "TREATMENT_8348",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2349",
        "submitter_treatment_id": "TREATMENT_8349",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2350",
        "submitter_treatment_id": "TREATMENT_8350",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2351",
        "submitter_treatment_id": "TREATMENT_8351",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2352",
        "submitter_treatment_id": "TREATMENT_8352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2353",
        "submitter_treatment_id": "TREATMENT_8353",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2354",
        "submitter_treatment_id": "TREATMENT_8354",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2355",
        "submitter_treatment_id": "TREATMENT_8355",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2356",
        "submitter_treatment_id": "TREATMENT_8356",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2357",
        "submitter_treatment_id": "TREATMENT_8357",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2358",
        "submitter_treatment_id": "TREATMENT_8358",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2359",
        "submitter_treatment_id": "TREATMENT_8359",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2360",
        "submitter_treatment_id": "TREATMENT_8360",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2361",
        "submitter_treatment_id": "TREATMENT_8361",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2362",
        "submitter_treatment_id": "TREATMENT_8362",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2363",
        "submitter_treatment_id": "TREATMENT_8363",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2364",
        "submitter_treatment_id": "TREATMENT_8364",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2365",
        "submitter_treatment_id": "TREATMENT_8365",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2366",
        "submitter_treatment_id": "TREATMENT_8366",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2367",
        "submitter_treatment_id": "TREATMENT_8367",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2368",
        "submitter_treatment_id": "TREATMENT_8368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2369",
        "submitter_treatment_id": "TREATMENT_8369",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2370",
        "submitter_treatment_id": "TREATMENT_8370",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2371",
        "submitter_treatment_id": "TREATMENT_8371",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2372",
        "submitter_treatment_id": "TREATMENT_8372",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2373",
        "submitter_treatment_id": "TREATMENT_8373",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2374",
        "submitter_treatment_id": "TREATMENT_8374",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2375",
        "submitter_treatment_id": "TREATMENT_8375",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2376",
        "submitter_treatment_id": "TREATMENT_8376",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2377",
        "submitter_treatment_id": "TREATMENT_8377",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2378",
        "submitter_treatment_id": "TREATMENT_8378",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2379",
        "submitter_treatment_id": "TREATMENT_8379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2380",
        "submitter_treatment_id": "TREATMENT_8380",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2381",
        "submitter_treatment_id": "TREATMENT_8381",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2382",
        "submitter_treatment_id": "TREATMENT_8382",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2383",
        "submitter_treatment_id": "TREATMENT_8383",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2384",
        "submitter_treatment_id": "TREATMENT_8384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2385",
        "submitter_treatment_id": "TREATMENT_8385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2386",
        "submitter_treatment_id": "TREATMENT_8386",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2387",
        "submitter_treatment_id": "TREATMENT_8387",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2388",
        "submitter_treatment_id": "TREATMENT_8388",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2389",
        "submitter_treatment_id": "TREATMENT_8389",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2390",
        "submitter_treatment_id": "TREATMENT_8390",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2391",
        "submitter_treatment_id": "TREATMENT_8391",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2392",
        "submitter_treatment_id": "TREATMENT_8392",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2393",
        "submitter_treatment_id": "TREATMENT_8393",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2394",
        "submitter_treatment_id": "TREATMENT_8394",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2395",
        "submitter_treatment_id": "TREATMENT_8395",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2396",
        "submitter_treatment_id": "TREATMENT_8396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2397",
        "submitter_treatment_id": "TREATMENT_8397",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2398",
        "submitter_treatment_id": "TREATMENT_8398",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2399",
        "submitter_treatment_id": "TREATMENT_8399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2400",
        "submitter_treatment_id": "TREATMENT_8400",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2401",
        "submitter_treatment_id": "TREATMENT_8401",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2402",
        "submitter_treatment_id": "TREATMENT_8402",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2403",
        "submitter_treatment_id": "TREATMENT_8403",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2404",
        "submitter_treatment_id": "TREATMENT_8404",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2405",
        "submitter_treatment_id": "TREATMENT_8405",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2406",
        "submitter_treatment_id": "TREATMENT_8406",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2407",
        "submitter_treatment_id": "TREATMENT_8407",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2408",
        "submitter_treatment_id": "TREATMENT_8408",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2409",
        "submitter_treatment_id": "TREATMENT_8409",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2410",
        "submitter_treatment_id": "TREATMENT_8410",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2411",
        "submitter_treatment_id": "TREATMENT_8411",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2412",
        "submitter_treatment_id": "TREATMENT_8412",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2413",
        "submitter_treatment_id": "TREATMENT_8413",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2414",
        "submitter_treatment_id": "TREATMENT_8414",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2415",
        "submitter_treatment_id": "TREATMENT_8415",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2416",
        "submitter_treatment_id": "TREATMENT_8416",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2417",
        "submitter_treatment_id": "TREATMENT_8417",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2418",
        "submitter_treatment_id": "TREATMENT_8418",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2419",
        "submitter_treatment_id": "TREATMENT_8419",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2420",
        "submitter_treatment_id": "TREATMENT_8420",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2421",
        "submitter_treatment_id": "TREATMENT_8421",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2422",
        "submitter_treatment_id": "TREATMENT_8422",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2423",
        "submitter_treatment_id": "TREATMENT_8423",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2424",
        "submitter_treatment_id": "TREATMENT_8424",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2425",
        "submitter_treatment_id": "TREATMENT_8425",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2426",
        "submitter_treatment_id": "TREATMENT_8426",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2427",
        "submitter_treatment_id": "TREATMENT_8427",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2428",
        "submitter_treatment_id": "TREATMENT_8428",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2429",
        "submitter_treatment_id": "TREATMENT_8429",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2430",
        "submitter_treatment_id": "TREATMENT_8430",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2431",
        "submitter_treatment_id": "TREATMENT_8431",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2432",
        "submitter_treatment_id": "TREATMENT_8432",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2433",
        "submitter_treatment_id": "TREATMENT_8433",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2434",
        "submitter_treatment_id": "TREATMENT_8434",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2435",
        "submitter_treatment_id": "TREATMENT_8435",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2436",
        "submitter_treatment_id": "TREATMENT_8436",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2437",
        "submitter_treatment_id": "TREATMENT_8437",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2438",
        "submitter_treatment_id": "TREATMENT_8438",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2439",
        "submitter_treatment_id": "TREATMENT_8439",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2440",
        "submitter_treatment_id": "TREATMENT_8440",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2441",
        "submitter_treatment_id": "TREATMENT_8441",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2442",
        "submitter_treatment_id": "TREATMENT_8442",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2443",
        "submitter_treatment_id": "TREATMENT_8443",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2444",
        "submitter_treatment_id": "TREATMENT_8444",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2445",
        "submitter_treatment_id": "TREATMENT_8445",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2446",
        "submitter_treatment_id": "TREATMENT_8446",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2447",
        "submitter_treatment_id": "TREATMENT_8447",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2448",
        "submitter_treatment_id": "TREATMENT_8448",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2449",
        "submitter_treatment_id": "TREATMENT_8449",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2450",
        "submitter_treatment_id": "TREATMENT_8450",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2451",
        "submitter_treatment_id": "TREATMENT_8451",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2452",
        "submitter_treatment_id": "TREATMENT_8452",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2453",
        "submitter_treatment_id": "TREATMENT_8453",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2454",
        "submitter_treatment_id": "TREATMENT_8454",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2455",
        "submitter_treatment_id": "TREATMENT_8455",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2456",
        "submitter_treatment_id": "TREATMENT_8456",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2457",
        "submitter_treatment_id": "TREATMENT_8457",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2458",
        "submitter_treatment_id": "TREATMENT_8458",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2459",
        "submitter_treatment_id": "TREATMENT_8459",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2460",
        "submitter_treatment_id": "TREATMENT_8460",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2461",
        "submitter_treatment_id": "TREATMENT_8461",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2462",
        "submitter_treatment_id": "TREATMENT_8462",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2463",
        "submitter_treatment_id": "TREATMENT_8463",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2464",
        "submitter_treatment_id": "TREATMENT_8464",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2465",
        "submitter_treatment_id": "TREATMENT_8465",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2466",
        "submitter_treatment_id": "TREATMENT_8466",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2467",
        "submitter_treatment_id": "TREATMENT_8467",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2468",
        "submitter_treatment_id": "TREATMENT_8468",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2469",
        "submitter_treatment_id": "TREATMENT_8469",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2470",
        "submitter_treatment_id": "TREATMENT_8470",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2471",
        "submitter_treatment_id": "TREATMENT_8471",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2472",
        "submitter_treatment_id": "TREATMENT_8472",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2473",
        "submitter_treatment_id": "TREATMENT_8473",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2474",
        "submitter_treatment_id": "TREATMENT_8474",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2475",
        "submitter_treatment_id": "TREATMENT_8475",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2476",
        "submitter_treatment_id": "TREATMENT_8476",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2477",
        "submitter_treatment_id": "TREATMENT_8477",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2478",
        "submitter_treatment_id": "TREATMENT_8478",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2479",
        "submitter_treatment_id": "TREATMENT_8479",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2480",
        "submitter_treatment_id": "TREATMENT_8480",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2481",
        "submitter_treatment_id": "TREATMENT_8481",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2482",
        "submitter_treatment_id": "TREATMENT_8482",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2483",
        "submitter_treatment_id": "TREATMENT_8483",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2484",
        "submitter_treatment_id": "TREATMENT_8484",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2485",
        "submitter_treatment_id": "TREATMENT_8485",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2486",
        "submitter_treatment_id": "TREATMENT_8486",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2487",
        "submitter_treatment_id": "TREATMENT_8487",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2488",
        "submitter_treatment_id": "TREATMENT_8488",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2489",
        "submitter_treatment_id": "TREATMENT_8489",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2490",
        "submitter_treatment_id": "TREATMENT_8490",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2491",
        "submitter_treatment_id": "TREATMENT_8491",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2492",
        "submitter_treatment_id": "TREATMENT_8492",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2493",
        "submitter_treatment_id": "TREATMENT_8493",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2494",
        "submitter_treatment_id": "TREATMENT_8494",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2495",
        "submitter_treatment_id": "TREATMENT_8495",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2496",
        "submitter_treatment_id": "TREATMENT_8496",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2497",
        "submitter_treatment_id": "TREATMENT_8497",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2498",
        "submitter_treatment_id": "TREATMENT_8498",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2499",
        "submitter_treatment_id": "TREATMENT_8499",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2500",
        "submitter_treatment_id": "TREATMENT_8500",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2001",
        "submitter_treatment_id": "TREATMENT_8501",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2002",
        "submitter_treatment_id": "TREATMENT_8502",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2003",
        "submitter_treatment_id": "TREATMENT_8503",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2004",
        "submitter_treatment_id": "TREATMENT_8504",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2005",
        "submitter_treatment_id": "TREATMENT_8505",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2006",
        "submitter_treatment_id": "TREATMENT_8506",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2007",
        "submitter_treatment_id": "TREATMENT_8507",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2008",
        "submitter_treatment_id": "TREATMENT_8508",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2009",
        "submitter_treatment_id": "TREATMENT_8509",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2010",
        "submitter_treatment_id": "TREATMENT_8510",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2011",
        "submitter_treatment_id": "TREATMENT_8511",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2012",
        "submitter_treatment_id": "TREATMENT_8512",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2013",
        "submitter_treatment_id": "TREATMENT_8513",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2014",
        "submitter_treatment_id": "TREATMENT_8514",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2015",
        "submitter_treatment_id": "TREATMENT_8515",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2016",
        "submitter_treatment_id": "TREATMENT_8516",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2017",
        "submitter_treatment_id": "TREATMENT_8517",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2018",
        "submitter_treatment_id": "TREATMENT_8518",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2019",
        "submitter_treatment_id": "TREATMENT_8519",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2020",
        "submitter_treatment_id": "TREATMENT_8520",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2021",
        "submitter_treatment_id": "TREATMENT_8521",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2022",
        "submitter_treatment_id": "TREATMENT_8522",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2023",
        "submitter_treatment_id": "TREATMENT_8523",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2024",
        "submitter_treatment_id": "TREATMENT_8524",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2025",
        "submitter_treatment_id": "TREATMENT_8525",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2026",
        "submitter_treatment_id": "TREATMENT_8526",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2027",
        "submitter_treatment_id": "TREATMENT_8527",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2028",
        "submitter_treatment_id": "TREATMENT_8528",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2029",
        "submitter_treatment_id": "TREATMENT_8529",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2030",
        "submitter_treatment_id": "TREATMENT_8530",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2031",
        "submitter_treatment_id": "TREATMENT_8531",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2032",
        "submitter_treatment_id": "TREATMENT_8532",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2033",
        "submitter_treatment_id": "TREATMENT_8533",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2034",
        "submitter_treatment_id": "TREATMENT_8534",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2035",
        "submitter_treatment_id": "TREATMENT_8535",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2036",
        "submitter_treatment_id": "TREATMENT_8536",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2037",
        "submitter_treatment_id": "TREATMENT_8537",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2038",
        "submitter_treatment_id": "TREATMENT_8538",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2039",
        "submitter_treatment_id": "TREATMENT_8539",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2040",
        "submitter_treatment_id": "TREATMENT_8540",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2041",
        "submitter_treatment_id": "TREATMENT_8541",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2042",
        "submitter_treatment_id": "TREATMENT_8542",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2043",
        "submitter_treatment_id": "TREATMENT_8543",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2044",
        "submitter_treatment_id": "TREATMENT_8544",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2045",
        "submitter_treatment_id": "TREATMENT_8545",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2046",
        "submitter_treatment_id": "TREATMENT_8546",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2047",
        "submitter_treatment_id": "TREATMENT_8547",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2048",
        "submitter_treatment_id": "TREATMENT_8548",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2049",
        "submitter_treatment_id": "TREATMENT_8549",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2050",
        "submitter_treatment_id": "TREATMENT_8550",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2051",
        "submitter_treatment_id": "TREATMENT_8551",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2052",
        "submitter_treatment_id": "TREATMENT_8552",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2053",
        "submitter_treatment_id": "TREATMENT_8553",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2054",
        "submitter_treatment_id": "TREATMENT_8554",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2055",
        "submitter_treatment_id": "TREATMENT_8555",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2056",
        "submitter_treatment_id": "TREATMENT_8556",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2057",
        "submitter_treatment_id": "TREATMENT_8557",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2058",
        "submitter_treatment_id": "TREATMENT_8558",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2059",
        "submitter_treatment_id": "TREATMENT_8559",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2060",
        "submitter_treatment_id": "TREATMENT_8560",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2061",
        "submitter_treatment_id": "TREATMENT_8561",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2062",
        "submitter_treatment_id": "TREATMENT_8562",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2063",
        "submitter_treatment_id": "TREATMENT_8563",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2064",
        "submitter_treatment_id": "TREATMENT_8564",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2065",
        "submitter_treatment_id": "TREATMENT_8565",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2066",
        "submitter_treatment_id": "TREATMENT_8566",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2067",
        "submitter_treatment_id": "TREATMENT_8567",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2068",
        "submitter_treatment_id": "TREATMENT_8568",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2069",
        "submitter_treatment_id": "TREATMENT_8569",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2070",
        "submitter_treatment_id": "TREATMENT_8570",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2071",
        "submitter_treatment_id": "TREATMENT_8571",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2072",
        "submitter_treatment_id": "TREATMENT_8572",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2073",
        "submitter_treatment_id": "TREATMENT_8573",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2074",
        "submitter_treatment_id": "TREATMENT_8574",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2075",
        "submitter_treatment_id": "TREATMENT_8575",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2076",
        "submitter_treatment_id": "TREATMENT_8576",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2077",
        "submitter_treatment_id": "TREATMENT_8577",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2078",
        "submitter_treatment_id": "TREATMENT_8578",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2079",
        "submitter_treatment_id": "TREATMENT_8579",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2080",
        "submitter_treatment_id": "TREATMENT_8580",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2081",
        "submitter_treatment_id": "TREATMENT_8581",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2082",
        "submitter_treatment_id": "TREATMENT_8582",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2083",
        "submitter_treatment_id": "TREATMENT_8583",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2084",
        "submitter_treatment_id": "TREATMENT_8584",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2085",
        "submitter_treatment_id": "TREATMENT_8585",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2086",
        "submitter_treatment_id": "TREATMENT_8586",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2087",
        "submitter_treatment_id": "TREATMENT_8587",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2088",
        "submitter_treatment_id": "TREATMENT_8588",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2089",
        "submitter_treatment_id": "TREATMENT_8589",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2090",
        "submitter_treatment_id": "TREATMENT_8590",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2091",
        "submitter_treatment_id": "TREATMENT_8591",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2092",
        "submitter_treatment_id": "TREATMENT_8592",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2093",
        "submitter_treatment_id": "TREATMENT_8593",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2094",
        "submitter_treatment_id": "TREATMENT_8594",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2095",
        "submitter_treatment_id": "TREATMENT_8595",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2096",
        "submitter_treatment_id": "TREATMENT_8596",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2097",
        "submitter_treatment_id": "TREATMENT_8597",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2098",
        "submitter_treatment_id": "TREATMENT_8598",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2099",
        "submitter_treatment_id": "TREATMENT_8599",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2100",
        "submitter_treatment_id": "TREATMENT_8600",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2101",
        "submitter_treatment_id": "TREATMENT_8601",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2102",
        "submitter_treatment_id": "TREATMENT_8602",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2103",
        "submitter_treatment_id": "TREATMENT_8603",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2104",
        "submitter_treatment_id": "TREATMENT_8604",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2105",
        "submitter_treatment_id": "TREATMENT_8605",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2106",
        "submitter_treatment_id": "TREATMENT_8606",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2107",
        "submitter_treatment_id": "TREATMENT_8607",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2108",
        "submitter_treatment_id": "TREATMENT_8608",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2109",
        "submitter_treatment_id": "TREATMENT_8609",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2110",
        "submitter_treatment_id": "TREATMENT_8610",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2111",
        "submitter_treatment_id": "TREATMENT_8611",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2112",
        "submitter_treatment_id": "TREATMENT_8612",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2113",
        "submitter_treatment_id": "TREATMENT_8613",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2114",
        "submitter_treatment_id": "TREATMENT_8614",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2115",
        "submitter_treatment_id": "TREATMENT_8615",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2116",
        "submitter_treatment_id": "TREATMENT_8616",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2117",
        "submitter_treatment_id": "TREATMENT_8617",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2118",
        "submitter_treatment_id": "TREATMENT_8618",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2119",
        "submitter_treatment_id": "TREATMENT_8619",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2120",
        "submitter_treatment_id": "TREATMENT_8620",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2121",
        "submitter_treatment_id": "TREATMENT_8621",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2122",
        "submitter_treatment_id": "TREATMENT_8622",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2123",
        "submitter_treatment_id": "TREATMENT_8623",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2124",
        "submitter_treatment_id": "TREATMENT_8624",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2125",
        "submitter_treatment_id": "TREATMENT_8625",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2126",
        "submitter_treatment_id": "TREATMENT_8626",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2127",
        "submitter_treatment_id": "TREATMENT_8627",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2128",
        "submitter_treatment_id": "TREATMENT_8628",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2129",
        "submitter_treatment_id": "TREATMENT_8629",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2130",
        "submitter_treatment_id": "TREATMENT_8630",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2131",
        "submitter_treatment_id": "TREATMENT_8631",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2132",
        "submitter_treatment_id": "TREATMENT_8632",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2133",
        "submitter_treatment_id": "TREATMENT_8633",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2134",
        "submitter_treatment_id": "TREATMENT_8634",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2135",
        "submitter_treatment_id": "TREATMENT_8635",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2136",
        "submitter_treatment_id": "TREATMENT_8636",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2137",
        "submitter_treatment_id": "TREATMENT_8637",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2138",
        "submitter_treatment_id": "TREATMENT_8638",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2139",
        "submitter_treatment_id": "TREATMENT_8639",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2140",
        "submitter_treatment_id": "TREATMENT_8640",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2141",
        "submitter_treatment_id": "TREATMENT_8641",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2142",
        "submitter_treatment_id": "TREATMENT_8642",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2143",
        "submitter_treatment_id": "TREATMENT_8643",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2144",
        "submitter_treatment_id": "TREATMENT_8644",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2145",
        "submitter_treatment_id": "TREATMENT_8645",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2146",
        "submitter_treatment_id": "TREATMENT_8646",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2147",
        "submitter_treatment_id": "TREATMENT_8647",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2148",
        "submitter_treatment_id": "TREATMENT_8648",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2149",
        "submitter_treatment_id": "TREATMENT_8649",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2150",
        "submitter_treatment_id": "TREATMENT_8650",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2151",
        "submitter_treatment_id": "TREATMENT_8651",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2152",
        "submitter_treatment_id": "TREATMENT_8652",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2153",
        "submitter_treatment_id": "TREATMENT_8653",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2154",
        "submitter_treatment_id": "TREATMENT_8654",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2155",
        "submitter_treatment_id": "TREATMENT_8655",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2156",
        "submitter_treatment_id": "TREATMENT_8656",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2157",
        "submitter_treatment_id": "TREATMENT_8657",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2158",
        "submitter_treatment_id": "TREATMENT_8658",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2159",
        "submitter_treatment_id": "TREATMENT_8659",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2160",
        "submitter_treatment_id": "TREATMENT_8660",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2161",
        "submitter_treatment_id": "TREATMENT_8661",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2162",
        "submitter_treatment_id": "TREATMENT_8662",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2163",
        "submitter_treatment_id": "TREATMENT_8663",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2164",
        "submitter_treatment_id": "TREATMENT_8664",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2165",
        "submitter_treatment_id": "TREATMENT_8665",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2166",
        "submitter_treatment_id": "TREATMENT_8666",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2167",
        "submitter_treatment_id": "TREATMENT_8667",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2168",
        "submitter_treatment_id": "TREATMENT_8668",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2169",
        "submitter_treatment_id": "TREATMENT_8669",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2170",
        "submitter_treatment_id": "TREATMENT_8670",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2171",
        "submitter_treatment_id": "TREATMENT_8671",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2172",
        "submitter_treatment_id": "TREATMENT_8672",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2173",
        "submitter_treatment_id": "TREATMENT_8673",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2174",
        "submitter_treatment_id": "TREATMENT_8674",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2175",
        "submitter_treatment_id": "TREATMENT_8675",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2176",
        "submitter_treatment_id": "TREATMENT_8676",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2177",
        "submitter_treatment_id": "TREATMENT_8677",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2178",
        "submitter_treatment_id": "TREATMENT_8678",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2179",
        "submitter_treatment_id": "TREATMENT_8679",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2180",
        "submitter_treatment_id": "TREATMENT_8680",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2181",
        "submitter_treatment_id": "TREATMENT_8681",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2182",
        "submitter_treatment_id": "TREATMENT_8682",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2183",
        "submitter_treatment_id": "TREATMENT_8683",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2184",
        "submitter_treatment_id": "TREATMENT_8684",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2185",
        "submitter_treatment_id": "TREATMENT_8685",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2186",
        "submitter_treatment_id": "TREATMENT_8686",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2187",
        "submitter_treatment_id": "TREATMENT_8687",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2188",
        "submitter_treatment_id": "TREATMENT_8688",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2189",
        "submitter_treatment_id": "TREATMENT_8689",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2190",
        "submitter_treatment_id": "TREATMENT_8690",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2191",
        "submitter_treatment_id": "TREATMENT_8691",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2192",
        "submitter_treatment_id": "TREATMENT_8692",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2193",
        "submitter_treatment_id": "TREATMENT_8693",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2194",
        "submitter_treatment_id": "TREATMENT_8694",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2195",
        "submitter_treatment_id": "TREATMENT_8695",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2196",
        "submitter_treatment_id": "TREATMENT_8696",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2197",
        "submitter_treatment_id": "TREATMENT_8697",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2198",
        "submitter_treatment_id": "TREATMENT_8698",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2199",
        "submitter_treatment_id": "TREATMENT_8699",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2200",
        "submitter_treatment_id": "TREATMENT_8700",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2201",
        "submitter_treatment_id": "TREATMENT_8701",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2202",
        "submitter_treatment_id": "TREATMENT_8702",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2203",
        "submitter_treatment_id": "TREATMENT_8703",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2204",
        "submitter_treatment_id": "TREATMENT_8704",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2205",
        "submitter_treatment_id": "TREATMENT_8705",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2206",
        "submitter_treatment_id": "TREATMENT_8706",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2207",
        "submitter_treatment_id": "TREATMENT_8707",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2208",
        "submitter_treatment_id": "TREATMENT_8708",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2209",
        "submitter_treatment_id": "TREATMENT_8709",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2210",
        "submitter_treatment_id": "TREATMENT_8710",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2211",
        "submitter_treatment_id": "TREATMENT_8711",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2212",
        "submitter_treatment_id": "TREATMENT_8712",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2213",
        "submitter_treatment_id": "TREATMENT_8713",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2214",
        "submitter_treatment_id": "TREATMENT_8714",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2215",
        "submitter_treatment_id": "TREATMENT_8715",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2216",
        "submitter_treatment_id": "TREATMENT_8716",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2217",
        "submitter_treatment_id": "TREATMENT_8717",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2218",
        "submitter_treatment_id": "TREATMENT_8718",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2219",
        "submitter_treatment_id": "TREATMENT_8719",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2220",
        "submitter_treatment_id": "TREATMENT_8720",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2221",
        "submitter_treatment_id": "TREATMENT_8721",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2222",
        "submitter_treatment_id": "TREATMENT_8722",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2223",
        "submitter_treatment_id": "TREATMENT_8723",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2224",
        "submitter_treatment_id": "TREATMENT_8724",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2225",
        "submitter_treatment_id": "TREATMENT_8725",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2226",
        "submitter_treatment_id": "TREATMENT_8726",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2227",
        "submitter_treatment_id": "TREATMENT_8727",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2228",
        "submitter_treatment_id": "TREATMENT_8728",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2229",
        "submitter_treatment_id": "TREATMENT_8729",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2230",
        "submitter_treatment_id": "TREATMENT_8730",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2231",
        "submitter_treatment_id": "TREATMENT_8731",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2232",
        "submitter_treatment_id": "TREATMENT_8732",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2233",
        "submitter_treatment_id": "TREATMENT_8733",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2234",
        "submitter_treatment_id": "TREATMENT_8734",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2235",
        "submitter_treatment_id": "TREATMENT_8735",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2236",
        "submitter_treatment_id": "TREATMENT_8736",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2237",
        "submitter_treatment_id": "TREATMENT_8737",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2238",
        "submitter_treatment_id": "TREATMENT_8738",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2239",
        "submitter_treatment_id": "TREATMENT_8739",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2240",
        "submitter_treatment_id": "TREATMENT_8740",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2241",
        "submitter_treatment_id": "TREATMENT_8741",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2242",
        "submitter_treatment_id": "TREATMENT_8742",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2243",
        "submitter_treatment_id": "TREATMENT_8743",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2244",
        "submitter_treatment_id": "TREATMENT_8744",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2245",
        "submitter_treatment_id": "TREATMENT_8745",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2246",
        "submitter_treatment_id": "TREATMENT_8746",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2247",
        "submitter_treatment_id": "TREATMENT_8747",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2248",
        "submitter_treatment_id": "TREATMENT_8748",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2249",
        "submitter_treatment_id": "TREATMENT_8749",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2250",
        "submitter_treatment_id": "TREATMENT_8750",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2251",
        "submitter_treatment_id": "TREATMENT_8751",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2252",
        "submitter_treatment_id": "TREATMENT_8752",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2253",
        "submitter_treatment_id": "TREATMENT_8753",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2254",
        "submitter_treatment_id": "TREATMENT_8754",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2255",
        "submitter_treatment_id": "TREATMENT_8755",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2256",
        "submitter_treatment_id": "TREATMENT_8756",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2257",
        "submitter_treatment_id": "TREATMENT_8757",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2258",
        "submitter_treatment_id": "TREATMENT_8758",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2259",
        "submitter_treatment_id": "TREATMENT_8759",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2260",
        "submitter_treatment_id": "TREATMENT_8760",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2261",
        "submitter_treatment_id": "TREATMENT_8761",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2262",
        "submitter_treatment_id": "TREATMENT_8762",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2263",
        "submitter_treatment_id": "TREATMENT_8763",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2264",
        "submitter_treatment_id": "TREATMENT_8764",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2265",
        "submitter_treatment_id": "TREATMENT_8765",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2266",
        "submitter_treatment_id": "TREATMENT_8766",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2267",
        "submitter_treatment_id": "TREATMENT_8767",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2268",
        "submitter_treatment_id": "TREATMENT_8768",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2269",
        "submitter_treatment_id": "TREATMENT_8769",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2270",
        "submitter_treatment_id": "TREATMENT_8770",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2271",
        "submitter_treatment_id": "TREATMENT_8771",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2272",
        "submitter_treatment_id": "TREATMENT_8772",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2273",
        "submitter_treatment_id": "TREATMENT_8773",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2274",
        "submitter_treatment_id": "TREATMENT_8774",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2275",
        "submitter_treatment_id": "TREATMENT_8775",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2276",
        "submitter_treatment_id": "TREATMENT_8776",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2277",
        "submitter_treatment_id": "TREATMENT_8777",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2278",
        "submitter_treatment_id": "TREATMENT_8778",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2279",
        "submitter_treatment_id": "TREATMENT_8779",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2280",
        "submitter_treatment_id": "TREATMENT_8780",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2281",
        "submitter_treatment_id": "TREATMENT_8781",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2282",
        "submitter_treatment_id": "TREATMENT_8782",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2283",
        "submitter_treatment_id": "TREATMENT_8783",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2284",
        "submitter_treatment_id": "TREATMENT_8784",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2285",
        "submitter_treatment_id": "TREATMENT_8785",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2286",
        "submitter_treatment_id": "TREATMENT_8786",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2287",
        "submitter_treatment_id": "TREATMENT_8787",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2288",
        "submitter_treatment_id": "TREATMENT_8788",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2289",
        "submitter_treatment_id": "TREATMENT_8789",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2290",
        "submitter_treatment_id": "TREATMENT_8790",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2291",
        "submitter_treatment_id": "TREATMENT_8791",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2292",
        "submitter_treatment_id": "TREATMENT_8792",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2293",
        "submitter_treatment_id": "TREATMENT_8793",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2294",
        "submitter_treatment_id": "TREATMENT_8794",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2295",
        "submitter_treatment_id": "TREATMENT_8795",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2296",
        "submitter_treatment_id": "TREATMENT_8796",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2297",
        "submitter_treatment_id": "TREATMENT_8797",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2298",
        "submitter_treatment_id": "TREATMENT_8798",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2299",
        "submitter_treatment_id": "TREATMENT_8799",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2300",
        "submitter_treatment_id": "TREATMENT_8800",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2301",
        "submitter_treatment_id": "TREATMENT_8801",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2302",
        "submitter_treatment_id": "TREATMENT_8802",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2303",
        "submitter_treatment_id": "TREATMENT_8803",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2304",
        "submitter_treatment_id": "TREATMENT_8804",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2305",
        "submitter_treatment_id": "TREATMENT_8805",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2306",
        "submitter_treatment_id": "TREATMENT_8806",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2307",
        "submitter_treatment_id": "TREATMENT_8807",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2308",
        "submitter_treatment_id": "TREATMENT_8808",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2309",
        "submitter_treatment_id": "TREATMENT_8809",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2310",
        "submitter_treatment_id": "TREATMENT_8810",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2311",
        "submitter_treatment_id": "TREATMENT_8811",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2312",
        "submitter_treatment_id": "TREATMENT_8812",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2313",
        "submitter_treatment_id": "TREATMENT_8813",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2314",
        "submitter_treatment_id": "TREATMENT_8814",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2315",
        "submitter_treatment_id": "TREATMENT_8815",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2316",
        "submitter_treatment_id": "TREATMENT_8816",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2317",
        "submitter_treatment_id": "TREATMENT_8817",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2318",
        "submitter_treatment_id": "TREATMENT_8818",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2319",
        "submitter_treatment_id": "TREATMENT_8819",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2320",
        "submitter_treatment_id": "TREATMENT_8820",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2321",
        "submitter_treatment_id": "TREATMENT_8821",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2322",
        "submitter_treatment_id": "TREATMENT_8822",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2323",
        "submitter_treatment_id": "TREATMENT_8823",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2324",
        "submitter_treatment_id": "TREATMENT_8824",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2325",
        "submitter_treatment_id": "TREATMENT_8825",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2326",
        "submitter_treatment_id": "TREATMENT_8826",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2327",
        "submitter_treatment_id": "TREATMENT_8827",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2328",
        "submitter_treatment_id": "TREATMENT_8828",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2329",
        "submitter_treatment_id": "TREATMENT_8829",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2330",
        "submitter_treatment_id": "TREATMENT_8830",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2331",
        "submitter_treatment_id": "TREATMENT_8831",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2332",
        "submitter_treatment_id": "TREATMENT_8832",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2333",
        "submitter_treatment_id": "TREATMENT_8833",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2334",
        "submitter_treatment_id": "TREATMENT_8834",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2335",
        "submitter_treatment_id": "TREATMENT_8835",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2336",
        "submitter_treatment_id": "TREATMENT_8836",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2337",
        "submitter_treatment_id": "TREATMENT_8837",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2338",
        "submitter_treatment_id": "TREATMENT_8838",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2339",
        "submitter_treatment_id": "TREATMENT_8839",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2340",
        "submitter_treatment_id": "TREATMENT_8840",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2341",
        "submitter_treatment_id": "TREATMENT_8841",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2342",
        "submitter_treatment_id": "TREATMENT_8842",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2343",
        "submitter_treatment_id": "TREATMENT_8843",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2344",
        "submitter_treatment_id": "TREATMENT_8844",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2345",
        "submitter_treatment_id": "TREATMENT_8845",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2346",
        "submitter_treatment_id": "TREATMENT_8846",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2347",
        "submitter_treatment_id": "TREATMENT_8847",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2348",
        "submitter_treatment_id": "TREATMENT_8848",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2349",
        "submitter_treatment_id": "TREATMENT_8849",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2350",
        "submitter_treatment_id": "TREATMENT_8850",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2351",
        "submitter_treatment_id": "TREATMENT_8851",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2352",
        "submitter_treatment_id": "TREATMENT_8852",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2353",
        "submitter_treatment_id": "TREATMENT_8853",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2354",
        "submitter_treatment_id": "TREATMENT_8854",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2355",
        "submitter_treatment_id": "TREATMENT_8855",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2356",
        "submitter_treatment_id": "TREATMENT_8856",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2357",
        "submitter_treatment_id": "TREATMENT_8857",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2358",
        "submitter_treatment_id": "TREATMENT_8858",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2359",
        "submitter_treatment_id": "TREATMENT_8859",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2360",
        "submitter_treatment_id": "TREATMENT_8860",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2361",
        "submitter_treatment_id": "TREATMENT_8861",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2362",
        "submitter_treatment_id": "TREATMENT_8862",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2363",
        "submitter_treatment_id": "TREATMENT_8863",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2364",
        "submitter_treatment_id": "TREATMENT_8864",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2365",
        "submitter_treatment_id": "TREATMENT_8865",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2366",
        "submitter_treatment_id": "TREATMENT_8866",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2367",
        "submitter_treatment_id": "TREATMENT_8867",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2368",
        "submitter_treatment_id": "TREATMENT_8868",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2369",
        "submitter_treatment_id": "TREATMENT_8869",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2370",
        "submitter_treatment_id": "TREATMENT_8870",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2371",
        "submitter_treatment_id": "TREATMENT_8871",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2372",
        "submitter_treatment_id": "TREATMENT_8872",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2373",
        "submitter_treatment_id": "TREATMENT_8873",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2374",
        "submitter_treatment_id": "TREATMENT_8874",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2375",
        "submitter_treatment_id": "TREATMENT_8875",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2376",
        "submitter_treatment_id": "TREATMENT_8876",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2377",
        "submitter_treatment_id": "TREATMENT_8877",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2378",
        "submitter_treatment_id": "TREATMENT_8878",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2379",
        "submitter_treatment_id": "TREATMENT_8879",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2380",
        "submitter_treatment_id": "TREATMENT_8880",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2381",
        "submitter_treatment_id": "TREATMENT_8881",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2382",
        "submitter_treatment_id": "TREATMENT_8882",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2383",
        "submitter_treatment_id": "TREATMENT_8883",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2384",
        "submitter_treatment_id": "TREATMENT_8884",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2385",
        "submitter_treatment_id": "TREATMENT_8885",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2386",
        "submitter_treatment_id": "TREATMENT_8886",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2387",
        "submitter_treatment_id": "TREATMENT_8887",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2388",
        "submitter_treatment_id": "TREATMENT_8888",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2389",
        "submitter_treatment_id": "TREATMENT_8889",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2390",
        "submitter_treatment_id": "TREATMENT_8890",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2391",
        "submitter_treatment_id": "TREATMENT_8891",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2392",
        "submitter_treatment_id": "TREATMENT_8892",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2393",
        "submitter_treatment_id": "TREATMENT_8893",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2394",
        "submitter_treatment_id": "TREATMENT_8894",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2395",
        "submitter_treatment_id": "TREATMENT_8895",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2396",
        "submitter_treatment_id": "TREATMENT_8896",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2397",
        "submitter_treatment_id": "TREATMENT_8897",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2398",
        "submitter_treatment_id": "TREATMENT_8898",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2399",
        "submitter_treatment_id": "TREATMENT_8899",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2400",
        "submitter_treatment_id": "TREATMENT_8900",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2401",
        "submitter_treatment_id": "TREATMENT_8901",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2402",
        "submitter_treatment_id": "TREATMENT_8902",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2403",
        "submitter_treatment_id": "TREATMENT_8903",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2404",
        "submitter_treatment_id": "TREATMENT_8904",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2405",
        "submitter_treatment_id": "TREATMENT_8905",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2406",
        "submitter_treatment_id": "TREATMENT_8906",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2407",
        "submitter_treatment_id": "TREATMENT_8907",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2408",
        "submitter_treatment_id": "TREATMENT_8908",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2409",
        "submitter_treatment_id": "TREATMENT_8909",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2410",
        "submitter_treatment_id": "TREATMENT_8910",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2411",
        "submitter_treatment_id": "TREATMENT_8911",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2412",
        "submitter_treatment_id": "TREATMENT_8912",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2413",
        "submitter_treatment_id": "TREATMENT_8913",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2414",
        "submitter_treatment_id": "TREATMENT_8914",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2415",
        "submitter_treatment_id": "TREATMENT_8915",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2416",
        "submitter_treatment_id": "TREATMENT_8916",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2417",
        "submitter_treatment_id": "TREATMENT_8917",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2418",
        "submitter_treatment_id": "TREATMENT_8918",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2419",
        "submitter_treatment_id": "TREATMENT_8919",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2420",
        "submitter_treatment_id": "TREATMENT_8920",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2421",
        "submitter_treatment_id": "TREATMENT_8921",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2422",
        "submitter_treatment_id": "TREATMENT_8922",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2423",
        "submitter_treatment_id": "TREATMENT_8923",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2424",
        "submitter_treatment_id": "TREATMENT_8924",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2425",
        "submitter_treatment_id": "TREATMENT_8925",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2426",
        "submitter_treatment_id": "TREATMENT_8926",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2427",
        "submitter_treatment_id": "TREATMENT_8927",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2428",
        "submitter_treatment_id": "TREATMENT_8928",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2429",
        "submitter_treatment_id": "TREATMENT_8929",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2430",
        "submitter_treatment_id": "TREATMENT_8930",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2431",
        "submitter_treatment_id": "TREATMENT_8931",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2432",
        "submitter_treatment_id": "TREATMENT_8932",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2433",
        "submitter_treatment_id": "TREATMENT_8933",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2434",
        "submitter_treatment_id": "TREATMENT_8934",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2435",
        "submitter_treatment_id": "TREATMENT_8935",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2436",
        "submitter_treatment_id": "TREATMENT_8936",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2437",
        "submitter_treatment_id": "TREATMENT_8937",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2438",
        "submitter_treatment_id": "TREATMENT_8938",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2439",
        "submitter_treatment_id": "TREATMENT_8939",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2440",
        "submitter_treatment_id": "TREATMENT_8940",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2441",
        "submitter_treatment_id": "TREATMENT_8941",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2442",
        "submitter_treatment_id": "TREATMENT_8942",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2443",
        "submitter_treatment_id": "TREATMENT_8943",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2444",
        "submitter_treatment_id": "TREATMENT_8944",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2445",
        "submitter_treatment_id": "TREATMENT_8945",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2446",
        "submitter_treatment_id": "TREATMENT_8946",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2447",
        "submitter_treatment_id": "TREATMENT_8947",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2448",
        "submitter_treatment_id": "TREATMENT_8948",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2449",
        "submitter_treatment_id": "TREATMENT_8949",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2450",
        "submitter_treatment_id": "TREATMENT_8950",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2451",
        "submitter_treatment_id": "TREATMENT_8951",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2452",
        "submitter_treatment_id": "TREATMENT_8952",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2453",
        "submitter_treatment_id": "TREATMENT_8953",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2454",
        "submitter_treatment_id": "TREATMENT_8954",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2455",
        "submitter_treatment_id": "TREATMENT_8955",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2456",
        "submitter_treatment_id": "TREATMENT_8956",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2457",
        "submitter_treatment_id": "TREATMENT_8957",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2458",
        "submitter_treatment_id": "TREATMENT_8958",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2459",
        "submitter_treatment_id": "TREATMENT_8959",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2460",
        "submitter_treatment_id": "TREATMENT_8960",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2461",
        "submitter_treatment_id": "TREATMENT_8961",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2462",
        "submitter_treatment_id": "TREATMENT_8962",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2463",
        "submitter_treatment_id": "TREATMENT_8963",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2464",
        "submitter_treatment_id": "TREATMENT_8964",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2465",
        "submitter_treatment_id": "TREATMENT_8965",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2466",
        "submitter_treatment_id": "TREATMENT_8966",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2467",
        "submitter_treatment_id": "TREATMENT_8967",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2468",
        "submitter_treatment_id": "TREATMENT_8968",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2469",
        "submitter_treatment_id": "TREATMENT_8969",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2470",
        "submitter_treatment_id": "TREATMENT_8970",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2471",
        "submitter_treatment_id": "TREATMENT_8971",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2472",
        "submitter_treatment_id": "TREATMENT_8972",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2473",
        "submitter_treatment_id": "TREATMENT_8973",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2474",
        "submitter_treatment_id": "TREATMENT_8974",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2475",
        "submitter_treatment_id": "TREATMENT_8975",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2476",
        "submitter_treatment_id": "TREATMENT_8976",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2477",
        "submitter_treatment_id": "TREATMENT_8977",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2478",
        "submitter_treatment_id": "TREATMENT_8978",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2479",
        "submitter_treatment_id": "TREATMENT_8979",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2480",
        "submitter_treatment_id": "TREATMENT_8980",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2481",
        "submitter_treatment_id": "TREATMENT_8981",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2482",
        "submitter_treatment_id": "TREATMENT_8982",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2483",
        "submitter_treatment_id": "TREATMENT_8983",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2484",
        "submitter_treatment_id": "TREATMENT_8984",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2485",
        "submitter_treatment_id": "TREATMENT_8985",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2486",
        "submitter_treatment_id": "TREATMENT_8986",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2487",
        "submitter_treatment_id": "TREATMENT_8987",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2488",
        "submitter_treatment_id": "TREATMENT_8988",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2489",
        "submitter_treatment_id": "TREATMENT_8989",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2490",
        "submitter_treatment_id": "TREATMENT_8990",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2491",
        "submitter_treatment_id": "TREATMENT_8991",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2492",
        "submitter_treatment_id": "TREATMENT_8992",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2493",
        "submitter_treatment_id": "TREATMENT_8993",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2494",
        "submitter_treatment_id": "TREATMENT_8994",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2495",
        "submitter_treatment_id": "TREATMENT_8995",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2496",
        "submitter_treatment_id": "TREATMENT_8996",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2497",
        "submitter_treatment_id": "TREATMENT_8997",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2498",
        "submitter_treatment_id": "TREATMENT_8998",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2499",
        "submitter_treatment_id": "TREATMENT_8999",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2500",
        "submitter_treatment_id": "TREATMENT_9000",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2001",
        "submitter_treatment_id": "TREATMENT_9001",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2002",
        "submitter_treatment_id": "TREATMENT_9002",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2003",
        "submitter_treatment_id": "TREATMENT_9003",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2004",
        "submitter_treatment_id": "TREATMENT_9004",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2005",
        "submitter_treatment_id": "TREATMENT_9005",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2006",
        "submitter_treatment_id": "TREATMENT_9006",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2007",
        "submitter_treatment_id": "TREATMENT_9007",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2008",
        "submitter_treatment_id": "TREATMENT_9008",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2009",
        "submitter_treatment_id": "TREATMENT_9009",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2010",
        "submitter_treatment_id": "TREATMENT_9010",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2011",
        "submitter_treatment_id": "TREATMENT_9011",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2012",
        "submitter_treatment_id": "TREATMENT_9012",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2013",
        "submitter_treatment_id": "TREATMENT_9013",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2014",
        "submitter_treatment_id": "TREATMENT_9014",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2015",
        "submitter_treatment_id": "TREATMENT_9015",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2016",
        "submitter_treatment_id": "TREATMENT_9016",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2017",
        "submitter_treatment_id": "TREATMENT_9017",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2018",
        "submitter_treatment_id": "TREATMENT_9018",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2019",
        "submitter_treatment_id": "TREATMENT_9019",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2020",
        "submitter_treatment_id": "TREATMENT_9020",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2021",
        "submitter_treatment_id": "TREATMENT_9021",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2022",
        "submitter_treatment_id": "TREATMENT_9022",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2023",
        "submitter_treatment_id": "TREATMENT_9023",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2024",
        "submitter_treatment_id": "TREATMENT_9024",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2025",
        "submitter_treatment_id": "TREATMENT_9025",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2026",
        "submitter_treatment_id": "TREATMENT_9026",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2027",
        "submitter_treatment_id": "TREATMENT_9027",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2028",
        "submitter_treatment_id": "TREATMENT_9028",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2029",
        "submitter_treatment_id": "TREATMENT_9029",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2030",
        "submitter_treatment_id": "TREATMENT_9030",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2031",
        "submitter_treatment_id": "TREATMENT_9031",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2032",
        "submitter_treatment_id": "TREATMENT_9032",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2033",
        "submitter_treatment_id": "TREATMENT_9033",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2034",
        "submitter_treatment_id": "TREATMENT_9034",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2035",
        "submitter_treatment_id": "TREATMENT_9035",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2036",
        "submitter_treatment_id": "TREATMENT_9036",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2037",
        "submitter_treatment_id": "TREATMENT_9037",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2038",
        "submitter_treatment_id": "TREATMENT_9038",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2039",
        "submitter_treatment_id": "TREATMENT_9039",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2040",
        "submitter_treatment_id": "TREATMENT_9040",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2041",
        "submitter_treatment_id": "TREATMENT_9041",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2042",
        "submitter_treatment_id": "TREATMENT_9042",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2043",
        "submitter_treatment_id": "TREATMENT_9043",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2044",
        "submitter_treatment_id": "TREATMENT_9044",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2045",
        "submitter_treatment_id": "TREATMENT_9045",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2046",
        "submitter_treatment_id": "TREATMENT_9046",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2047",
        "submitter_treatment_id": "TREATMENT_9047",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2048",
        "submitter_treatment_id": "TREATMENT_9048",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2049",
        "submitter_treatment_id": "TREATMENT_9049",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2050",
        "submitter_treatment_id": "TREATMENT_9050",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2051",
        "submitter_treatment_id": "TREATMENT_9051",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2052",
        "submitter_treatment_id": "TREATMENT_9052",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2053",
        "submitter_treatment_id": "TREATMENT_9053",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2054",
        "submitter_treatment_id": "TREATMENT_9054",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2055",
        "submitter_treatment_id": "TREATMENT_9055",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2056",
        "submitter_treatment_id": "TREATMENT_9056",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2057",
        "submitter_treatment_id": "TREATMENT_9057",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2058",
        "submitter_treatment_id": "TREATMENT_9058",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2059",
        "submitter_treatment_id": "TREATMENT_9059",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2060",
        "submitter_treatment_id": "TREATMENT_9060",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2061",
        "submitter_treatment_id": "TREATMENT_9061",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2062",
        "submitter_treatment_id": "TREATMENT_9062",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2063",
        "submitter_treatment_id": "TREATMENT_9063",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2064",
        "submitter_treatment_id": "TREATMENT_9064",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2065",
        "submitter_treatment_id": "TREATMENT_9065",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2066",
        "submitter_treatment_id": "TREATMENT_9066",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2067",
        "submitter_treatment_id": "TREATMENT_9067",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2068",
        "submitter_treatment_id": "TREATMENT_9068",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2069",
        "submitter_treatment_id": "TREATMENT_9069",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2070",
        "submitter_treatment_id": "TREATMENT_9070",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2071",
        "submitter_treatment_id": "TREATMENT_9071",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2072",
        "submitter_treatment_id": "TREATMENT_9072",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2073",
        "submitter_treatment_id": "TREATMENT_9073",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2074",
        "submitter_treatment_id": "TREATMENT_9074",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2075",
        "submitter_treatment_id": "TREATMENT_9075",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2076",
        "submitter_treatment_id": "TREATMENT_9076",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2077",
        "submitter_treatment_id": "TREATMENT_9077",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2078",
        "submitter_treatment_id": "TREATMENT_9078",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2079",
        "submitter_treatment_id": "TREATMENT_9079",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2080",
        "submitter_treatment_id": "TREATMENT_9080",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2081",
        "submitter_treatment_id": "TREATMENT_9081",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2082",
        "submitter_treatment_id": "TREATMENT_9082",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2083",
        "submitter_treatment_id": "TREATMENT_9083",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2084",
        "submitter_treatment_id": "TREATMENT_9084",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2085",
        "submitter_treatment_id": "TREATMENT_9085",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2086",
        "submitter_treatment_id": "TREATMENT_9086",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2087",
        "submitter_treatment_id": "TREATMENT_9087",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2088",
        "submitter_treatment_id": "TREATMENT_9088",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2089",
        "submitter_treatment_id": "TREATMENT_9089",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2090",
        "submitter_treatment_id": "TREATMENT_9090",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2091",
        "submitter_treatment_id": "TREATMENT_9091",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2092",
        "submitter_treatment_id": "TREATMENT_9092",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2093",
        "submitter_treatment_id": "TREATMENT_9093",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2094",
        "submitter_treatment_id": "TREATMENT_9094",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2095",
        "submitter_treatment_id": "TREATMENT_9095",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2096",
        "submitter_treatment_id": "TREATMENT_9096",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2097",
        "submitter_treatment_id": "TREATMENT_9097",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2098",
        "submitter_treatment_id": "TREATMENT_9098",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2099",
        "submitter_treatment_id": "TREATMENT_9099",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2100",
        "submitter_treatment_id": "TREATMENT_9100",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2101",
        "submitter_treatment_id": "TREATMENT_9101",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2102",
        "submitter_treatment_id": "TREATMENT_9102",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2103",
        "submitter_treatment_id": "TREATMENT_9103",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2104",
        "submitter_treatment_id": "TREATMENT_9104",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2105",
        "submitter_treatment_id": "TREATMENT_9105",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2106",
        "submitter_treatment_id": "TREATMENT_9106",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2107",
        "submitter_treatment_id": "TREATMENT_9107",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2108",
        "submitter_treatment_id": "TREATMENT_9108",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2109",
        "submitter_treatment_id": "TREATMENT_9109",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2110",
        "submitter_treatment_id": "TREATMENT_9110",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2111",
        "submitter_treatment_id": "TREATMENT_9111",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2112",
        "submitter_treatment_id": "TREATMENT_9112",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2113",
        "submitter_treatment_id": "TREATMENT_9113",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2114",
        "submitter_treatment_id": "TREATMENT_9114",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2115",
        "submitter_treatment_id": "TREATMENT_9115",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2116",
        "submitter_treatment_id": "TREATMENT_9116",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2117",
        "submitter_treatment_id": "TREATMENT_9117",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2118",
        "submitter_treatment_id": "TREATMENT_9118",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2119",
        "submitter_treatment_id": "TREATMENT_9119",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2120",
        "submitter_treatment_id": "TREATMENT_9120",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2121",
        "submitter_treatment_id": "TREATMENT_9121",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2122",
        "submitter_treatment_id": "TREATMENT_9122",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2123",
        "submitter_treatment_id": "TREATMENT_9123",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2124",
        "submitter_treatment_id": "TREATMENT_9124",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2125",
        "submitter_treatment_id": "TREATMENT_9125",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2126",
        "submitter_treatment_id": "TREATMENT_9126",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2127",
        "submitter_treatment_id": "TREATMENT_9127",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2128",
        "submitter_treatment_id": "TREATMENT_9128",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2129",
        "submitter_treatment_id": "TREATMENT_9129",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2130",
        "submitter_treatment_id": "TREATMENT_9130",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2131",
        "submitter_treatment_id": "TREATMENT_9131",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2132",
        "submitter_treatment_id": "TREATMENT_9132",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2133",
        "submitter_treatment_id": "TREATMENT_9133",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2134",
        "submitter_treatment_id": "TREATMENT_9134",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2135",
        "submitter_treatment_id": "TREATMENT_9135",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2136",
        "submitter_treatment_id": "TREATMENT_9136",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2137",
        "submitter_treatment_id": "TREATMENT_9137",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2138",
        "submitter_treatment_id": "TREATMENT_9138",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2139",
        "submitter_treatment_id": "TREATMENT_9139",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2140",
        "submitter_treatment_id": "TREATMENT_9140",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2141",
        "submitter_treatment_id": "TREATMENT_9141",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2142",
        "submitter_treatment_id": "TREATMENT_9142",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2143",
        "submitter_treatment_id": "TREATMENT_9143",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2144",
        "submitter_treatment_id": "TREATMENT_9144",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2145",
        "submitter_treatment_id": "TREATMENT_9145",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2146",
        "submitter_treatment_id": "TREATMENT_9146",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2147",
        "submitter_treatment_id": "TREATMENT_9147",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2148",
        "submitter_treatment_id": "TREATMENT_9148",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2149",
        "submitter_treatment_id": "TREATMENT_9149",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2150",
        "submitter_treatment_id": "TREATMENT_9150",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2151",
        "submitter_treatment_id": "TREATMENT_9151",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2152",
        "submitter_treatment_id": "TREATMENT_9152",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2153",
        "submitter_treatment_id": "TREATMENT_9153",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2154",
        "submitter_treatment_id": "TREATMENT_9154",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2155",
        "submitter_treatment_id": "TREATMENT_9155",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2156",
        "submitter_treatment_id": "TREATMENT_9156",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2157",
        "submitter_treatment_id": "TREATMENT_9157",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2158",
        "submitter_treatment_id": "TREATMENT_9158",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2159",
        "submitter_treatment_id": "TREATMENT_9159",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2160",
        "submitter_treatment_id": "TREATMENT_9160",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2161",
        "submitter_treatment_id": "TREATMENT_9161",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2162",
        "submitter_treatment_id": "TREATMENT_9162",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2163",
        "submitter_treatment_id": "TREATMENT_9163",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2164",
        "submitter_treatment_id": "TREATMENT_9164",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2165",
        "submitter_treatment_id": "TREATMENT_9165",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2166",
        "submitter_treatment_id": "TREATMENT_9166",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2167",
        "submitter_treatment_id": "TREATMENT_9167",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2168",
        "submitter_treatment_id": "TREATMENT_9168",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2169",
        "submitter_treatment_id": "TREATMENT_9169",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2170",
        "submitter_treatment_id": "TREATMENT_9170",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2171",
        "submitter_treatment_id": "TREATMENT_9171",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2172",
        "submitter_treatment_id": "TREATMENT_9172",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2173",
        "submitter_treatment_id": "TREATMENT_9173",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2174",
        "submitter_treatment_id": "TREATMENT_9174",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2175",
        "submitter_treatment_id": "TREATMENT_9175",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2176",
        "submitter_treatment_id": "TREATMENT_9176",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2177",
        "submitter_treatment_id": "TREATMENT_9177",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2178",
        "submitter_treatment_id": "TREATMENT_9178",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2179",
        "submitter_treatment_id": "TREATMENT_9179",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2180",
        "submitter_treatment_id": "TREATMENT_9180",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2181",
        "submitter_treatment_id": "TREATMENT_9181",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2182",
        "submitter_treatment_id": "TREATMENT_9182",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2183",
        "submitter_treatment_id": "TREATMENT_9183",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2184",
        "submitter_treatment_id": "TREATMENT_9184",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2185",
        "submitter_treatment_id": "TREATMENT_9185",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2186",
        "submitter_treatment_id": "TREATMENT_9186",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2187",
        "submitter_treatment_id": "TREATMENT_9187",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2188",
        "submitter_treatment_id": "TREATMENT_9188",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2189",
        "submitter_treatment_id": "TREATMENT_9189",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2190",
        "submitter_treatment_id": "TREATMENT_9190",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2191",
        "submitter_treatment_id": "TREATMENT_9191",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2192",
        "submitter_treatment_id": "TREATMENT_9192",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2193",
        "submitter_treatment_id": "TREATMENT_9193",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2194",
        "submitter_treatment_id": "TREATMENT_9194",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2195",
        "submitter_treatment_id": "TREATMENT_9195",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2196",
        "submitter_treatment_id": "TREATMENT_9196",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2197",
        "submitter_treatment_id": "TREATMENT_9197",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2198",
        "submitter_treatment_id": "TREATMENT_9198",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2199",
        "submitter_treatment_id": "TREATMENT_9199",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2200",
        "submitter_treatment_id": "TREATMENT_9200",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2201",
        "submitter_treatment_id": "TREATMENT_9201",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2202",
        "submitter_treatment_id": "TREATMENT_9202",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2203",
        "submitter_treatment_id": "TREATMENT_9203",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2204",
        "submitter_treatment_id": "TREATMENT_9204",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2205",
        "submitter_treatment_id": "TREATMENT_9205",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2206",
        "submitter_treatment_id": "TREATMENT_9206",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2207",
        "submitter_treatment_id": "TREATMENT_9207",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2208",
        "submitter_treatment_id": "TREATMENT_9208",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2209",
        "submitter_treatment_id": "TREATMENT_9209",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2210",
        "submitter_treatment_id": "TREATMENT_9210",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2211",
        "submitter_treatment_id": "TREATMENT_9211",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2212",
        "submitter_treatment_id": "TREATMENT_9212",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2213",
        "submitter_treatment_id": "TREATMENT_9213",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2214",
        "submitter_treatment_id": "TREATMENT_9214",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2215",
        "submitter_treatment_id": "TREATMENT_9215",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2216",
        "submitter_treatment_id": "TREATMENT_9216",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2217",
        "submitter_treatment_id": "TREATMENT_9217",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2218",
        "submitter_treatment_id": "TREATMENT_9218",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2219",
        "submitter_treatment_id": "TREATMENT_9219",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2220",
        "submitter_treatment_id": "TREATMENT_9220",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2221",
        "submitter_treatment_id": "TREATMENT_9221",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2222",
        "submitter_treatment_id": "TREATMENT_9222",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2223",
        "submitter_treatment_id": "TREATMENT_9223",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2224",
        "submitter_treatment_id": "TREATMENT_9224",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2225",
        "submitter_treatment_id": "TREATMENT_9225",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2226",
        "submitter_treatment_id": "TREATMENT_9226",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2227",
        "submitter_treatment_id": "TREATMENT_9227",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2228",
        "submitter_treatment_id": "TREATMENT_9228",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2229",
        "submitter_treatment_id": "TREATMENT_9229",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2230",
        "submitter_treatment_id": "TREATMENT_9230",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2231",
        "submitter_treatment_id": "TREATMENT_9231",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2232",
        "submitter_treatment_id": "TREATMENT_9232",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2233",
        "submitter_treatment_id": "TREATMENT_9233",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2234",
        "submitter_treatment_id": "TREATMENT_9234",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2235",
        "submitter_treatment_id": "TREATMENT_9235",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2236",
        "submitter_treatment_id": "TREATMENT_9236",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2237",
        "submitter_treatment_id": "TREATMENT_9237",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2238",
        "submitter_treatment_id": "TREATMENT_9238",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2239",
        "submitter_treatment_id": "TREATMENT_9239",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2240",
        "submitter_treatment_id": "TREATMENT_9240",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2241",
        "submitter_treatment_id": "TREATMENT_9241",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2242",
        "submitter_treatment_id": "TREATMENT_9242",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2243",
        "submitter_treatment_id": "TREATMENT_9243",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2244",
        "submitter_treatment_id": "TREATMENT_9244",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2245",
        "submitter_treatment_id": "TREATMENT_9245",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2246",
        "submitter_treatment_id": "TREATMENT_9246",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2247",
        "submitter_treatment_id": "TREATMENT_9247",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2248",
        "submitter_treatment_id": "TREATMENT_9248",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2249",
        "submitter_treatment_id": "TREATMENT_9249",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2250",
        "submitter_treatment_id": "TREATMENT_9250",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2251",
        "submitter_treatment_id": "TREATMENT_9251",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2252",
        "submitter_treatment_id": "TREATMENT_9252",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2253",
        "submitter_treatment_id": "TREATMENT_9253",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2254",
        "submitter_treatment_id": "TREATMENT_9254",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2255",
        "submitter_treatment_id": "TREATMENT_9255",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2256",
        "submitter_treatment_id": "TREATMENT_9256",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2257",
        "submitter_treatment_id": "TREATMENT_9257",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2258",
        "submitter_treatment_id": "TREATMENT_9258",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2259",
        "submitter_treatment_id": "TREATMENT_9259",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2260",
        "submitter_treatment_id": "TREATMENT_9260",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2261",
        "submitter_treatment_id": "TREATMENT_9261",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2262",
        "submitter_treatment_id": "TREATMENT_9262",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2263",
        "submitter_treatment_id": "TREATMENT_9263",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2264",
        "submitter_treatment_id": "TREATMENT_9264",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2265",
        "submitter_treatment_id": "TREATMENT_9265",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2266",
        "submitter_treatment_id": "TREATMENT_9266",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2267",
        "submitter_treatment_id": "TREATMENT_9267",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2268",
        "submitter_treatment_id": "TREATMENT_9268",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2269",
        "submitter_treatment_id": "TREATMENT_9269",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2270",
        "submitter_treatment_id": "TREATMENT_9270",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2271",
        "submitter_treatment_id": "TREATMENT_9271",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2272",
        "submitter_treatment_id": "TREATMENT_9272",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2273",
        "submitter_treatment_id": "TREATMENT_9273",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2274",
        "submitter_treatment_id": "TREATMENT_9274",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2275",
        "submitter_treatment_id": "TREATMENT_9275",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2276",
        "submitter_treatment_id": "TREATMENT_9276",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2277",
        "submitter_treatment_id": "TREATMENT_9277",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2278",
        "submitter_treatment_id": "TREATMENT_9278",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2279",
        "submitter_treatment_id": "TREATMENT_9279",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2280",
        "submitter_treatment_id": "TREATMENT_9280",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2281",
        "submitter_treatment_id": "TREATMENT_9281",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2282",
        "submitter_treatment_id": "TREATMENT_9282",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2283",
        "submitter_treatment_id": "TREATMENT_9283",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2284",
        "submitter_treatment_id": "TREATMENT_9284",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2285",
        "submitter_treatment_id": "TREATMENT_9285",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2286",
        "submitter_treatment_id": "TREATMENT_9286",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2287",
        "submitter_treatment_id": "TREATMENT_9287",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2288",
        "submitter_treatment_id": "TREATMENT_9288",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2289",
        "submitter_treatment_id": "TREATMENT_9289",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2290",
        "submitter_treatment_id": "TREATMENT_9290",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2291",
        "submitter_treatment_id": "TREATMENT_9291",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2292",
        "submitter_treatment_id": "TREATMENT_9292",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2293",
        "submitter_treatment_id": "TREATMENT_9293",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2294",
        "submitter_treatment_id": "TREATMENT_9294",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2295",
        "submitter_treatment_id": "TREATMENT_9295",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2296",
        "submitter_treatment_id": "TREATMENT_9296",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2297",
        "submitter_treatment_id": "TREATMENT_9297",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2298",
        "submitter_treatment_id": "TREATMENT_9298",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2299",
        "submitter_treatment_id": "TREATMENT_9299",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2300",
        "submitter_treatment_id": "TREATMENT_9300",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2301",
        "submitter_treatment_id": "TREATMENT_9301",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2302",
        "submitter_treatment_id": "TREATMENT_9302",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2303",
        "submitter_treatment_id": "TREATMENT_9303",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2304",
        "submitter_treatment_id": "TREATMENT_9304",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2305",
        "submitter_treatment_id": "TREATMENT_9305",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2306",
        "submitter_treatment_id": "TREATMENT_9306",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2307",
        "submitter_treatment_id": "TREATMENT_9307",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2308",
        "submitter_treatment_id": "TREATMENT_9308",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2309",
        "submitter_treatment_id": "TREATMENT_9309",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2310",
        "submitter_treatment_id": "TREATMENT_9310",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2311",
        "submitter_treatment_id": "TREATMENT_9311",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2312",
        "submitter_treatment_id": "TREATMENT_9312",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2313",
        "submitter_treatment_id": "TREATMENT_9313",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2314",
        "submitter_treatment_id": "TREATMENT_9314",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2315",
        "submitter_treatment_id": "TREATMENT_9315",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2316",
        "submitter_treatment_id": "TREATMENT_9316",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2317",
        "submitter_treatment_id": "TREATMENT_9317",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2318",
        "submitter_treatment_id": "TREATMENT_9318",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2319",
        "submitter_treatment_id": "TREATMENT_9319",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2320",
        "submitter_treatment_id": "TREATMENT_9320",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2321",
        "submitter_treatment_id": "TREATMENT_9321",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2322",
        "submitter_treatment_id": "TREATMENT_9322",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2323",
        "submitter_treatment_id": "TREATMENT_9323",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2324",
        "submitter_treatment_id": "TREATMENT_9324",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2325",
        "submitter_treatment_id": "TREATMENT_9325",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2326",
        "submitter_treatment_id": "TREATMENT_9326",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2327",
        "submitter_treatment_id": "TREATMENT_9327",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2328",
        "submitter_treatment_id": "TREATMENT_9328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2329",
        "submitter_treatment_id": "TREATMENT_9329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2330",
        "submitter_treatment_id": "TREATMENT_9330",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2331",
        "submitter_treatment_id": "TREATMENT_9331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2332",
        "submitter_treatment_id": "TREATMENT_9332",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2333",
        "submitter_treatment_id": "TREATMENT_9333",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2334",
        "submitter_treatment_id": "TREATMENT_9334",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2335",
        "submitter_treatment_id": "TREATMENT_9335",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2336",
        "submitter_treatment_id": "TREATMENT_9336",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2337",
        "submitter_treatment_id": "TREATMENT_9337",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2338",
        "submitter_treatment_id": "TREATMENT_9338",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2339",
        "submitter_treatment_id": "TREATMENT_9339",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2340",
        "submitter_treatment_id": "TREATMENT_9340",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2341",
        "submitter_treatment_id": "TREATMENT_9341",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2342",
        "submitter_treatment_id": "TREATMENT_9342",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2343",
        "submitter_treatment_id": "TREATMENT_9343",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2344",
        "submitter_treatment_id": "TREATMENT_9344",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2345",
        "submitter_treatment_id": "TREATMENT_9345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2346",
        "submitter_treatment_id": "TREATMENT_9346",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2347",
        "submitter_treatment_id": "TREATMENT_9347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2348",
        "submitter_treatment_id": "TREATMENT_9348",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2349",
        "submitter_treatment_id": "TREATMENT_9349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2350",
        "submitter_treatment_id": "TREATMENT_9350",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2351",
        "submitter_treatment_id": "TREATMENT_9351",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2352",
        "submitter_treatment_id": "TREATMENT_9352",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2353",
        "submitter_treatment_id": "TREATMENT_9353",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2354",
        "submitter_treatment_id": "TREATMENT_9354",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2355",
        "submitter_treatment_id": "TREATMENT_9355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2356",
        "submitter_treatment_id": "TREATMENT_9356",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2357",
        "submitter_treatment_id": "TREATMENT_9357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2358",
        "submitter_treatment_id": "TREATMENT_9358",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2359",
        "submitter_treatment_id": "TREATMENT_9359",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2360",
        "submitter_treatment_id": "TREATMENT_9360",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2361",
        "submitter_treatment_id": "TREATMENT_9361",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2362",
        "submitter_treatment_id": "TREATMENT_9362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2363",
        "submitter_treatment_id": "TREATMENT_9363",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2364",
        "submitter_treatment_id": "TREATMENT_9364",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2365",
        "submitter_treatment_id": "TREATMENT_9365",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2366",
        "submitter_treatment_id": "TREATMENT_9366",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2367",
        "submitter_treatment_id": "TREATMENT_9367",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2368",
        "submitter_treatment_id": "TREATMENT_9368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2369",
        "submitter_treatment_id": "TREATMENT_9369",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2370",
        "submitter_treatment_id": "TREATMENT_9370",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2371",
        "submitter_treatment_id": "TREATMENT_9371",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2372",
        "submitter_treatment_id": "TREATMENT_9372",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2373",
        "submitter_treatment_id": "TREATMENT_9373",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2374",
        "submitter_treatment_id": "TREATMENT_9374",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2375",
        "submitter_treatment_id": "TREATMENT_9375",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2376",
        "submitter_treatment_id": "TREATMENT_9376",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2377",
        "submitter_treatment_id": "TREATMENT_9377",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2378",
        "submitter_treatment_id": "TREATMENT_9378",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2379",
        "submitter_treatment_id": "TREATMENT_9379",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2380",
        "submitter_treatment_id": "TREATMENT_9380",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2381",
        "submitter_treatment_id": "TREATMENT_9381",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2382",
        "submitter_treatment_id": "TREATMENT_9382",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2383",
        "submitter_treatment_id": "TREATMENT_9383",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2384",
        "submitter_treatment_id": "TREATMENT_9384",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2385",
        "submitter_treatment_id": "TREATMENT_9385",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2386",
        "submitter_treatment_id": "TREATMENT_9386",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2387",
        "submitter_treatment_id": "TREATMENT_9387",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2388",
        "submitter_treatment_id": "TREATMENT_9388",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2389",
        "submitter_treatment_id": "TREATMENT_9389",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2390",
        "submitter_treatment_id": "TREATMENT_9390",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2391",
        "submitter_treatment_id": "TREATMENT_9391",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2392",
        "submitter_treatment_id": "TREATMENT_9392",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2393",
        "submitter_treatment_id": "TREATMENT_9393",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2394",
        "submitter_treatment_id": "TREATMENT_9394",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2395",
        "submitter_treatment_id": "TREATMENT_9395",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2396",
        "submitter_treatment_id": "TREATMENT_9396",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2397",
        "submitter_treatment_id": "TREATMENT_9397",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2398",
        "submitter_treatment_id": "TREATMENT_9398",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2399",
        "submitter_treatment_id": "TREATMENT_9399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2400",
        "submitter_treatment_id": "TREATMENT_9400",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2401",
        "submitter_treatment_id": "TREATMENT_9401",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2402",
        "submitter_treatment_id": "TREATMENT_9402",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2403",
        "submitter_treatment_id": "TREATMENT_9403",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2404",
        "submitter_treatment_id": "TREATMENT_9404",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2405",
        "submitter_treatment_id": "TREATMENT_9405",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2406",
        "submitter_treatment_id": "TREATMENT_9406",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2407",
        "submitter_treatment_id": "TREATMENT_9407",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2408",
        "submitter_treatment_id": "TREATMENT_9408",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2409",
        "submitter_treatment_id": "TREATMENT_9409",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2410",
        "submitter_treatment_id": "TREATMENT_9410",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2411",
        "submitter_treatment_id": "TREATMENT_9411",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2412",
        "submitter_treatment_id": "TREATMENT_9412",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2413",
        "submitter_treatment_id": "TREATMENT_9413",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2414",
        "submitter_treatment_id": "TREATMENT_9414",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2415",
        "submitter_treatment_id": "TREATMENT_9415",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2416",
        "submitter_treatment_id": "TREATMENT_9416",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2417",
        "submitter_treatment_id": "TREATMENT_9417",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2418",
        "submitter_treatment_id": "TREATMENT_9418",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2419",
        "submitter_treatment_id": "TREATMENT_9419",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2420",
        "submitter_treatment_id": "TREATMENT_9420",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2421",
        "submitter_treatment_id": "TREATMENT_9421",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2422",
        "submitter_treatment_id": "TREATMENT_9422",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2423",
        "submitter_treatment_id": "TREATMENT_9423",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2424",
        "submitter_treatment_id": "TREATMENT_9424",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2425",
        "submitter_treatment_id": "TREATMENT_9425",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2426",
        "submitter_treatment_id": "TREATMENT_9426",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2427",
        "submitter_treatment_id": "TREATMENT_9427",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2428",
        "submitter_treatment_id": "TREATMENT_9428",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2429",
        "submitter_treatment_id": "TREATMENT_9429",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2430",
        "submitter_treatment_id": "TREATMENT_9430",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2431",
        "submitter_treatment_id": "TREATMENT_9431",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2432",
        "submitter_treatment_id": "TREATMENT_9432",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2433",
        "submitter_treatment_id": "TREATMENT_9433",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2434",
        "submitter_treatment_id": "TREATMENT_9434",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2435",
        "submitter_treatment_id": "TREATMENT_9435",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2436",
        "submitter_treatment_id": "TREATMENT_9436",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2437",
        "submitter_treatment_id": "TREATMENT_9437",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2438",
        "submitter_treatment_id": "TREATMENT_9438",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2439",
        "submitter_treatment_id": "TREATMENT_9439",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2440",
        "submitter_treatment_id": "TREATMENT_9440",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2441",
        "submitter_treatment_id": "TREATMENT_9441",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2442",
        "submitter_treatment_id": "TREATMENT_9442",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2443",
        "submitter_treatment_id": "TREATMENT_9443",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2444",
        "submitter_treatment_id": "TREATMENT_9444",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2445",
        "submitter_treatment_id": "TREATMENT_9445",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2446",
        "submitter_treatment_id": "TREATMENT_9446",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2447",
        "submitter_treatment_id": "TREATMENT_9447",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2448",
        "submitter_treatment_id": "TREATMENT_9448",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2449",
        "submitter_treatment_id": "TREATMENT_9449",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2450",
        "submitter_treatment_id": "TREATMENT_9450",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2451",
        "submitter_treatment_id": "TREATMENT_9451",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2452",
        "submitter_treatment_id": "TREATMENT_9452",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2453",
        "submitter_treatment_id": "TREATMENT_9453",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2454",
        "submitter_treatment_id": "TREATMENT_9454",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2455",
        "submitter_treatment_id": "TREATMENT_9455",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2456",
        "submitter_treatment_id": "TREATMENT_9456",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2457",
        "submitter_treatment_id": "TREATMENT_9457",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2458",
        "submitter_treatment_id": "TREATMENT_9458",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2459",
        "submitter_treatment_id": "TREATMENT_9459",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2460",
        "submitter_treatment_id": "TREATMENT_9460",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2461",
        "submitter_treatment_id": "TREATMENT_9461",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2462",
        "submitter_treatment_id": "TREATMENT_9462",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2463",
        "submitter_treatment_id": "TREATMENT_9463",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2464",
        "submitter_treatment_id": "TREATMENT_9464",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2465",
        "submitter_treatment_id": "TREATMENT_9465",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2466",
        "submitter_treatment_id": "TREATMENT_9466",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2467",
        "submitter_treatment_id": "TREATMENT_9467",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2468",
        "submitter_treatment_id": "TREATMENT_9468",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2469",
        "submitter_treatment_id": "TREATMENT_9469",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2470",
        "submitter_treatment_id": "TREATMENT_9470",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2471",
        "submitter_treatment_id": "TREATMENT_9471",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2472",
        "submitter_treatment_id": "TREATMENT_9472",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2473",
        "submitter_treatment_id": "TREATMENT_9473",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2474",
        "submitter_treatment_id": "TREATMENT_9474",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2475",
        "submitter_treatment_id": "TREATMENT_9475",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2476",
        "submitter_treatment_id": "TREATMENT_9476",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2477",
        "submitter_treatment_id": "TREATMENT_9477",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2478",
        "submitter_treatment_id": "TREATMENT_9478",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2479",
        "submitter_treatment_id": "TREATMENT_9479",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2480",
        "submitter_treatment_id": "TREATMENT_9480",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2481",
        "submitter_treatment_id": "TREATMENT_9481",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2482",
        "submitter_treatment_id": "TREATMENT_9482",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2483",
        "submitter_treatment_id": "TREATMENT_9483",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2484",
        "submitter_treatment_id": "TREATMENT_9484",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2485",
        "submitter_treatment_id": "TREATMENT_9485",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2486",
        "submitter_treatment_id": "TREATMENT_9486",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2487",
        "submitter_treatment_id": "TREATMENT_9487",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2488",
        "submitter_treatment_id": "TREATMENT_9488",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2489",
        "submitter_treatment_id": "TREATMENT_9489",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2490",
        "submitter_treatment_id": "TREATMENT_9490",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2491",
        "submitter_treatment_id": "TREATMENT_9491",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2492",
        "submitter_treatment_id": "TREATMENT_9492",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2493",
        "submitter_treatment_id": "TREATMENT_9493",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2494",
        "submitter_treatment_id": "TREATMENT_9494",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2495",
        "submitter_treatment_id": "TREATMENT_9495",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2496",
        "submitter_treatment_id": "TREATMENT_9496",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2497",
        "submitter_treatment_id": "TREATMENT_9497",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2498",
        "submitter_treatment_id": "TREATMENT_9498",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2499",
        "submitter_treatment_id": "TREATMENT_9499",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2500",
        "submitter_treatment_id": "TREATMENT_9500",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2001",
        "submitter_treatment_id": "TREATMENT_9501",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2002",
        "submitter_treatment_id": "TREATMENT_9502",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2003",
        "submitter_treatment_id": "TREATMENT_9503",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2004",
        "submitter_treatment_id": "TREATMENT_9504",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2005",
        "submitter_treatment_id": "TREATMENT_9505",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2006",
        "submitter_treatment_id": "TREATMENT_9506",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2007",
        "submitter_treatment_id": "TREATMENT_9507",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2008",
        "submitter_treatment_id": "TREATMENT_9508",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2009",
        "submitter_treatment_id": "TREATMENT_9509",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2010",
        "submitter_treatment_id": "TREATMENT_9510",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2011",
        "submitter_treatment_id": "TREATMENT_9511",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2012",
        "submitter_treatment_id": "TREATMENT_9512",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2013",
        "submitter_treatment_id": "TREATMENT_9513",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2014",
        "submitter_treatment_id": "TREATMENT_9514",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2015",
        "submitter_treatment_id": "TREATMENT_9515",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2016",
        "submitter_treatment_id": "TREATMENT_9516",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2017",
        "submitter_treatment_id": "TREATMENT_9517",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2018",
        "submitter_treatment_id": "TREATMENT_9518",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2019",
        "submitter_treatment_id": "TREATMENT_9519",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2020",
        "submitter_treatment_id": "TREATMENT_9520",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2021",
        "submitter_treatment_id": "TREATMENT_9521",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2022",
        "submitter_treatment_id": "TREATMENT_9522",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2023",
        "submitter_treatment_id": "TREATMENT_9523",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2024",
        "submitter_treatment_id": "TREATMENT_9524",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2025",
        "submitter_treatment_id": "TREATMENT_9525",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2026",
        "submitter_treatment_id": "TREATMENT_9526",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2027",
        "submitter_treatment_id": "TREATMENT_9527",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2028",
        "submitter_treatment_id": "TREATMENT_9528",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2029",
        "submitter_treatment_id": "TREATMENT_9529",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2030",
        "submitter_treatment_id": "TREATMENT_9530",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2031",
        "submitter_treatment_id": "TREATMENT_9531",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2032",
        "submitter_treatment_id": "TREATMENT_9532",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2033",
        "submitter_treatment_id": "TREATMENT_9533",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2034",
        "submitter_treatment_id": "TREATMENT_9534",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2035",
        "submitter_treatment_id": "TREATMENT_9535",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2036",
        "submitter_treatment_id": "TREATMENT_9536",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2037",
        "submitter_treatment_id": "TREATMENT_9537",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2038",
        "submitter_treatment_id": "TREATMENT_9538",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2039",
        "submitter_treatment_id": "TREATMENT_9539",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2040",
        "submitter_treatment_id": "TREATMENT_9540",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2041",
        "submitter_treatment_id": "TREATMENT_9541",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2042",
        "submitter_treatment_id": "TREATMENT_9542",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2043",
        "submitter_treatment_id": "TREATMENT_9543",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2044",
        "submitter_treatment_id": "TREATMENT_9544",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2045",
        "submitter_treatment_id": "TREATMENT_9545",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2046",
        "submitter_treatment_id": "TREATMENT_9546",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2047",
        "submitter_treatment_id": "TREATMENT_9547",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2048",
        "submitter_treatment_id": "TREATMENT_9548",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2049",
        "submitter_treatment_id": "TREATMENT_9549",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2050",
        "submitter_treatment_id": "TREATMENT_9550",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2051",
        "submitter_treatment_id": "TREATMENT_9551",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2052",
        "submitter_treatment_id": "TREATMENT_9552",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2053",
        "submitter_treatment_id": "TREATMENT_9553",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2054",
        "submitter_treatment_id": "TREATMENT_9554",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2055",
        "submitter_treatment_id": "TREATMENT_9555",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2056",
        "submitter_treatment_id": "TREATMENT_9556",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2057",
        "submitter_treatment_id": "TREATMENT_9557",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2058",
        "submitter_treatment_id": "TREATMENT_9558",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2059",
        "submitter_treatment_id": "TREATMENT_9559",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2060",
        "submitter_treatment_id": "TREATMENT_9560",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2061",
        "submitter_treatment_id": "TREATMENT_9561",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2062",
        "submitter_treatment_id": "TREATMENT_9562",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2063",
        "submitter_treatment_id": "TREATMENT_9563",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2064",
        "submitter_treatment_id": "TREATMENT_9564",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2065",
        "submitter_treatment_id": "TREATMENT_9565",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2066",
        "submitter_treatment_id": "TREATMENT_9566",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2067",
        "submitter_treatment_id": "TREATMENT_9567",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2068",
        "submitter_treatment_id": "TREATMENT_9568",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2069",
        "submitter_treatment_id": "TREATMENT_9569",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2070",
        "submitter_treatment_id": "TREATMENT_9570",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2071",
        "submitter_treatment_id": "TREATMENT_9571",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2072",
        "submitter_treatment_id": "TREATMENT_9572",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2073",
        "submitter_treatment_id": "TREATMENT_9573",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2074",
        "submitter_treatment_id": "TREATMENT_9574",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2075",
        "submitter_treatment_id": "TREATMENT_9575",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2076",
        "submitter_treatment_id": "TREATMENT_9576",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2077",
        "submitter_treatment_id": "TREATMENT_9577",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2078",
        "submitter_treatment_id": "TREATMENT_9578",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2079",
        "submitter_treatment_id": "TREATMENT_9579",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2080",
        "submitter_treatment_id": "TREATMENT_9580",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2081",
        "submitter_treatment_id": "TREATMENT_9581",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2082",
        "submitter_treatment_id": "TREATMENT_9582",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2083",
        "submitter_treatment_id": "TREATMENT_9583",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2084",
        "submitter_treatment_id": "TREATMENT_9584",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2085",
        "submitter_treatment_id": "TREATMENT_9585",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2086",
        "submitter_treatment_id": "TREATMENT_9586",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2087",
        "submitter_treatment_id": "TREATMENT_9587",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2088",
        "submitter_treatment_id": "TREATMENT_9588",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2089",
        "submitter_treatment_id": "TREATMENT_9589",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2090",
        "submitter_treatment_id": "TREATMENT_9590",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2091",
        "submitter_treatment_id": "TREATMENT_9591",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2092",
        "submitter_treatment_id": "TREATMENT_9592",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2093",
        "submitter_treatment_id": "TREATMENT_9593",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2094",
        "submitter_treatment_id": "TREATMENT_9594",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2095",
        "submitter_treatment_id": "TREATMENT_9595",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2096",
        "submitter_treatment_id": "TREATMENT_9596",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2097",
        "submitter_treatment_id": "TREATMENT_9597",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2098",
        "submitter_treatment_id": "TREATMENT_9598",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2099",
        "submitter_treatment_id": "TREATMENT_9599",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2100",
        "submitter_treatment_id": "TREATMENT_9600",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2101",
        "submitter_treatment_id": "TREATMENT_9601",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2102",
        "submitter_treatment_id": "TREATMENT_9602",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2103",
        "submitter_treatment_id": "TREATMENT_9603",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2104",
        "submitter_treatment_id": "TREATMENT_9604",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2105",
        "submitter_treatment_id": "TREATMENT_9605",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2106",
        "submitter_treatment_id": "TREATMENT_9606",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2107",
        "submitter_treatment_id": "TREATMENT_9607",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2108",
        "submitter_treatment_id": "TREATMENT_9608",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2109",
        "submitter_treatment_id": "TREATMENT_9609",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2110",
        "submitter_treatment_id": "TREATMENT_9610",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2111",
        "submitter_treatment_id": "TREATMENT_9611",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2112",
        "submitter_treatment_id": "TREATMENT_9612",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2113",
        "submitter_treatment_id": "TREATMENT_9613",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2114",
        "submitter_treatment_id": "TREATMENT_9614",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2115",
        "submitter_treatment_id": "TREATMENT_9615",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2116",
        "submitter_treatment_id": "TREATMENT_9616",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2117",
        "submitter_treatment_id": "TREATMENT_9617",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2118",
        "submitter_treatment_id": "TREATMENT_9618",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2119",
        "submitter_treatment_id": "TREATMENT_9619",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2120",
        "submitter_treatment_id": "TREATMENT_9620",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2121",
        "submitter_treatment_id": "TREATMENT_9621",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2122",
        "submitter_treatment_id": "TREATMENT_9622",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2123",
        "submitter_treatment_id": "TREATMENT_9623",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2124",
        "submitter_treatment_id": "TREATMENT_9624",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2125",
        "submitter_treatment_id": "TREATMENT_9625",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2126",
        "submitter_treatment_id": "TREATMENT_9626",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2127",
        "submitter_treatment_id": "TREATMENT_9627",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2128",
        "submitter_treatment_id": "TREATMENT_9628",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2129",
        "submitter_treatment_id": "TREATMENT_9629",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2130",
        "submitter_treatment_id": "TREATMENT_9630",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2131",
        "submitter_treatment_id": "TREATMENT_9631",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2132",
        "submitter_treatment_id": "TREATMENT_9632",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2133",
        "submitter_treatment_id": "TREATMENT_9633",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2134",
        "submitter_treatment_id": "TREATMENT_9634",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2135",
        "submitter_treatment_id": "TREATMENT_9635",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2136",
        "submitter_treatment_id": "TREATMENT_9636",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2137",
        "submitter_treatment_id": "TREATMENT_9637",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2138",
        "submitter_treatment_id": "TREATMENT_9638",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2139",
        "submitter_treatment_id": "TREATMENT_9639",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2140",
        "submitter_treatment_id": "TREATMENT_9640",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2141",
        "submitter_treatment_id": "TREATMENT_9641",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2142",
        "submitter_treatment_id": "TREATMENT_9642",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2143",
        "submitter_treatment_id": "TREATMENT_9643",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2144",
        "submitter_treatment_id": "TREATMENT_9644",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2145",
        "submitter_treatment_id": "TREATMENT_9645",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2146",
        "submitter_treatment_id": "TREATMENT_9646",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2147",
        "submitter_treatment_id": "TREATMENT_9647",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2148",
        "submitter_treatment_id": "TREATMENT_9648",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2149",
        "submitter_treatment_id": "TREATMENT_9649",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2150",
        "submitter_treatment_id": "TREATMENT_9650",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2151",
        "submitter_treatment_id": "TREATMENT_9651",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2152",
        "submitter_treatment_id": "TREATMENT_9652",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2153",
        "submitter_treatment_id": "TREATMENT_9653",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2154",
        "submitter_treatment_id": "TREATMENT_9654",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2155",
        "submitter_treatment_id": "TREATMENT_9655",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2156",
        "submitter_treatment_id": "TREATMENT_9656",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2157",
        "submitter_treatment_id": "TREATMENT_9657",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2158",
        "submitter_treatment_id": "TREATMENT_9658",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2159",
        "submitter_treatment_id": "TREATMENT_9659",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2160",
        "submitter_treatment_id": "TREATMENT_9660",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2161",
        "submitter_treatment_id": "TREATMENT_9661",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2162",
        "submitter_treatment_id": "TREATMENT_9662",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2163",
        "submitter_treatment_id": "TREATMENT_9663",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2164",
        "submitter_treatment_id": "TREATMENT_9664",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2165",
        "submitter_treatment_id": "TREATMENT_9665",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2166",
        "submitter_treatment_id": "TREATMENT_9666",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2167",
        "submitter_treatment_id": "TREATMENT_9667",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2168",
        "submitter_treatment_id": "TREATMENT_9668",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2169",
        "submitter_treatment_id": "TREATMENT_9669",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2170",
        "submitter_treatment_id": "TREATMENT_9670",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2171",
        "submitter_treatment_id": "TREATMENT_9671",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2172",
        "submitter_treatment_id": "TREATMENT_9672",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2173",
        "submitter_treatment_id": "TREATMENT_9673",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2174",
        "submitter_treatment_id": "TREATMENT_9674",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2175",
        "submitter_treatment_id": "TREATMENT_9675",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2176",
        "submitter_treatment_id": "TREATMENT_9676",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2177",
        "submitter_treatment_id": "TREATMENT_9677",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2178",
        "submitter_treatment_id": "TREATMENT_9678",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2179",
        "submitter_treatment_id": "TREATMENT_9679",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2180",
        "submitter_treatment_id": "TREATMENT_9680",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2181",
        "submitter_treatment_id": "TREATMENT_9681",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2182",
        "submitter_treatment_id": "TREATMENT_9682",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2183",
        "submitter_treatment_id": "TREATMENT_9683",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2184",
        "submitter_treatment_id": "TREATMENT_9684",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2185",
        "submitter_treatment_id": "TREATMENT_9685",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2186",
        "submitter_treatment_id": "TREATMENT_9686",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2187",
        "submitter_treatment_id": "TREATMENT_9687",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2188",
        "submitter_treatment_id": "TREATMENT_9688",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2189",
        "submitter_treatment_id": "TREATMENT_9689",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2190",
        "submitter_treatment_id": "TREATMENT_9690",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2191",
        "submitter_treatment_id": "TREATMENT_9691",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2192",
        "submitter_treatment_id": "TREATMENT_9692",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2193",
        "submitter_treatment_id": "TREATMENT_9693",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2194",
        "submitter_treatment_id": "TREATMENT_9694",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2195",
        "submitter_treatment_id": "TREATMENT_9695",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2196",
        "submitter_treatment_id": "TREATMENT_9696",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2197",
        "submitter_treatment_id": "TREATMENT_9697",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2198",
        "submitter_treatment_id": "TREATMENT_9698",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2199",
        "submitter_treatment_id": "TREATMENT_9699",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2200",
        "submitter_treatment_id": "TREATMENT_9700",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2201",
        "submitter_treatment_id": "TREATMENT_9701",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2202",
        "submitter_treatment_id": "TREATMENT_9702",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2203",
        "submitter_treatment_id": "TREATMENT_9703",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2204",
        "submitter_treatment_id": "TREATMENT_9704",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2205",
        "submitter_treatment_id": "TREATMENT_9705",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2206",
        "submitter_treatment_id": "TREATMENT_9706",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2207",
        "submitter_treatment_id": "TREATMENT_9707",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2208",
        "submitter_treatment_id": "TREATMENT_9708",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2209",
        "submitter_treatment_id": "TREATMENT_9709",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2210",
        "submitter_treatment_id": "TREATMENT_9710",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2211",
        "submitter_treatment_id": "TREATMENT_9711",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2212",
        "submitter_treatment_id": "TREATMENT_9712",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2213",
        "submitter_treatment_id": "TREATMENT_9713",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2214",
        "submitter_treatment_id": "TREATMENT_9714",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2215",
        "submitter_treatment_id": "TREATMENT_9715",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2216",
        "submitter_treatment_id": "TREATMENT_9716",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2217",
        "submitter_treatment_id": "TREATMENT_9717",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2218",
        "submitter_treatment_id": "TREATMENT_9718",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2219",
        "submitter_treatment_id": "TREATMENT_9719",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2220",
        "submitter_treatment_id": "TREATMENT_9720",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2221",
        "submitter_treatment_id": "TREATMENT_9721",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2222",
        "submitter_treatment_id": "TREATMENT_9722",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2223",
        "submitter_treatment_id": "TREATMENT_9723",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2224",
        "submitter_treatment_id": "TREATMENT_9724",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2225",
        "submitter_treatment_id": "TREATMENT_9725",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2226",
        "submitter_treatment_id": "TREATMENT_9726",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2227",
        "submitter_treatment_id": "TREATMENT_9727",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2228",
        "submitter_treatment_id": "TREATMENT_9728",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2229",
        "submitter_treatment_id": "TREATMENT_9729",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2230",
        "submitter_treatment_id": "TREATMENT_9730",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2231",
        "submitter_treatment_id": "TREATMENT_9731",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2232",
        "submitter_treatment_id": "TREATMENT_9732",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2233",
        "submitter_treatment_id": "TREATMENT_9733",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2234",
        "submitter_treatment_id": "TREATMENT_9734",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2235",
        "submitter_treatment_id": "TREATMENT_9735",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2236",
        "submitter_treatment_id": "TREATMENT_9736",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2237",
        "submitter_treatment_id": "TREATMENT_9737",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2238",
        "submitter_treatment_id": "TREATMENT_9738",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2239",
        "submitter_treatment_id": "TREATMENT_9739",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2240",
        "submitter_treatment_id": "TREATMENT_9740",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2241",
        "submitter_treatment_id": "TREATMENT_9741",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2242",
        "submitter_treatment_id": "TREATMENT_9742",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2243",
        "submitter_treatment_id": "TREATMENT_9743",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2244",
        "submitter_treatment_id": "TREATMENT_9744",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2245",
        "submitter_treatment_id": "TREATMENT_9745",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2246",
        "submitter_treatment_id": "TREATMENT_9746",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2247",
        "submitter_treatment_id": "TREATMENT_9747",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2248",
        "submitter_treatment_id": "TREATMENT_9748",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2249",
        "submitter_treatment_id": "TREATMENT_9749",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2250",
        "submitter_treatment_id": "TREATMENT_9750",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2251",
        "submitter_treatment_id": "TREATMENT_9751",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2252",
        "submitter_treatment_id": "TREATMENT_9752",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2253",
        "submitter_treatment_id": "TREATMENT_9753",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2254",
        "submitter_treatment_id": "TREATMENT_9754",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2255",
        "submitter_treatment_id": "TREATMENT_9755",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2256",
        "submitter_treatment_id": "TREATMENT_9756",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2257",
        "submitter_treatment_id": "TREATMENT_9757",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2258",
        "submitter_treatment_id": "TREATMENT_9758",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2259",
        "submitter_treatment_id": "TREATMENT_9759",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2260",
        "submitter_treatment_id": "TREATMENT_9760",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2261",
        "submitter_treatment_id": "TREATMENT_9761",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2262",
        "submitter_treatment_id": "TREATMENT_9762",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2263",
        "submitter_treatment_id": "TREATMENT_9763",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2264",
        "submitter_treatment_id": "TREATMENT_9764",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2265",
        "submitter_treatment_id": "TREATMENT_9765",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2266",
        "submitter_treatment_id": "TREATMENT_9766",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2267",
        "submitter_treatment_id": "TREATMENT_9767",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2268",
        "submitter_treatment_id": "TREATMENT_9768",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2269",
        "submitter_treatment_id": "TREATMENT_9769",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2270",
        "submitter_treatment_id": "TREATMENT_9770",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2271",
        "submitter_treatment_id": "TREATMENT_9771",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2272",
        "submitter_treatment_id": "TREATMENT_9772",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2273",
        "submitter_treatment_id": "TREATMENT_9773",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2274",
        "submitter_treatment_id": "TREATMENT_9774",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2275",
        "submitter_treatment_id": "TREATMENT_9775",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2276",
        "submitter_treatment_id": "TREATMENT_9776",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2277",
        "submitter_treatment_id": "TREATMENT_9777",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2278",
        "submitter_treatment_id": "TREATMENT_9778",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2279",
        "submitter_treatment_id": "TREATMENT_9779",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2280",
        "submitter_treatment_id": "TREATMENT_9780",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2281",
        "submitter_treatment_id": "TREATMENT_9781",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2282",
        "submitter_treatment_id": "TREATMENT_9782",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2283",
        "submitter_treatment_id": "TREATMENT_9783",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2284",
        "submitter_treatment_id": "TREATMENT_9784",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2285",
        "submitter_treatment_id": "TREATMENT_9785",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2286",
        "submitter_treatment_id": "TREATMENT_9786",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2287",
        "submitter_treatment_id": "TREATMENT_9787",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2288",
        "submitter_treatment_id": "TREATMENT_9788",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2289",
        "submitter_treatment_id": "TREATMENT_9789",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2290",
        "submitter_treatment_id": "TREATMENT_9790",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2291",
        "submitter_treatment_id": "TREATMENT_9791",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2292",
        "submitter_treatment_id": "TREATMENT_9792",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2293",
        "submitter_treatment_id": "TREATMENT_9793",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2294",
        "submitter_treatment_id": "TREATMENT_9794",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2295",
        "submitter_treatment_id": "TREATMENT_9795",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2296",
        "submitter_treatment_id": "TREATMENT_9796",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2297",
        "submitter_treatment_id": "TREATMENT_9797",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2298",
        "submitter_treatment_id": "TREATMENT_9798",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2299",
        "submitter_treatment_id": "TREATMENT_9799",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2300",
        "submitter_treatment_id": "TREATMENT_9800",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2301",
        "submitter_treatment_id": "TREATMENT_9801",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2302",
        "submitter_treatment_id": "TREATMENT_9802",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2303",
        "submitter_treatment_id": "TREATMENT_9803",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2304",
        "submitter_treatment_id": "TREATMENT_9804",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2305",
        "submitter_treatment_id": "TREATMENT_9805",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2306",
        "submitter_treatment_id": "TREATMENT_9806",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2307",
        "submitter_treatment_id": "TREATMENT_9807",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2308",
        "submitter_treatment_id": "TREATMENT_9808",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2309",
        "submitter_treatment_id": "TREATMENT_9809",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2310",
        "submitter_treatment_id": "TREATMENT_9810",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2311",
        "submitter_treatment_id": "TREATMENT_9811",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2312",
        "submitter_treatment_id": "TREATMENT_9812",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2313",
        "submitter_treatment_id": "TREATMENT_9813",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2314",
        "submitter_treatment_id": "TREATMENT_9814",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2315",
        "submitter_treatment_id": "TREATMENT_9815",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2316",
        "submitter_treatment_id": "TREATMENT_9816",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2317",
        "submitter_treatment_id": "TREATMENT_9817",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2318",
        "submitter_treatment_id": "TREATMENT_9818",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2319",
        "submitter_treatment_id": "TREATMENT_9819",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2320",
        "submitter_treatment_id": "TREATMENT_9820",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2321",
        "submitter_treatment_id": "TREATMENT_9821",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2322",
        "submitter_treatment_id": "TREATMENT_9822",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2323",
        "submitter_treatment_id": "TREATMENT_9823",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2324",
        "submitter_treatment_id": "TREATMENT_9824",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2325",
        "submitter_treatment_id": "TREATMENT_9825",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2326",
        "submitter_treatment_id": "TREATMENT_9826",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2327",
        "submitter_treatment_id": "TREATMENT_9827",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2328",
        "submitter_treatment_id": "TREATMENT_9828",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2329",
        "submitter_treatment_id": "TREATMENT_9829",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2330",
        "submitter_treatment_id": "TREATMENT_9830",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2331",
        "submitter_treatment_id": "TREATMENT_9831",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2332",
        "submitter_treatment_id": "TREATMENT_9832",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2333",
        "submitter_treatment_id": "TREATMENT_9833",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2334",
        "submitter_treatment_id": "TREATMENT_9834",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2335",
        "submitter_treatment_id": "TREATMENT_9835",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2336",
        "submitter_treatment_id": "TREATMENT_9836",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2337",
        "submitter_treatment_id": "TREATMENT_9837",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2338",
        "submitter_treatment_id": "TREATMENT_9838",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2339",
        "submitter_treatment_id": "TREATMENT_9839",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2340",
        "submitter_treatment_id": "TREATMENT_9840",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2341",
        "submitter_treatment_id": "TREATMENT_9841",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2342",
        "submitter_treatment_id": "TREATMENT_9842",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2343",
        "submitter_treatment_id": "TREATMENT_9843",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2344",
        "submitter_treatment_id": "TREATMENT_9844",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2345",
        "submitter_treatment_id": "TREATMENT_9845",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2346",
        "submitter_treatment_id": "TREATMENT_9846",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2347",
        "submitter_treatment_id": "TREATMENT_9847",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2348",
        "submitter_treatment_id": "TREATMENT_9848",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2349",
        "submitter_treatment_id": "TREATMENT_9849",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2350",
        "submitter_treatment_id": "TREATMENT_9850",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2351",
        "submitter_treatment_id": "TREATMENT_9851",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2352",
        "submitter_treatment_id": "TREATMENT_9852",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2353",
        "submitter_treatment_id": "TREATMENT_9853",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2354",
        "submitter_treatment_id": "TREATMENT_9854",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2355",
        "submitter_treatment_id": "TREATMENT_9855",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2356",
        "submitter_treatment_id": "TREATMENT_9856",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2357",
        "submitter_treatment_id": "TREATMENT_9857",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2358",
        "submitter_treatment_id": "TREATMENT_9858",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2359",
        "submitter_treatment_id": "TREATMENT_9859",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2360",
        "submitter_treatment_id": "TREATMENT_9860",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2361",
        "submitter_treatment_id": "TREATMENT_9861",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2362",
        "submitter_treatment_id": "TREATMENT_9862",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2363",
        "submitter_treatment_id": "TREATMENT_9863",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2364",
        "submitter_treatment_id": "TREATMENT_9864",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2365",
        "submitter_treatment_id": "TREATMENT_9865",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2366",
        "submitter_treatment_id": "TREATMENT_9866",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2367",
        "submitter_treatment_id": "TREATMENT_9867",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2368",
        "submitter_treatment_id": "TREATMENT_9868",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2369",
        "submitter_treatment_id": "TREATMENT_9869",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2370",
        "submitter_treatment_id": "TREATMENT_9870",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2371",
        "submitter_treatment_id": "TREATMENT_9871",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2372",
        "submitter_treatment_id": "TREATMENT_9872",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2373",
        "submitter_treatment_id": "TREATMENT_9873",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2374",
        "submitter_treatment_id": "TREATMENT_9874",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2375",
        "submitter_treatment_id": "TREATMENT_9875",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2376",
        "submitter_treatment_id": "TREATMENT_9876",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2377",
        "submitter_treatment_id": "TREATMENT_9877",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2378",
        "submitter_treatment_id": "TREATMENT_9878",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2379",
        "submitter_treatment_id": "TREATMENT_9879",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2380",
        "submitter_treatment_id": "TREATMENT_9880",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2381",
        "submitter_treatment_id": "TREATMENT_9881",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2382",
        "submitter_treatment_id": "TREATMENT_9882",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2383",
        "submitter_treatment_id": "TREATMENT_9883",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2384",
        "submitter_treatment_id": "TREATMENT_9884",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2385",
        "submitter_treatment_id": "TREATMENT_9885",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2386",
        "submitter_treatment_id": "TREATMENT_9886",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2387",
        "submitter_treatment_id": "TREATMENT_9887",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2388",
        "submitter_treatment_id": "TREATMENT_9888",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2389",
        "submitter_treatment_id": "TREATMENT_9889",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2390",
        "submitter_treatment_id": "TREATMENT_9890",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2391",
        "submitter_treatment_id": "TREATMENT_9891",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2392",
        "submitter_treatment_id": "TREATMENT_9892",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2393",
        "submitter_treatment_id": "TREATMENT_9893",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2394",
        "submitter_treatment_id": "TREATMENT_9894",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2395",
        "submitter_treatment_id": "TREATMENT_9895",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2396",
        "submitter_treatment_id": "TREATMENT_9896",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2397",
        "submitter_treatment_id": "TREATMENT_9897",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2398",
        "submitter_treatment_id": "TREATMENT_9898",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2399",
        "submitter_treatment_id": "TREATMENT_9899",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2400",
        "submitter_treatment_id": "TREATMENT_9900",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2401",
        "submitter_treatment_id": "TREATMENT_9901",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2402",
        "submitter_treatment_id": "TREATMENT_9902",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2403",
        "submitter_treatment_id": "TREATMENT_9903",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2404",
        "submitter_treatment_id": "TREATMENT_9904",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2405",
        "submitter_treatment_id": "TREATMENT_9905",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2406",
        "submitter_treatment_id": "TREATMENT_9906",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2407",
        "submitter_treatment_id": "TREATMENT_9907",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2408",
        "submitter_treatment_id": "TREATMENT_9908",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2409",
        "submitter_treatment_id": "TREATMENT_9909",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2410",
        "submitter_treatment_id": "TREATMENT_9910",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2411",
        "submitter_treatment_id": "TREATMENT_9911",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2412",
        "submitter_treatment_id": "TREATMENT_9912",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2413",
        "submitter_treatment_id": "TREATMENT_9913",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2414",
        "submitter_treatment_id": "TREATMENT_9914",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2415",
        "submitter_treatment_id": "TREATMENT_9915",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2416",
        "submitter_treatment_id": "TREATMENT_9916",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2417",
        "submitter_treatment_id": "TREATMENT_9917",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2418",
        "submitter_treatment_id": "TREATMENT_9918",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2419",
        "submitter_treatment_id": "TREATMENT_9919",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2420",
        "submitter_treatment_id": "TREATMENT_9920",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2421",
        "submitter_treatment_id": "TREATMENT_9921",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2422",
        "submitter_treatment_id": "TREATMENT_9922",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2423",
        "submitter_treatment_id": "TREATMENT_9923",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2424",
        "submitter_treatment_id": "TREATMENT_9924",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2425",
        "submitter_treatment_id": "TREATMENT_9925",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2426",
        "submitter_treatment_id": "TREATMENT_9926",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2427",
        "submitter_treatment_id": "TREATMENT_9927",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2428",
        "submitter_treatment_id": "TREATMENT_9928",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2429",
        "submitter_treatment_id": "TREATMENT_9929",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2430",
        "submitter_treatment_id": "TREATMENT_9930",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2431",
        "submitter_treatment_id": "TREATMENT_9931",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2432",
        "submitter_treatment_id": "TREATMENT_9932",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2433",
        "submitter_treatment_id": "TREATMENT_9933",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2434",
        "submitter_treatment_id": "TREATMENT_9934",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2435",
        "submitter_treatment_id": "TREATMENT_9935",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2436",
        "submitter_treatment_id": "TREATMENT_9936",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2437",
        "submitter_treatment_id": "TREATMENT_9937",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2438",
        "submitter_treatment_id": "TREATMENT_9938",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2439",
        "submitter_treatment_id": "TREATMENT_9939",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2440",
        "submitter_treatment_id": "TREATMENT_9940",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2441",
        "submitter_treatment_id": "TREATMENT_9941",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2442",
        "submitter_treatment_id": "TREATMENT_9942",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2443",
        "submitter_treatment_id": "TREATMENT_9943",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2444",
        "submitter_treatment_id": "TREATMENT_9944",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2445",
        "submitter_treatment_id": "TREATMENT_9945",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2446",
        "submitter_treatment_id": "TREATMENT_9946",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2447",
        "submitter_treatment_id": "TREATMENT_9947",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2448",
        "submitter_treatment_id": "TREATMENT_9948",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2449",
        "submitter_treatment_id": "TREATMENT_9949",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2450",
        "submitter_treatment_id": "TREATMENT_9950",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2451",
        "submitter_treatment_id": "TREATMENT_9951",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2452",
        "submitter_treatment_id": "TREATMENT_9952",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2453",
        "submitter_treatment_id": "TREATMENT_9953",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2454",
        "submitter_treatment_id": "TREATMENT_9954",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2455",
        "submitter_treatment_id": "TREATMENT_9955",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2456",
        "submitter_treatment_id": "TREATMENT_9956",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2457",
        "submitter_treatment_id": "TREATMENT_9957",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2458",
        "submitter_treatment_id": "TREATMENT_9958",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2459",
        "submitter_treatment_id": "TREATMENT_9959",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2460",
        "submitter_treatment_id": "TREATMENT_9960",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2461",
        "submitter_treatment_id": "TREATMENT_9961",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2462",
        "submitter_treatment_id": "TREATMENT_9962",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2463",
        "submitter_treatment_id": "TREATMENT_9963",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2464",
        "submitter_treatment_id": "TREATMENT_9964",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2465",
        "submitter_treatment_id": "TREATMENT_9965",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2466",
        "submitter_treatment_id": "TREATMENT_9966",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2467",
        "submitter_treatment_id": "TREATMENT_9967",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2468",
        "submitter_treatment_id": "TREATMENT_9968",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2469",
        "submitter_treatment_id": "TREATMENT_9969",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2470",
        "submitter_treatment_id": "TREATMENT_9970",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2471",
        "submitter_treatment_id": "TREATMENT_9971",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2472",
        "submitter_treatment_id": "TREATMENT_9972",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2473",
        "submitter_treatment_id": "TREATMENT_9973",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2474",
        "submitter_treatment_id": "TREATMENT_9974",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2475",
        "submitter_treatment_id": "TREATMENT_9975",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2476",
        "submitter_treatment_id": "TREATMENT_9976",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2477",
        "submitter_treatment_id": "TREATMENT_9977",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2478",
        "submitter_treatment_id": "TREATMENT_9978",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2479",
        "submitter_treatment_id": "TREATMENT_9979",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2480",
        "submitter_treatment_id": "TREATMENT_9980",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2481",
        "submitter_treatment_id": "TREATMENT_9981",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2482",
        "submitter_treatment_id": "TREATMENT_9982",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2483",
        "submitter_treatment_id": "TREATMENT_9983",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2484",
        "submitter_treatment_id": "TREATMENT_9984",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2485",
        "submitter_treatment_id": "TREATMENT_9985",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2486",
        "submitter_treatment_id": "TREATMENT_9986",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2487",
        "submitter_treatment_id": "TREATMENT_9987",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2488",
        "submitter_treatment_id": "TREATMENT_9988",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2489",
        "submitter_treatment_id": "TREATMENT_9989",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2490",
        "submitter_treatment_id": "TREATMENT_9990",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2491",
        "submitter_treatment_id": "TREATMENT_9991",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2492",
        "submitter_treatment_id": "TREATMENT_9992",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2493",
        "submitter_treatment_id": "TREATMENT_9993",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2494",
        "submitter_treatment_id": "TREATMENT_9994",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2495",
        "submitter_treatment_id": "TREATMENT_9995",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2496",
        "submitter_treatment_id": "TREATMENT_9996",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2497",
        "submitter_treatment_id": "TREATMENT_9997",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2498",
        "submitter_treatment_id": "TREATMENT_9998",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2499",
        "submitter_treatment_id": "TREATMENT_9999",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-5",
        "submitter_donor_id": "DONOR_2500",
        "submitter_treatment_id": "TREATMENT_10000",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2501",
        "submitter_treatment_id": "TREATMENT_10001",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2502",
        "submitter_treatment_id": "TREATMENT_10002",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2503",
        "submitter_treatment_id": "TREATMENT_10003",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2504",
        "submitter_treatment_id": "TREATMENT_10004",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2505",
        "submitter_treatment_id": "TREATMENT_10005",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2506",
        "submitter_treatment_id": "TREATMENT_10006",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2507",
        "submitter_treatment_id": "TREATMENT_10007",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2508",
        "submitter_treatment_id": "TREATMENT_10008",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2509",
        "submitter_treatment_id": "TREATMENT_10009",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2510",
        "submitter_treatment_id": "TREATMENT_10010",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2511",
        "submitter_treatment_id": "TREATMENT_10011",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2512",
        "submitter_treatment_id": "TREATMENT_10012",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2513",
        "submitter_treatment_id": "TREATMENT_10013",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2514",
        "submitter_treatment_id": "TREATMENT_10014",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2515",
        "submitter_treatment_id": "TREATMENT_10015",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2516",
        "submitter_treatment_id": "TREATMENT_10016",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2517",
        "submitter_treatment_id": "TREATMENT_10017",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2518",
        "submitter_treatment_id": "TREATMENT_10018",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2519",
        "submitter_treatment_id": "TREATMENT_10019",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2520",
        "submitter_treatment_id": "TREATMENT_10020",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2521",
        "submitter_treatment_id": "TREATMENT_10021",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2522",
        "submitter_treatment_id": "TREATMENT_10022",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2523",
        "submitter_treatment_id": "TREATMENT_10023",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2524",
        "submitter_treatment_id": "TREATMENT_10024",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2525",
        "submitter_treatment_id": "TREATMENT_10025",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2526",
        "submitter_treatment_id": "TREATMENT_10026",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2527",
        "submitter_treatment_id": "TREATMENT_10027",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2528",
        "submitter_treatment_id": "TREATMENT_10028",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2529",
        "submitter_treatment_id": "TREATMENT_10029",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2530",
        "submitter_treatment_id": "TREATMENT_10030",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2531",
        "submitter_treatment_id": "TREATMENT_10031",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2532",
        "submitter_treatment_id": "TREATMENT_10032",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2533",
        "submitter_treatment_id": "TREATMENT_10033",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2534",
        "submitter_treatment_id": "TREATMENT_10034",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2535",
        "submitter_treatment_id": "TREATMENT_10035",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2536",
        "submitter_treatment_id": "TREATMENT_10036",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2537",
        "submitter_treatment_id": "TREATMENT_10037",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2538",
        "submitter_treatment_id": "TREATMENT_10038",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2539",
        "submitter_treatment_id": "TREATMENT_10039",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2540",
        "submitter_treatment_id": "TREATMENT_10040",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2541",
        "submitter_treatment_id": "TREATMENT_10041",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2542",
        "submitter_treatment_id": "TREATMENT_10042",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2543",
        "submitter_treatment_id": "TREATMENT_10043",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2544",
        "submitter_treatment_id": "TREATMENT_10044",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2545",
        "submitter_treatment_id": "TREATMENT_10045",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2546",
        "submitter_treatment_id": "TREATMENT_10046",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2547",
        "submitter_treatment_id": "TREATMENT_10047",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2548",
        "submitter_treatment_id": "TREATMENT_10048",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2549",
        "submitter_treatment_id": "TREATMENT_10049",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2550",
        "submitter_treatment_id": "TREATMENT_10050",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2551",
        "submitter_treatment_id": "TREATMENT_10051",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2552",
        "submitter_treatment_id": "TREATMENT_10052",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2553",
        "submitter_treatment_id": "TREATMENT_10053",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2554",
        "submitter_treatment_id": "TREATMENT_10054",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2555",
        "submitter_treatment_id": "TREATMENT_10055",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2556",
        "submitter_treatment_id": "TREATMENT_10056",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2557",
        "submitter_treatment_id": "TREATMENT_10057",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2558",
        "submitter_treatment_id": "TREATMENT_10058",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2559",
        "submitter_treatment_id": "TREATMENT_10059",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2560",
        "submitter_treatment_id": "TREATMENT_10060",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2561",
        "submitter_treatment_id": "TREATMENT_10061",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2562",
        "submitter_treatment_id": "TREATMENT_10062",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2563",
        "submitter_treatment_id": "TREATMENT_10063",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2564",
        "submitter_treatment_id": "TREATMENT_10064",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2565",
        "submitter_treatment_id": "TREATMENT_10065",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2566",
        "submitter_treatment_id": "TREATMENT_10066",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2567",
        "submitter_treatment_id": "TREATMENT_10067",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2568",
        "submitter_treatment_id": "TREATMENT_10068",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2569",
        "submitter_treatment_id": "TREATMENT_10069",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2570",
        "submitter_treatment_id": "TREATMENT_10070",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2571",
        "submitter_treatment_id": "TREATMENT_10071",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2572",
        "submitter_treatment_id": "TREATMENT_10072",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2573",
        "submitter_treatment_id": "TREATMENT_10073",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2574",
        "submitter_treatment_id": "TREATMENT_10074",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2575",
        "submitter_treatment_id": "TREATMENT_10075",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2576",
        "submitter_treatment_id": "TREATMENT_10076",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2577",
        "submitter_treatment_id": "TREATMENT_10077",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2578",
        "submitter_treatment_id": "TREATMENT_10078",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2579",
        "submitter_treatment_id": "TREATMENT_10079",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2580",
        "submitter_treatment_id": "TREATMENT_10080",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2581",
        "submitter_treatment_id": "TREATMENT_10081",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2582",
        "submitter_treatment_id": "TREATMENT_10082",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2583",
        "submitter_treatment_id": "TREATMENT_10083",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2584",
        "submitter_treatment_id": "TREATMENT_10084",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2585",
        "submitter_treatment_id": "TREATMENT_10085",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2586",
        "submitter_treatment_id": "TREATMENT_10086",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2587",
        "submitter_treatment_id": "TREATMENT_10087",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2588",
        "submitter_treatment_id": "TREATMENT_10088",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2589",
        "submitter_treatment_id": "TREATMENT_10089",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2590",
        "submitter_treatment_id": "TREATMENT_10090",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2591",
        "submitter_treatment_id": "TREATMENT_10091",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2592",
        "submitter_treatment_id": "TREATMENT_10092",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2593",
        "submitter_treatment_id": "TREATMENT_10093",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2594",
        "submitter_treatment_id": "TREATMENT_10094",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2595",
        "submitter_treatment_id": "TREATMENT_10095",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2596",
        "submitter_treatment_id": "TREATMENT_10096",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2597",
        "submitter_treatment_id": "TREATMENT_10097",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2598",
        "submitter_treatment_id": "TREATMENT_10098",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2599",
        "submitter_treatment_id": "TREATMENT_10099",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2600",
        "submitter_treatment_id": "TREATMENT_10100",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2601",
        "submitter_treatment_id": "TREATMENT_10101",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2602",
        "submitter_treatment_id": "TREATMENT_10102",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2603",
        "submitter_treatment_id": "TREATMENT_10103",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2604",
        "submitter_treatment_id": "TREATMENT_10104",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2605",
        "submitter_treatment_id": "TREATMENT_10105",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2606",
        "submitter_treatment_id": "TREATMENT_10106",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2607",
        "submitter_treatment_id": "TREATMENT_10107",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2608",
        "submitter_treatment_id": "TREATMENT_10108",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2609",
        "submitter_treatment_id": "TREATMENT_10109",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2610",
        "submitter_treatment_id": "TREATMENT_10110",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2611",
        "submitter_treatment_id": "TREATMENT_10111",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2612",
        "submitter_treatment_id": "TREATMENT_10112",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2613",
        "submitter_treatment_id": "TREATMENT_10113",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2614",
        "submitter_treatment_id": "TREATMENT_10114",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2615",
        "submitter_treatment_id": "TREATMENT_10115",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2616",
        "submitter_treatment_id": "TREATMENT_10116",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2617",
        "submitter_treatment_id": "TREATMENT_10117",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2618",
        "submitter_treatment_id": "TREATMENT_10118",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2619",
        "submitter_treatment_id": "TREATMENT_10119",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2620",
        "submitter_treatment_id": "TREATMENT_10120",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2621",
        "submitter_treatment_id": "TREATMENT_10121",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2622",
        "submitter_treatment_id": "TREATMENT_10122",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2623",
        "submitter_treatment_id": "TREATMENT_10123",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2624",
        "submitter_treatment_id": "TREATMENT_10124",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2625",
        "submitter_treatment_id": "TREATMENT_10125",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2626",
        "submitter_treatment_id": "TREATMENT_10126",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2627",
        "submitter_treatment_id": "TREATMENT_10127",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2628",
        "submitter_treatment_id": "TREATMENT_10128",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2629",
        "submitter_treatment_id": "TREATMENT_10129",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2630",
        "submitter_treatment_id": "TREATMENT_10130",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2631",
        "submitter_treatment_id": "TREATMENT_10131",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2632",
        "submitter_treatment_id": "TREATMENT_10132",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2633",
        "submitter_treatment_id": "TREATMENT_10133",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2634",
        "submitter_treatment_id": "TREATMENT_10134",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2635",
        "submitter_treatment_id": "TREATMENT_10135",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2636",
        "submitter_treatment_id": "TREATMENT_10136",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2637",
        "submitter_treatment_id": "TREATMENT_10137",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2638",
        "submitter_treatment_id": "TREATMENT_10138",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2639",
        "submitter_treatment_id": "TREATMENT_10139",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2640",
        "submitter_treatment_id": "TREATMENT_10140",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2641",
        "submitter_treatment_id": "TREATMENT_10141",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2642",
        "submitter_treatment_id": "TREATMENT_10142",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2643",
        "submitter_treatment_id": "TREATMENT_10143",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2644",
        "submitter_treatment_id": "TREATMENT_10144",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2645",
        "submitter_treatment_id": "TREATMENT_10145",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2646",
        "submitter_treatment_id": "TREATMENT_10146",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2647",
        "submitter_treatment_id": "TREATMENT_10147",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2648",
        "submitter_treatment_id": "TREATMENT_10148",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2649",
        "submitter_treatment_id": "TREATMENT_10149",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2650",
        "submitter_treatment_id": "TREATMENT_10150",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2651",
        "submitter_treatment_id": "TREATMENT_10151",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2652",
        "submitter_treatment_id": "TREATMENT_10152",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2653",
        "submitter_treatment_id": "TREATMENT_10153",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2654",
        "submitter_treatment_id": "TREATMENT_10154",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2655",
        "submitter_treatment_id": "TREATMENT_10155",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2656",
        "submitter_treatment_id": "TREATMENT_10156",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2657",
        "submitter_treatment_id": "TREATMENT_10157",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2658",
        "submitter_treatment_id": "TREATMENT_10158",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2659",
        "submitter_treatment_id": "TREATMENT_10159",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2660",
        "submitter_treatment_id": "TREATMENT_10160",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2661",
        "submitter_treatment_id": "TREATMENT_10161",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2662",
        "submitter_treatment_id": "TREATMENT_10162",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2663",
        "submitter_treatment_id": "TREATMENT_10163",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2664",
        "submitter_treatment_id": "TREATMENT_10164",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2665",
        "submitter_treatment_id": "TREATMENT_10165",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2666",
        "submitter_treatment_id": "TREATMENT_10166",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2667",
        "submitter_treatment_id": "TREATMENT_10167",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2668",
        "submitter_treatment_id": "TREATMENT_10168",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2669",
        "submitter_treatment_id": "TREATMENT_10169",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2670",
        "submitter_treatment_id": "TREATMENT_10170",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2671",
        "submitter_treatment_id": "TREATMENT_10171",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2672",
        "submitter_treatment_id": "TREATMENT_10172",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2673",
        "submitter_treatment_id": "TREATMENT_10173",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2674",
        "submitter_treatment_id": "TREATMENT_10174",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2675",
        "submitter_treatment_id": "TREATMENT_10175",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2676",
        "submitter_treatment_id": "TREATMENT_10176",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2677",
        "submitter_treatment_id": "TREATMENT_10177",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2678",
        "submitter_treatment_id": "TREATMENT_10178",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2679",
        "submitter_treatment_id": "TREATMENT_10179",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2680",
        "submitter_treatment_id": "TREATMENT_10180",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2681",
        "submitter_treatment_id": "TREATMENT_10181",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2682",
        "submitter_treatment_id": "TREATMENT_10182",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2683",
        "submitter_treatment_id": "TREATMENT_10183",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2684",
        "submitter_treatment_id": "TREATMENT_10184",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2685",
        "submitter_treatment_id": "TREATMENT_10185",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2686",
        "submitter_treatment_id": "TREATMENT_10186",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2687",
        "submitter_treatment_id": "TREATMENT_10187",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2688",
        "submitter_treatment_id": "TREATMENT_10188",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2689",
        "submitter_treatment_id": "TREATMENT_10189",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2690",
        "submitter_treatment_id": "TREATMENT_10190",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2691",
        "submitter_treatment_id": "TREATMENT_10191",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2692",
        "submitter_treatment_id": "TREATMENT_10192",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2693",
        "submitter_treatment_id": "TREATMENT_10193",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2694",
        "submitter_treatment_id": "TREATMENT_10194",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2695",
        "submitter_treatment_id": "TREATMENT_10195",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2696",
        "submitter_treatment_id": "TREATMENT_10196",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2697",
        "submitter_treatment_id": "TREATMENT_10197",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2698",
        "submitter_treatment_id": "TREATMENT_10198",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2699",
        "submitter_treatment_id": "TREATMENT_10199",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2700",
        "submitter_treatment_id": "TREATMENT_10200",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2701",
        "submitter_treatment_id": "TREATMENT_10201",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2702",
        "submitter_treatment_id": "TREATMENT_10202",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2703",
        "submitter_treatment_id": "TREATMENT_10203",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2704",
        "submitter_treatment_id": "TREATMENT_10204",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2705",
        "submitter_treatment_id": "TREATMENT_10205",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2706",
        "submitter_treatment_id": "TREATMENT_10206",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2707",
        "submitter_treatment_id": "TREATMENT_10207",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2708",
        "submitter_treatment_id": "TREATMENT_10208",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2709",
        "submitter_treatment_id": "TREATMENT_10209",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2710",
        "submitter_treatment_id": "TREATMENT_10210",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2711",
        "submitter_treatment_id": "TREATMENT_10211",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2712",
        "submitter_treatment_id": "TREATMENT_10212",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2713",
        "submitter_treatment_id": "TREATMENT_10213",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2714",
        "submitter_treatment_id": "TREATMENT_10214",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2715",
        "submitter_treatment_id": "TREATMENT_10215",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2716",
        "submitter_treatment_id": "TREATMENT_10216",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2717",
        "submitter_treatment_id": "TREATMENT_10217",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2718",
        "submitter_treatment_id": "TREATMENT_10218",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2719",
        "submitter_treatment_id": "TREATMENT_10219",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2720",
        "submitter_treatment_id": "TREATMENT_10220",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2721",
        "submitter_treatment_id": "TREATMENT_10221",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2722",
        "submitter_treatment_id": "TREATMENT_10222",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2723",
        "submitter_treatment_id": "TREATMENT_10223",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2724",
        "submitter_treatment_id": "TREATMENT_10224",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2725",
        "submitter_treatment_id": "TREATMENT_10225",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2726",
        "submitter_treatment_id": "TREATMENT_10226",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2727",
        "submitter_treatment_id": "TREATMENT_10227",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2728",
        "submitter_treatment_id": "TREATMENT_10228",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2729",
        "submitter_treatment_id": "TREATMENT_10229",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2730",
        "submitter_treatment_id": "TREATMENT_10230",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2731",
        "submitter_treatment_id": "TREATMENT_10231",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2732",
        "submitter_treatment_id": "TREATMENT_10232",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2733",
        "submitter_treatment_id": "TREATMENT_10233",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2734",
        "submitter_treatment_id": "TREATMENT_10234",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2735",
        "submitter_treatment_id": "TREATMENT_10235",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2736",
        "submitter_treatment_id": "TREATMENT_10236",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2737",
        "submitter_treatment_id": "TREATMENT_10237",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2738",
        "submitter_treatment_id": "TREATMENT_10238",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2739",
        "submitter_treatment_id": "TREATMENT_10239",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2740",
        "submitter_treatment_id": "TREATMENT_10240",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2741",
        "submitter_treatment_id": "TREATMENT_10241",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2742",
        "submitter_treatment_id": "TREATMENT_10242",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2743",
        "submitter_treatment_id": "TREATMENT_10243",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2744",
        "submitter_treatment_id": "TREATMENT_10244",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2745",
        "submitter_treatment_id": "TREATMENT_10245",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2746",
        "submitter_treatment_id": "TREATMENT_10246",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2747",
        "submitter_treatment_id": "TREATMENT_10247",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2748",
        "submitter_treatment_id": "TREATMENT_10248",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2749",
        "submitter_treatment_id": "TREATMENT_10249",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2750",
        "submitter_treatment_id": "TREATMENT_10250",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2751",
        "submitter_treatment_id": "TREATMENT_10251",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2752",
        "submitter_treatment_id": "TREATMENT_10252",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2753",
        "submitter_treatment_id": "TREATMENT_10253",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2754",
        "submitter_treatment_id": "TREATMENT_10254",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2755",
        "submitter_treatment_id": "TREATMENT_10255",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2756",
        "submitter_treatment_id": "TREATMENT_10256",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2757",
        "submitter_treatment_id": "TREATMENT_10257",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2758",
        "submitter_treatment_id": "TREATMENT_10258",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2759",
        "submitter_treatment_id": "TREATMENT_10259",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2760",
        "submitter_treatment_id": "TREATMENT_10260",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2761",
        "submitter_treatment_id": "TREATMENT_10261",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2762",
        "submitter_treatment_id": "TREATMENT_10262",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2763",
        "submitter_treatment_id": "TREATMENT_10263",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2764",
        "submitter_treatment_id": "TREATMENT_10264",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2765",
        "submitter_treatment_id": "TREATMENT_10265",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2766",
        "submitter_treatment_id": "TREATMENT_10266",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2767",
        "submitter_treatment_id": "TREATMENT_10267",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2768",
        "submitter_treatment_id": "TREATMENT_10268",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2769",
        "submitter_treatment_id": "TREATMENT_10269",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2770",
        "submitter_treatment_id": "TREATMENT_10270",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2771",
        "submitter_treatment_id": "TREATMENT_10271",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2772",
        "submitter_treatment_id": "TREATMENT_10272",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2773",
        "submitter_treatment_id": "TREATMENT_10273",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2774",
        "submitter_treatment_id": "TREATMENT_10274",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2775",
        "submitter_treatment_id": "TREATMENT_10275",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2776",
        "submitter_treatment_id": "TREATMENT_10276",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2777",
        "submitter_treatment_id": "TREATMENT_10277",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2778",
        "submitter_treatment_id": "TREATMENT_10278",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2779",
        "submitter_treatment_id": "TREATMENT_10279",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2780",
        "submitter_treatment_id": "TREATMENT_10280",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2781",
        "submitter_treatment_id": "TREATMENT_10281",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2782",
        "submitter_treatment_id": "TREATMENT_10282",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2783",
        "submitter_treatment_id": "TREATMENT_10283",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2784",
        "submitter_treatment_id": "TREATMENT_10284",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2785",
        "submitter_treatment_id": "TREATMENT_10285",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2786",
        "submitter_treatment_id": "TREATMENT_10286",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2787",
        "submitter_treatment_id": "TREATMENT_10287",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2788",
        "submitter_treatment_id": "TREATMENT_10288",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2789",
        "submitter_treatment_id": "TREATMENT_10289",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2790",
        "submitter_treatment_id": "TREATMENT_10290",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2791",
        "submitter_treatment_id": "TREATMENT_10291",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2792",
        "submitter_treatment_id": "TREATMENT_10292",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2793",
        "submitter_treatment_id": "TREATMENT_10293",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2794",
        "submitter_treatment_id": "TREATMENT_10294",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2795",
        "submitter_treatment_id": "TREATMENT_10295",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2796",
        "submitter_treatment_id": "TREATMENT_10296",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2797",
        "submitter_treatment_id": "TREATMENT_10297",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2798",
        "submitter_treatment_id": "TREATMENT_10298",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2799",
        "submitter_treatment_id": "TREATMENT_10299",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2800",
        "submitter_treatment_id": "TREATMENT_10300",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2801",
        "submitter_treatment_id": "TREATMENT_10301",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2802",
        "submitter_treatment_id": "TREATMENT_10302",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2803",
        "submitter_treatment_id": "TREATMENT_10303",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2804",
        "submitter_treatment_id": "TREATMENT_10304",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2805",
        "submitter_treatment_id": "TREATMENT_10305",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2806",
        "submitter_treatment_id": "TREATMENT_10306",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2807",
        "submitter_treatment_id": "TREATMENT_10307",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2808",
        "submitter_treatment_id": "TREATMENT_10308",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2809",
        "submitter_treatment_id": "TREATMENT_10309",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2810",
        "submitter_treatment_id": "TREATMENT_10310",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2811",
        "submitter_treatment_id": "TREATMENT_10311",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2812",
        "submitter_treatment_id": "TREATMENT_10312",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2813",
        "submitter_treatment_id": "TREATMENT_10313",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2814",
        "submitter_treatment_id": "TREATMENT_10314",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2815",
        "submitter_treatment_id": "TREATMENT_10315",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2816",
        "submitter_treatment_id": "TREATMENT_10316",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2817",
        "submitter_treatment_id": "TREATMENT_10317",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2818",
        "submitter_treatment_id": "TREATMENT_10318",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2819",
        "submitter_treatment_id": "TREATMENT_10319",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2820",
        "submitter_treatment_id": "TREATMENT_10320",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2821",
        "submitter_treatment_id": "TREATMENT_10321",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2822",
        "submitter_treatment_id": "TREATMENT_10322",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2823",
        "submitter_treatment_id": "TREATMENT_10323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2824",
        "submitter_treatment_id": "TREATMENT_10324",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2825",
        "submitter_treatment_id": "TREATMENT_10325",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2826",
        "submitter_treatment_id": "TREATMENT_10326",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2827",
        "submitter_treatment_id": "TREATMENT_10327",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2828",
        "submitter_treatment_id": "TREATMENT_10328",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2829",
        "submitter_treatment_id": "TREATMENT_10329",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2830",
        "submitter_treatment_id": "TREATMENT_10330",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2831",
        "submitter_treatment_id": "TREATMENT_10331",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2832",
        "submitter_treatment_id": "TREATMENT_10332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2833",
        "submitter_treatment_id": "TREATMENT_10333",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2834",
        "submitter_treatment_id": "TREATMENT_10334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2835",
        "submitter_treatment_id": "TREATMENT_10335",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2836",
        "submitter_treatment_id": "TREATMENT_10336",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2837",
        "submitter_treatment_id": "TREATMENT_10337",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2838",
        "submitter_treatment_id": "TREATMENT_10338",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2839",
        "submitter_treatment_id": "TREATMENT_10339",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2840",
        "submitter_treatment_id": "TREATMENT_10340",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2841",
        "submitter_treatment_id": "TREATMENT_10341",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2842",
        "submitter_treatment_id": "TREATMENT_10342",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2843",
        "submitter_treatment_id": "TREATMENT_10343",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2844",
        "submitter_treatment_id": "TREATMENT_10344",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2845",
        "submitter_treatment_id": "TREATMENT_10345",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2846",
        "submitter_treatment_id": "TREATMENT_10346",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2847",
        "submitter_treatment_id": "TREATMENT_10347",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2848",
        "submitter_treatment_id": "TREATMENT_10348",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2849",
        "submitter_treatment_id": "TREATMENT_10349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2850",
        "submitter_treatment_id": "TREATMENT_10350",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2851",
        "submitter_treatment_id": "TREATMENT_10351",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2852",
        "submitter_treatment_id": "TREATMENT_10352",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2853",
        "submitter_treatment_id": "TREATMENT_10353",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2854",
        "submitter_treatment_id": "TREATMENT_10354",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2855",
        "submitter_treatment_id": "TREATMENT_10355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2856",
        "submitter_treatment_id": "TREATMENT_10356",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2857",
        "submitter_treatment_id": "TREATMENT_10357",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2858",
        "submitter_treatment_id": "TREATMENT_10358",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2859",
        "submitter_treatment_id": "TREATMENT_10359",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2860",
        "submitter_treatment_id": "TREATMENT_10360",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2861",
        "submitter_treatment_id": "TREATMENT_10361",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2862",
        "submitter_treatment_id": "TREATMENT_10362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2863",
        "submitter_treatment_id": "TREATMENT_10363",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2864",
        "submitter_treatment_id": "TREATMENT_10364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2865",
        "submitter_treatment_id": "TREATMENT_10365",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2866",
        "submitter_treatment_id": "TREATMENT_10366",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2867",
        "submitter_treatment_id": "TREATMENT_10367",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2868",
        "submitter_treatment_id": "TREATMENT_10368",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2869",
        "submitter_treatment_id": "TREATMENT_10369",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2870",
        "submitter_treatment_id": "TREATMENT_10370",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2871",
        "submitter_treatment_id": "TREATMENT_10371",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2872",
        "submitter_treatment_id": "TREATMENT_10372",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2873",
        "submitter_treatment_id": "TREATMENT_10373",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2874",
        "submitter_treatment_id": "TREATMENT_10374",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2875",
        "submitter_treatment_id": "TREATMENT_10375",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2876",
        "submitter_treatment_id": "TREATMENT_10376",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2877",
        "submitter_treatment_id": "TREATMENT_10377",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2878",
        "submitter_treatment_id": "TREATMENT_10378",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2879",
        "submitter_treatment_id": "TREATMENT_10379",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2880",
        "submitter_treatment_id": "TREATMENT_10380",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2881",
        "submitter_treatment_id": "TREATMENT_10381",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2882",
        "submitter_treatment_id": "TREATMENT_10382",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2883",
        "submitter_treatment_id": "TREATMENT_10383",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2884",
        "submitter_treatment_id": "TREATMENT_10384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2885",
        "submitter_treatment_id": "TREATMENT_10385",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2886",
        "submitter_treatment_id": "TREATMENT_10386",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2887",
        "submitter_treatment_id": "TREATMENT_10387",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2888",
        "submitter_treatment_id": "TREATMENT_10388",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2889",
        "submitter_treatment_id": "TREATMENT_10389",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2890",
        "submitter_treatment_id": "TREATMENT_10390",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2891",
        "submitter_treatment_id": "TREATMENT_10391",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2892",
        "submitter_treatment_id": "TREATMENT_10392",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2893",
        "submitter_treatment_id": "TREATMENT_10393",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2894",
        "submitter_treatment_id": "TREATMENT_10394",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2895",
        "submitter_treatment_id": "TREATMENT_10395",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2896",
        "submitter_treatment_id": "TREATMENT_10396",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2897",
        "submitter_treatment_id": "TREATMENT_10397",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2898",
        "submitter_treatment_id": "TREATMENT_10398",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2899",
        "submitter_treatment_id": "TREATMENT_10399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2900",
        "submitter_treatment_id": "TREATMENT_10400",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2901",
        "submitter_treatment_id": "TREATMENT_10401",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2902",
        "submitter_treatment_id": "TREATMENT_10402",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2903",
        "submitter_treatment_id": "TREATMENT_10403",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2904",
        "submitter_treatment_id": "TREATMENT_10404",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2905",
        "submitter_treatment_id": "TREATMENT_10405",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2906",
        "submitter_treatment_id": "TREATMENT_10406",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2907",
        "submitter_treatment_id": "TREATMENT_10407",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2908",
        "submitter_treatment_id": "TREATMENT_10408",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2909",
        "submitter_treatment_id": "TREATMENT_10409",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2910",
        "submitter_treatment_id": "TREATMENT_10410",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2911",
        "submitter_treatment_id": "TREATMENT_10411",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2912",
        "submitter_treatment_id": "TREATMENT_10412",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2913",
        "submitter_treatment_id": "TREATMENT_10413",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2914",
        "submitter_treatment_id": "TREATMENT_10414",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2915",
        "submitter_treatment_id": "TREATMENT_10415",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2916",
        "submitter_treatment_id": "TREATMENT_10416",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2917",
        "submitter_treatment_id": "TREATMENT_10417",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2918",
        "submitter_treatment_id": "TREATMENT_10418",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2919",
        "submitter_treatment_id": "TREATMENT_10419",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2920",
        "submitter_treatment_id": "TREATMENT_10420",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2921",
        "submitter_treatment_id": "TREATMENT_10421",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2922",
        "submitter_treatment_id": "TREATMENT_10422",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2923",
        "submitter_treatment_id": "TREATMENT_10423",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2924",
        "submitter_treatment_id": "TREATMENT_10424",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2925",
        "submitter_treatment_id": "TREATMENT_10425",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2926",
        "submitter_treatment_id": "TREATMENT_10426",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2927",
        "submitter_treatment_id": "TREATMENT_10427",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2928",
        "submitter_treatment_id": "TREATMENT_10428",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2929",
        "submitter_treatment_id": "TREATMENT_10429",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2930",
        "submitter_treatment_id": "TREATMENT_10430",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2931",
        "submitter_treatment_id": "TREATMENT_10431",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2932",
        "submitter_treatment_id": "TREATMENT_10432",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2933",
        "submitter_treatment_id": "TREATMENT_10433",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2934",
        "submitter_treatment_id": "TREATMENT_10434",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2935",
        "submitter_treatment_id": "TREATMENT_10435",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2936",
        "submitter_treatment_id": "TREATMENT_10436",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2937",
        "submitter_treatment_id": "TREATMENT_10437",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2938",
        "submitter_treatment_id": "TREATMENT_10438",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2939",
        "submitter_treatment_id": "TREATMENT_10439",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2940",
        "submitter_treatment_id": "TREATMENT_10440",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2941",
        "submitter_treatment_id": "TREATMENT_10441",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2942",
        "submitter_treatment_id": "TREATMENT_10442",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2943",
        "submitter_treatment_id": "TREATMENT_10443",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2944",
        "submitter_treatment_id": "TREATMENT_10444",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2945",
        "submitter_treatment_id": "TREATMENT_10445",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2946",
        "submitter_treatment_id": "TREATMENT_10446",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2947",
        "submitter_treatment_id": "TREATMENT_10447",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2948",
        "submitter_treatment_id": "TREATMENT_10448",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2949",
        "submitter_treatment_id": "TREATMENT_10449",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2950",
        "submitter_treatment_id": "TREATMENT_10450",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2951",
        "submitter_treatment_id": "TREATMENT_10451",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2952",
        "submitter_treatment_id": "TREATMENT_10452",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2953",
        "submitter_treatment_id": "TREATMENT_10453",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2954",
        "submitter_treatment_id": "TREATMENT_10454",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2955",
        "submitter_treatment_id": "TREATMENT_10455",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2956",
        "submitter_treatment_id": "TREATMENT_10456",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2957",
        "submitter_treatment_id": "TREATMENT_10457",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2958",
        "submitter_treatment_id": "TREATMENT_10458",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2959",
        "submitter_treatment_id": "TREATMENT_10459",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2960",
        "submitter_treatment_id": "TREATMENT_10460",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2961",
        "submitter_treatment_id": "TREATMENT_10461",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2962",
        "submitter_treatment_id": "TREATMENT_10462",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2963",
        "submitter_treatment_id": "TREATMENT_10463",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2964",
        "submitter_treatment_id": "TREATMENT_10464",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2965",
        "submitter_treatment_id": "TREATMENT_10465",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2966",
        "submitter_treatment_id": "TREATMENT_10466",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2967",
        "submitter_treatment_id": "TREATMENT_10467",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2968",
        "submitter_treatment_id": "TREATMENT_10468",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2969",
        "submitter_treatment_id": "TREATMENT_10469",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2970",
        "submitter_treatment_id": "TREATMENT_10470",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2971",
        "submitter_treatment_id": "TREATMENT_10471",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2972",
        "submitter_treatment_id": "TREATMENT_10472",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2973",
        "submitter_treatment_id": "TREATMENT_10473",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2974",
        "submitter_treatment_id": "TREATMENT_10474",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2975",
        "submitter_treatment_id": "TREATMENT_10475",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2976",
        "submitter_treatment_id": "TREATMENT_10476",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2977",
        "submitter_treatment_id": "TREATMENT_10477",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2978",
        "submitter_treatment_id": "TREATMENT_10478",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2979",
        "submitter_treatment_id": "TREATMENT_10479",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2980",
        "submitter_treatment_id": "TREATMENT_10480",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2981",
        "submitter_treatment_id": "TREATMENT_10481",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2982",
        "submitter_treatment_id": "TREATMENT_10482",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2983",
        "submitter_treatment_id": "TREATMENT_10483",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2984",
        "submitter_treatment_id": "TREATMENT_10484",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2985",
        "submitter_treatment_id": "TREATMENT_10485",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2986",
        "submitter_treatment_id": "TREATMENT_10486",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2987",
        "submitter_treatment_id": "TREATMENT_10487",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2988",
        "submitter_treatment_id": "TREATMENT_10488",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2989",
        "submitter_treatment_id": "TREATMENT_10489",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2990",
        "submitter_treatment_id": "TREATMENT_10490",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2991",
        "submitter_treatment_id": "TREATMENT_10491",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2992",
        "submitter_treatment_id": "TREATMENT_10492",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2993",
        "submitter_treatment_id": "TREATMENT_10493",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2994",
        "submitter_treatment_id": "TREATMENT_10494",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2995",
        "submitter_treatment_id": "TREATMENT_10495",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2996",
        "submitter_treatment_id": "TREATMENT_10496",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2997",
        "submitter_treatment_id": "TREATMENT_10497",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2998",
        "submitter_treatment_id": "TREATMENT_10498",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2999",
        "submitter_treatment_id": "TREATMENT_10499",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_3000",
        "submitter_treatment_id": "TREATMENT_10500",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2501",
        "submitter_treatment_id": "TREATMENT_10501",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2502",
        "submitter_treatment_id": "TREATMENT_10502",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2503",
        "submitter_treatment_id": "TREATMENT_10503",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2504",
        "submitter_treatment_id": "TREATMENT_10504",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2505",
        "submitter_treatment_id": "TREATMENT_10505",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2506",
        "submitter_treatment_id": "TREATMENT_10506",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2507",
        "submitter_treatment_id": "TREATMENT_10507",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2508",
        "submitter_treatment_id": "TREATMENT_10508",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2509",
        "submitter_treatment_id": "TREATMENT_10509",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2510",
        "submitter_treatment_id": "TREATMENT_10510",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2511",
        "submitter_treatment_id": "TREATMENT_10511",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2512",
        "submitter_treatment_id": "TREATMENT_10512",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2513",
        "submitter_treatment_id": "TREATMENT_10513",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2514",
        "submitter_treatment_id": "TREATMENT_10514",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2515",
        "submitter_treatment_id": "TREATMENT_10515",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2516",
        "submitter_treatment_id": "TREATMENT_10516",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2517",
        "submitter_treatment_id": "TREATMENT_10517",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2518",
        "submitter_treatment_id": "TREATMENT_10518",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2519",
        "submitter_treatment_id": "TREATMENT_10519",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2520",
        "submitter_treatment_id": "TREATMENT_10520",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2521",
        "submitter_treatment_id": "TREATMENT_10521",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2522",
        "submitter_treatment_id": "TREATMENT_10522",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2523",
        "submitter_treatment_id": "TREATMENT_10523",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2524",
        "submitter_treatment_id": "TREATMENT_10524",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2525",
        "submitter_treatment_id": "TREATMENT_10525",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2526",
        "submitter_treatment_id": "TREATMENT_10526",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2527",
        "submitter_treatment_id": "TREATMENT_10527",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2528",
        "submitter_treatment_id": "TREATMENT_10528",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2529",
        "submitter_treatment_id": "TREATMENT_10529",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2530",
        "submitter_treatment_id": "TREATMENT_10530",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2531",
        "submitter_treatment_id": "TREATMENT_10531",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2532",
        "submitter_treatment_id": "TREATMENT_10532",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2533",
        "submitter_treatment_id": "TREATMENT_10533",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2534",
        "submitter_treatment_id": "TREATMENT_10534",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2535",
        "submitter_treatment_id": "TREATMENT_10535",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2536",
        "submitter_treatment_id": "TREATMENT_10536",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2537",
        "submitter_treatment_id": "TREATMENT_10537",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2538",
        "submitter_treatment_id": "TREATMENT_10538",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2539",
        "submitter_treatment_id": "TREATMENT_10539",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2540",
        "submitter_treatment_id": "TREATMENT_10540",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2541",
        "submitter_treatment_id": "TREATMENT_10541",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2542",
        "submitter_treatment_id": "TREATMENT_10542",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2543",
        "submitter_treatment_id": "TREATMENT_10543",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2544",
        "submitter_treatment_id": "TREATMENT_10544",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2545",
        "submitter_treatment_id": "TREATMENT_10545",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2546",
        "submitter_treatment_id": "TREATMENT_10546",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2547",
        "submitter_treatment_id": "TREATMENT_10547",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2548",
        "submitter_treatment_id": "TREATMENT_10548",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2549",
        "submitter_treatment_id": "TREATMENT_10549",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2550",
        "submitter_treatment_id": "TREATMENT_10550",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2551",
        "submitter_treatment_id": "TREATMENT_10551",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2552",
        "submitter_treatment_id": "TREATMENT_10552",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2553",
        "submitter_treatment_id": "TREATMENT_10553",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2554",
        "submitter_treatment_id": "TREATMENT_10554",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2555",
        "submitter_treatment_id": "TREATMENT_10555",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2556",
        "submitter_treatment_id": "TREATMENT_10556",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2557",
        "submitter_treatment_id": "TREATMENT_10557",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2558",
        "submitter_treatment_id": "TREATMENT_10558",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2559",
        "submitter_treatment_id": "TREATMENT_10559",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2560",
        "submitter_treatment_id": "TREATMENT_10560",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2561",
        "submitter_treatment_id": "TREATMENT_10561",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2562",
        "submitter_treatment_id": "TREATMENT_10562",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2563",
        "submitter_treatment_id": "TREATMENT_10563",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2564",
        "submitter_treatment_id": "TREATMENT_10564",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2565",
        "submitter_treatment_id": "TREATMENT_10565",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2566",
        "submitter_treatment_id": "TREATMENT_10566",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2567",
        "submitter_treatment_id": "TREATMENT_10567",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2568",
        "submitter_treatment_id": "TREATMENT_10568",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2569",
        "submitter_treatment_id": "TREATMENT_10569",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2570",
        "submitter_treatment_id": "TREATMENT_10570",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2571",
        "submitter_treatment_id": "TREATMENT_10571",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2572",
        "submitter_treatment_id": "TREATMENT_10572",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2573",
        "submitter_treatment_id": "TREATMENT_10573",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2574",
        "submitter_treatment_id": "TREATMENT_10574",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2575",
        "submitter_treatment_id": "TREATMENT_10575",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2576",
        "submitter_treatment_id": "TREATMENT_10576",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2577",
        "submitter_treatment_id": "TREATMENT_10577",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2578",
        "submitter_treatment_id": "TREATMENT_10578",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2579",
        "submitter_treatment_id": "TREATMENT_10579",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2580",
        "submitter_treatment_id": "TREATMENT_10580",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2581",
        "submitter_treatment_id": "TREATMENT_10581",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2582",
        "submitter_treatment_id": "TREATMENT_10582",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2583",
        "submitter_treatment_id": "TREATMENT_10583",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2584",
        "submitter_treatment_id": "TREATMENT_10584",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2585",
        "submitter_treatment_id": "TREATMENT_10585",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2586",
        "submitter_treatment_id": "TREATMENT_10586",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2587",
        "submitter_treatment_id": "TREATMENT_10587",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2588",
        "submitter_treatment_id": "TREATMENT_10588",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2589",
        "submitter_treatment_id": "TREATMENT_10589",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2590",
        "submitter_treatment_id": "TREATMENT_10590",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2591",
        "submitter_treatment_id": "TREATMENT_10591",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2592",
        "submitter_treatment_id": "TREATMENT_10592",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2593",
        "submitter_treatment_id": "TREATMENT_10593",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2594",
        "submitter_treatment_id": "TREATMENT_10594",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2595",
        "submitter_treatment_id": "TREATMENT_10595",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2596",
        "submitter_treatment_id": "TREATMENT_10596",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2597",
        "submitter_treatment_id": "TREATMENT_10597",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2598",
        "submitter_treatment_id": "TREATMENT_10598",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2599",
        "submitter_treatment_id": "TREATMENT_10599",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2600",
        "submitter_treatment_id": "TREATMENT_10600",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2601",
        "submitter_treatment_id": "TREATMENT_10601",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2602",
        "submitter_treatment_id": "TREATMENT_10602",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2603",
        "submitter_treatment_id": "TREATMENT_10603",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2604",
        "submitter_treatment_id": "TREATMENT_10604",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2605",
        "submitter_treatment_id": "TREATMENT_10605",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2606",
        "submitter_treatment_id": "TREATMENT_10606",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2607",
        "submitter_treatment_id": "TREATMENT_10607",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2608",
        "submitter_treatment_id": "TREATMENT_10608",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2609",
        "submitter_treatment_id": "TREATMENT_10609",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2610",
        "submitter_treatment_id": "TREATMENT_10610",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2611",
        "submitter_treatment_id": "TREATMENT_10611",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2612",
        "submitter_treatment_id": "TREATMENT_10612",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2613",
        "submitter_treatment_id": "TREATMENT_10613",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2614",
        "submitter_treatment_id": "TREATMENT_10614",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2615",
        "submitter_treatment_id": "TREATMENT_10615",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2616",
        "submitter_treatment_id": "TREATMENT_10616",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2617",
        "submitter_treatment_id": "TREATMENT_10617",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2618",
        "submitter_treatment_id": "TREATMENT_10618",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2619",
        "submitter_treatment_id": "TREATMENT_10619",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2620",
        "submitter_treatment_id": "TREATMENT_10620",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2621",
        "submitter_treatment_id": "TREATMENT_10621",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2622",
        "submitter_treatment_id": "TREATMENT_10622",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2623",
        "submitter_treatment_id": "TREATMENT_10623",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2624",
        "submitter_treatment_id": "TREATMENT_10624",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2625",
        "submitter_treatment_id": "TREATMENT_10625",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2626",
        "submitter_treatment_id": "TREATMENT_10626",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2627",
        "submitter_treatment_id": "TREATMENT_10627",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2628",
        "submitter_treatment_id": "TREATMENT_10628",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2629",
        "submitter_treatment_id": "TREATMENT_10629",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2630",
        "submitter_treatment_id": "TREATMENT_10630",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2631",
        "submitter_treatment_id": "TREATMENT_10631",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2632",
        "submitter_treatment_id": "TREATMENT_10632",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2633",
        "submitter_treatment_id": "TREATMENT_10633",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2634",
        "submitter_treatment_id": "TREATMENT_10634",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2635",
        "submitter_treatment_id": "TREATMENT_10635",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2636",
        "submitter_treatment_id": "TREATMENT_10636",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2637",
        "submitter_treatment_id": "TREATMENT_10637",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2638",
        "submitter_treatment_id": "TREATMENT_10638",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2639",
        "submitter_treatment_id": "TREATMENT_10639",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2640",
        "submitter_treatment_id": "TREATMENT_10640",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2641",
        "submitter_treatment_id": "TREATMENT_10641",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2642",
        "submitter_treatment_id": "TREATMENT_10642",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2643",
        "submitter_treatment_id": "TREATMENT_10643",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2644",
        "submitter_treatment_id": "TREATMENT_10644",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2645",
        "submitter_treatment_id": "TREATMENT_10645",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2646",
        "submitter_treatment_id": "TREATMENT_10646",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2647",
        "submitter_treatment_id": "TREATMENT_10647",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2648",
        "submitter_treatment_id": "TREATMENT_10648",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2649",
        "submitter_treatment_id": "TREATMENT_10649",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2650",
        "submitter_treatment_id": "TREATMENT_10650",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2651",
        "submitter_treatment_id": "TREATMENT_10651",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2652",
        "submitter_treatment_id": "TREATMENT_10652",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2653",
        "submitter_treatment_id": "TREATMENT_10653",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2654",
        "submitter_treatment_id": "TREATMENT_10654",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2655",
        "submitter_treatment_id": "TREATMENT_10655",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2656",
        "submitter_treatment_id": "TREATMENT_10656",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2657",
        "submitter_treatment_id": "TREATMENT_10657",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2658",
        "submitter_treatment_id": "TREATMENT_10658",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2659",
        "submitter_treatment_id": "TREATMENT_10659",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2660",
        "submitter_treatment_id": "TREATMENT_10660",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2661",
        "submitter_treatment_id": "TREATMENT_10661",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2662",
        "submitter_treatment_id": "TREATMENT_10662",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2663",
        "submitter_treatment_id": "TREATMENT_10663",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2664",
        "submitter_treatment_id": "TREATMENT_10664",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2665",
        "submitter_treatment_id": "TREATMENT_10665",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2666",
        "submitter_treatment_id": "TREATMENT_10666",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2667",
        "submitter_treatment_id": "TREATMENT_10667",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2668",
        "submitter_treatment_id": "TREATMENT_10668",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2669",
        "submitter_treatment_id": "TREATMENT_10669",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2670",
        "submitter_treatment_id": "TREATMENT_10670",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2671",
        "submitter_treatment_id": "TREATMENT_10671",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2672",
        "submitter_treatment_id": "TREATMENT_10672",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2673",
        "submitter_treatment_id": "TREATMENT_10673",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2674",
        "submitter_treatment_id": "TREATMENT_10674",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2675",
        "submitter_treatment_id": "TREATMENT_10675",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2676",
        "submitter_treatment_id": "TREATMENT_10676",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2677",
        "submitter_treatment_id": "TREATMENT_10677",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2678",
        "submitter_treatment_id": "TREATMENT_10678",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2679",
        "submitter_treatment_id": "TREATMENT_10679",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2680",
        "submitter_treatment_id": "TREATMENT_10680",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2681",
        "submitter_treatment_id": "TREATMENT_10681",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2682",
        "submitter_treatment_id": "TREATMENT_10682",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2683",
        "submitter_treatment_id": "TREATMENT_10683",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2684",
        "submitter_treatment_id": "TREATMENT_10684",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2685",
        "submitter_treatment_id": "TREATMENT_10685",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2686",
        "submitter_treatment_id": "TREATMENT_10686",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2687",
        "submitter_treatment_id": "TREATMENT_10687",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2688",
        "submitter_treatment_id": "TREATMENT_10688",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2689",
        "submitter_treatment_id": "TREATMENT_10689",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2690",
        "submitter_treatment_id": "TREATMENT_10690",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2691",
        "submitter_treatment_id": "TREATMENT_10691",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2692",
        "submitter_treatment_id": "TREATMENT_10692",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2693",
        "submitter_treatment_id": "TREATMENT_10693",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2694",
        "submitter_treatment_id": "TREATMENT_10694",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2695",
        "submitter_treatment_id": "TREATMENT_10695",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2696",
        "submitter_treatment_id": "TREATMENT_10696",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2697",
        "submitter_treatment_id": "TREATMENT_10697",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2698",
        "submitter_treatment_id": "TREATMENT_10698",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2699",
        "submitter_treatment_id": "TREATMENT_10699",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2700",
        "submitter_treatment_id": "TREATMENT_10700",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2701",
        "submitter_treatment_id": "TREATMENT_10701",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2702",
        "submitter_treatment_id": "TREATMENT_10702",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2703",
        "submitter_treatment_id": "TREATMENT_10703",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2704",
        "submitter_treatment_id": "TREATMENT_10704",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2705",
        "submitter_treatment_id": "TREATMENT_10705",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2706",
        "submitter_treatment_id": "TREATMENT_10706",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2707",
        "submitter_treatment_id": "TREATMENT_10707",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2708",
        "submitter_treatment_id": "TREATMENT_10708",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2709",
        "submitter_treatment_id": "TREATMENT_10709",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2710",
        "submitter_treatment_id": "TREATMENT_10710",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2711",
        "submitter_treatment_id": "TREATMENT_10711",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2712",
        "submitter_treatment_id": "TREATMENT_10712",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2713",
        "submitter_treatment_id": "TREATMENT_10713",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2714",
        "submitter_treatment_id": "TREATMENT_10714",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2715",
        "submitter_treatment_id": "TREATMENT_10715",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2716",
        "submitter_treatment_id": "TREATMENT_10716",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2717",
        "submitter_treatment_id": "TREATMENT_10717",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2718",
        "submitter_treatment_id": "TREATMENT_10718",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2719",
        "submitter_treatment_id": "TREATMENT_10719",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2720",
        "submitter_treatment_id": "TREATMENT_10720",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2721",
        "submitter_treatment_id": "TREATMENT_10721",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2722",
        "submitter_treatment_id": "TREATMENT_10722",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2723",
        "submitter_treatment_id": "TREATMENT_10723",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2724",
        "submitter_treatment_id": "TREATMENT_10724",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2725",
        "submitter_treatment_id": "TREATMENT_10725",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2726",
        "submitter_treatment_id": "TREATMENT_10726",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2727",
        "submitter_treatment_id": "TREATMENT_10727",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2728",
        "submitter_treatment_id": "TREATMENT_10728",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2729",
        "submitter_treatment_id": "TREATMENT_10729",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2730",
        "submitter_treatment_id": "TREATMENT_10730",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2731",
        "submitter_treatment_id": "TREATMENT_10731",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2732",
        "submitter_treatment_id": "TREATMENT_10732",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2733",
        "submitter_treatment_id": "TREATMENT_10733",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2734",
        "submitter_treatment_id": "TREATMENT_10734",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2735",
        "submitter_treatment_id": "TREATMENT_10735",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2736",
        "submitter_treatment_id": "TREATMENT_10736",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2737",
        "submitter_treatment_id": "TREATMENT_10737",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2738",
        "submitter_treatment_id": "TREATMENT_10738",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2739",
        "submitter_treatment_id": "TREATMENT_10739",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2740",
        "submitter_treatment_id": "TREATMENT_10740",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2741",
        "submitter_treatment_id": "TREATMENT_10741",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2742",
        "submitter_treatment_id": "TREATMENT_10742",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2743",
        "submitter_treatment_id": "TREATMENT_10743",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2744",
        "submitter_treatment_id": "TREATMENT_10744",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2745",
        "submitter_treatment_id": "TREATMENT_10745",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2746",
        "submitter_treatment_id": "TREATMENT_10746",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2747",
        "submitter_treatment_id": "TREATMENT_10747",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2748",
        "submitter_treatment_id": "TREATMENT_10748",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2749",
        "submitter_treatment_id": "TREATMENT_10749",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2750",
        "submitter_treatment_id": "TREATMENT_10750",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2751",
        "submitter_treatment_id": "TREATMENT_10751",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2752",
        "submitter_treatment_id": "TREATMENT_10752",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2753",
        "submitter_treatment_id": "TREATMENT_10753",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2754",
        "submitter_treatment_id": "TREATMENT_10754",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2755",
        "submitter_treatment_id": "TREATMENT_10755",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2756",
        "submitter_treatment_id": "TREATMENT_10756",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2757",
        "submitter_treatment_id": "TREATMENT_10757",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2758",
        "submitter_treatment_id": "TREATMENT_10758",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2759",
        "submitter_treatment_id": "TREATMENT_10759",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2760",
        "submitter_treatment_id": "TREATMENT_10760",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2761",
        "submitter_treatment_id": "TREATMENT_10761",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2762",
        "submitter_treatment_id": "TREATMENT_10762",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2763",
        "submitter_treatment_id": "TREATMENT_10763",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2764",
        "submitter_treatment_id": "TREATMENT_10764",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2765",
        "submitter_treatment_id": "TREATMENT_10765",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2766",
        "submitter_treatment_id": "TREATMENT_10766",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2767",
        "submitter_treatment_id": "TREATMENT_10767",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2768",
        "submitter_treatment_id": "TREATMENT_10768",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2769",
        "submitter_treatment_id": "TREATMENT_10769",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2770",
        "submitter_treatment_id": "TREATMENT_10770",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2771",
        "submitter_treatment_id": "TREATMENT_10771",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2772",
        "submitter_treatment_id": "TREATMENT_10772",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2773",
        "submitter_treatment_id": "TREATMENT_10773",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2774",
        "submitter_treatment_id": "TREATMENT_10774",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2775",
        "submitter_treatment_id": "TREATMENT_10775",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2776",
        "submitter_treatment_id": "TREATMENT_10776",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2777",
        "submitter_treatment_id": "TREATMENT_10777",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2778",
        "submitter_treatment_id": "TREATMENT_10778",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2779",
        "submitter_treatment_id": "TREATMENT_10779",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2780",
        "submitter_treatment_id": "TREATMENT_10780",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2781",
        "submitter_treatment_id": "TREATMENT_10781",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2782",
        "submitter_treatment_id": "TREATMENT_10782",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2783",
        "submitter_treatment_id": "TREATMENT_10783",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2784",
        "submitter_treatment_id": "TREATMENT_10784",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2785",
        "submitter_treatment_id": "TREATMENT_10785",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2786",
        "submitter_treatment_id": "TREATMENT_10786",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2787",
        "submitter_treatment_id": "TREATMENT_10787",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2788",
        "submitter_treatment_id": "TREATMENT_10788",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2789",
        "submitter_treatment_id": "TREATMENT_10789",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2790",
        "submitter_treatment_id": "TREATMENT_10790",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2791",
        "submitter_treatment_id": "TREATMENT_10791",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2792",
        "submitter_treatment_id": "TREATMENT_10792",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2793",
        "submitter_treatment_id": "TREATMENT_10793",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2794",
        "submitter_treatment_id": "TREATMENT_10794",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2795",
        "submitter_treatment_id": "TREATMENT_10795",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2796",
        "submitter_treatment_id": "TREATMENT_10796",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2797",
        "submitter_treatment_id": "TREATMENT_10797",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2798",
        "submitter_treatment_id": "TREATMENT_10798",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2799",
        "submitter_treatment_id": "TREATMENT_10799",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2800",
        "submitter_treatment_id": "TREATMENT_10800",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2801",
        "submitter_treatment_id": "TREATMENT_10801",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2802",
        "submitter_treatment_id": "TREATMENT_10802",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2803",
        "submitter_treatment_id": "TREATMENT_10803",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2804",
        "submitter_treatment_id": "TREATMENT_10804",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2805",
        "submitter_treatment_id": "TREATMENT_10805",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2806",
        "submitter_treatment_id": "TREATMENT_10806",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2807",
        "submitter_treatment_id": "TREATMENT_10807",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2808",
        "submitter_treatment_id": "TREATMENT_10808",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2809",
        "submitter_treatment_id": "TREATMENT_10809",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2810",
        "submitter_treatment_id": "TREATMENT_10810",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2811",
        "submitter_treatment_id": "TREATMENT_10811",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2812",
        "submitter_treatment_id": "TREATMENT_10812",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2813",
        "submitter_treatment_id": "TREATMENT_10813",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2814",
        "submitter_treatment_id": "TREATMENT_10814",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2815",
        "submitter_treatment_id": "TREATMENT_10815",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2816",
        "submitter_treatment_id": "TREATMENT_10816",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2817",
        "submitter_treatment_id": "TREATMENT_10817",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2818",
        "submitter_treatment_id": "TREATMENT_10818",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2819",
        "submitter_treatment_id": "TREATMENT_10819",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2820",
        "submitter_treatment_id": "TREATMENT_10820",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2821",
        "submitter_treatment_id": "TREATMENT_10821",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2822",
        "submitter_treatment_id": "TREATMENT_10822",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2823",
        "submitter_treatment_id": "TREATMENT_10823",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2824",
        "submitter_treatment_id": "TREATMENT_10824",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2825",
        "submitter_treatment_id": "TREATMENT_10825",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2826",
        "submitter_treatment_id": "TREATMENT_10826",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2827",
        "submitter_treatment_id": "TREATMENT_10827",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2828",
        "submitter_treatment_id": "TREATMENT_10828",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2829",
        "submitter_treatment_id": "TREATMENT_10829",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2830",
        "submitter_treatment_id": "TREATMENT_10830",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2831",
        "submitter_treatment_id": "TREATMENT_10831",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2832",
        "submitter_treatment_id": "TREATMENT_10832",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2833",
        "submitter_treatment_id": "TREATMENT_10833",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2834",
        "submitter_treatment_id": "TREATMENT_10834",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2835",
        "submitter_treatment_id": "TREATMENT_10835",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2836",
        "submitter_treatment_id": "TREATMENT_10836",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2837",
        "submitter_treatment_id": "TREATMENT_10837",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2838",
        "submitter_treatment_id": "TREATMENT_10838",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2839",
        "submitter_treatment_id": "TREATMENT_10839",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2840",
        "submitter_treatment_id": "TREATMENT_10840",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2841",
        "submitter_treatment_id": "TREATMENT_10841",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2842",
        "submitter_treatment_id": "TREATMENT_10842",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2843",
        "submitter_treatment_id": "TREATMENT_10843",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2844",
        "submitter_treatment_id": "TREATMENT_10844",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2845",
        "submitter_treatment_id": "TREATMENT_10845",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2846",
        "submitter_treatment_id": "TREATMENT_10846",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2847",
        "submitter_treatment_id": "TREATMENT_10847",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2848",
        "submitter_treatment_id": "TREATMENT_10848",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2849",
        "submitter_treatment_id": "TREATMENT_10849",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2850",
        "submitter_treatment_id": "TREATMENT_10850",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2851",
        "submitter_treatment_id": "TREATMENT_10851",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2852",
        "submitter_treatment_id": "TREATMENT_10852",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2853",
        "submitter_treatment_id": "TREATMENT_10853",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2854",
        "submitter_treatment_id": "TREATMENT_10854",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2855",
        "submitter_treatment_id": "TREATMENT_10855",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2856",
        "submitter_treatment_id": "TREATMENT_10856",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2857",
        "submitter_treatment_id": "TREATMENT_10857",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2858",
        "submitter_treatment_id": "TREATMENT_10858",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2859",
        "submitter_treatment_id": "TREATMENT_10859",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2860",
        "submitter_treatment_id": "TREATMENT_10860",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2861",
        "submitter_treatment_id": "TREATMENT_10861",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2862",
        "submitter_treatment_id": "TREATMENT_10862",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2863",
        "submitter_treatment_id": "TREATMENT_10863",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2864",
        "submitter_treatment_id": "TREATMENT_10864",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2865",
        "submitter_treatment_id": "TREATMENT_10865",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2866",
        "submitter_treatment_id": "TREATMENT_10866",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2867",
        "submitter_treatment_id": "TREATMENT_10867",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2868",
        "submitter_treatment_id": "TREATMENT_10868",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2869",
        "submitter_treatment_id": "TREATMENT_10869",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2870",
        "submitter_treatment_id": "TREATMENT_10870",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2871",
        "submitter_treatment_id": "TREATMENT_10871",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2872",
        "submitter_treatment_id": "TREATMENT_10872",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2873",
        "submitter_treatment_id": "TREATMENT_10873",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2874",
        "submitter_treatment_id": "TREATMENT_10874",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2875",
        "submitter_treatment_id": "TREATMENT_10875",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2876",
        "submitter_treatment_id": "TREATMENT_10876",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2877",
        "submitter_treatment_id": "TREATMENT_10877",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2878",
        "submitter_treatment_id": "TREATMENT_10878",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2879",
        "submitter_treatment_id": "TREATMENT_10879",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2880",
        "submitter_treatment_id": "TREATMENT_10880",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2881",
        "submitter_treatment_id": "TREATMENT_10881",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2882",
        "submitter_treatment_id": "TREATMENT_10882",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2883",
        "submitter_treatment_id": "TREATMENT_10883",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2884",
        "submitter_treatment_id": "TREATMENT_10884",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2885",
        "submitter_treatment_id": "TREATMENT_10885",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2886",
        "submitter_treatment_id": "TREATMENT_10886",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2887",
        "submitter_treatment_id": "TREATMENT_10887",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2888",
        "submitter_treatment_id": "TREATMENT_10888",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2889",
        "submitter_treatment_id": "TREATMENT_10889",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2890",
        "submitter_treatment_id": "TREATMENT_10890",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2891",
        "submitter_treatment_id": "TREATMENT_10891",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2892",
        "submitter_treatment_id": "TREATMENT_10892",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2893",
        "submitter_treatment_id": "TREATMENT_10893",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2894",
        "submitter_treatment_id": "TREATMENT_10894",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2895",
        "submitter_treatment_id": "TREATMENT_10895",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2896",
        "submitter_treatment_id": "TREATMENT_10896",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2897",
        "submitter_treatment_id": "TREATMENT_10897",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2898",
        "submitter_treatment_id": "TREATMENT_10898",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2899",
        "submitter_treatment_id": "TREATMENT_10899",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2900",
        "submitter_treatment_id": "TREATMENT_10900",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2901",
        "submitter_treatment_id": "TREATMENT_10901",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2902",
        "submitter_treatment_id": "TREATMENT_10902",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2903",
        "submitter_treatment_id": "TREATMENT_10903",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2904",
        "submitter_treatment_id": "TREATMENT_10904",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2905",
        "submitter_treatment_id": "TREATMENT_10905",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2906",
        "submitter_treatment_id": "TREATMENT_10906",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2907",
        "submitter_treatment_id": "TREATMENT_10907",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2908",
        "submitter_treatment_id": "TREATMENT_10908",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2909",
        "submitter_treatment_id": "TREATMENT_10909",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2910",
        "submitter_treatment_id": "TREATMENT_10910",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2911",
        "submitter_treatment_id": "TREATMENT_10911",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2912",
        "submitter_treatment_id": "TREATMENT_10912",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2913",
        "submitter_treatment_id": "TREATMENT_10913",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2914",
        "submitter_treatment_id": "TREATMENT_10914",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2915",
        "submitter_treatment_id": "TREATMENT_10915",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2916",
        "submitter_treatment_id": "TREATMENT_10916",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2917",
        "submitter_treatment_id": "TREATMENT_10917",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2918",
        "submitter_treatment_id": "TREATMENT_10918",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2919",
        "submitter_treatment_id": "TREATMENT_10919",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2920",
        "submitter_treatment_id": "TREATMENT_10920",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2921",
        "submitter_treatment_id": "TREATMENT_10921",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2922",
        "submitter_treatment_id": "TREATMENT_10922",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2923",
        "submitter_treatment_id": "TREATMENT_10923",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2924",
        "submitter_treatment_id": "TREATMENT_10924",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2925",
        "submitter_treatment_id": "TREATMENT_10925",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2926",
        "submitter_treatment_id": "TREATMENT_10926",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2927",
        "submitter_treatment_id": "TREATMENT_10927",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2928",
        "submitter_treatment_id": "TREATMENT_10928",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2929",
        "submitter_treatment_id": "TREATMENT_10929",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2930",
        "submitter_treatment_id": "TREATMENT_10930",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2931",
        "submitter_treatment_id": "TREATMENT_10931",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2932",
        "submitter_treatment_id": "TREATMENT_10932",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2933",
        "submitter_treatment_id": "TREATMENT_10933",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2934",
        "submitter_treatment_id": "TREATMENT_10934",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2935",
        "submitter_treatment_id": "TREATMENT_10935",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2936",
        "submitter_treatment_id": "TREATMENT_10936",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2937",
        "submitter_treatment_id": "TREATMENT_10937",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2938",
        "submitter_treatment_id": "TREATMENT_10938",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2939",
        "submitter_treatment_id": "TREATMENT_10939",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2940",
        "submitter_treatment_id": "TREATMENT_10940",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2941",
        "submitter_treatment_id": "TREATMENT_10941",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2942",
        "submitter_treatment_id": "TREATMENT_10942",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2943",
        "submitter_treatment_id": "TREATMENT_10943",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2944",
        "submitter_treatment_id": "TREATMENT_10944",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2945",
        "submitter_treatment_id": "TREATMENT_10945",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2946",
        "submitter_treatment_id": "TREATMENT_10946",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2947",
        "submitter_treatment_id": "TREATMENT_10947",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2948",
        "submitter_treatment_id": "TREATMENT_10948",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2949",
        "submitter_treatment_id": "TREATMENT_10949",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2950",
        "submitter_treatment_id": "TREATMENT_10950",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2951",
        "submitter_treatment_id": "TREATMENT_10951",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2952",
        "submitter_treatment_id": "TREATMENT_10952",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2953",
        "submitter_treatment_id": "TREATMENT_10953",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2954",
        "submitter_treatment_id": "TREATMENT_10954",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2955",
        "submitter_treatment_id": "TREATMENT_10955",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2956",
        "submitter_treatment_id": "TREATMENT_10956",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2957",
        "submitter_treatment_id": "TREATMENT_10957",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2958",
        "submitter_treatment_id": "TREATMENT_10958",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2959",
        "submitter_treatment_id": "TREATMENT_10959",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2960",
        "submitter_treatment_id": "TREATMENT_10960",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2961",
        "submitter_treatment_id": "TREATMENT_10961",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2962",
        "submitter_treatment_id": "TREATMENT_10962",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2963",
        "submitter_treatment_id": "TREATMENT_10963",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2964",
        "submitter_treatment_id": "TREATMENT_10964",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2965",
        "submitter_treatment_id": "TREATMENT_10965",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2966",
        "submitter_treatment_id": "TREATMENT_10966",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2967",
        "submitter_treatment_id": "TREATMENT_10967",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2968",
        "submitter_treatment_id": "TREATMENT_10968",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2969",
        "submitter_treatment_id": "TREATMENT_10969",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2970",
        "submitter_treatment_id": "TREATMENT_10970",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2971",
        "submitter_treatment_id": "TREATMENT_10971",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2972",
        "submitter_treatment_id": "TREATMENT_10972",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2973",
        "submitter_treatment_id": "TREATMENT_10973",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2974",
        "submitter_treatment_id": "TREATMENT_10974",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2975",
        "submitter_treatment_id": "TREATMENT_10975",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2976",
        "submitter_treatment_id": "TREATMENT_10976",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2977",
        "submitter_treatment_id": "TREATMENT_10977",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2978",
        "submitter_treatment_id": "TREATMENT_10978",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2979",
        "submitter_treatment_id": "TREATMENT_10979",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2980",
        "submitter_treatment_id": "TREATMENT_10980",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2981",
        "submitter_treatment_id": "TREATMENT_10981",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2982",
        "submitter_treatment_id": "TREATMENT_10982",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2983",
        "submitter_treatment_id": "TREATMENT_10983",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2984",
        "submitter_treatment_id": "TREATMENT_10984",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2985",
        "submitter_treatment_id": "TREATMENT_10985",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2986",
        "submitter_treatment_id": "TREATMENT_10986",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2987",
        "submitter_treatment_id": "TREATMENT_10987",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2988",
        "submitter_treatment_id": "TREATMENT_10988",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2989",
        "submitter_treatment_id": "TREATMENT_10989",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2990",
        "submitter_treatment_id": "TREATMENT_10990",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2991",
        "submitter_treatment_id": "TREATMENT_10991",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2992",
        "submitter_treatment_id": "TREATMENT_10992",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2993",
        "submitter_treatment_id": "TREATMENT_10993",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2994",
        "submitter_treatment_id": "TREATMENT_10994",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2995",
        "submitter_treatment_id": "TREATMENT_10995",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2996",
        "submitter_treatment_id": "TREATMENT_10996",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2997",
        "submitter_treatment_id": "TREATMENT_10997",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2998",
        "submitter_treatment_id": "TREATMENT_10998",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2999",
        "submitter_treatment_id": "TREATMENT_10999",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_3000",
        "submitter_treatment_id": "TREATMENT_11000",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2501",
        "submitter_treatment_id": "TREATMENT_11001",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2502",
        "submitter_treatment_id": "TREATMENT_11002",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2503",
        "submitter_treatment_id": "TREATMENT_11003",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2504",
        "submitter_treatment_id": "TREATMENT_11004",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2505",
        "submitter_treatment_id": "TREATMENT_11005",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2506",
        "submitter_treatment_id": "TREATMENT_11006",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2507",
        "submitter_treatment_id": "TREATMENT_11007",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2508",
        "submitter_treatment_id": "TREATMENT_11008",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2509",
        "submitter_treatment_id": "TREATMENT_11009",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2510",
        "submitter_treatment_id": "TREATMENT_11010",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2511",
        "submitter_treatment_id": "TREATMENT_11011",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2512",
        "submitter_treatment_id": "TREATMENT_11012",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2513",
        "submitter_treatment_id": "TREATMENT_11013",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2514",
        "submitter_treatment_id": "TREATMENT_11014",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2515",
        "submitter_treatment_id": "TREATMENT_11015",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2516",
        "submitter_treatment_id": "TREATMENT_11016",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2517",
        "submitter_treatment_id": "TREATMENT_11017",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2518",
        "submitter_treatment_id": "TREATMENT_11018",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2519",
        "submitter_treatment_id": "TREATMENT_11019",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2520",
        "submitter_treatment_id": "TREATMENT_11020",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2521",
        "submitter_treatment_id": "TREATMENT_11021",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2522",
        "submitter_treatment_id": "TREATMENT_11022",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2523",
        "submitter_treatment_id": "TREATMENT_11023",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2524",
        "submitter_treatment_id": "TREATMENT_11024",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2525",
        "submitter_treatment_id": "TREATMENT_11025",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2526",
        "submitter_treatment_id": "TREATMENT_11026",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2527",
        "submitter_treatment_id": "TREATMENT_11027",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2528",
        "submitter_treatment_id": "TREATMENT_11028",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2529",
        "submitter_treatment_id": "TREATMENT_11029",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2530",
        "submitter_treatment_id": "TREATMENT_11030",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2531",
        "submitter_treatment_id": "TREATMENT_11031",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2532",
        "submitter_treatment_id": "TREATMENT_11032",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2533",
        "submitter_treatment_id": "TREATMENT_11033",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2534",
        "submitter_treatment_id": "TREATMENT_11034",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2535",
        "submitter_treatment_id": "TREATMENT_11035",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2536",
        "submitter_treatment_id": "TREATMENT_11036",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2537",
        "submitter_treatment_id": "TREATMENT_11037",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2538",
        "submitter_treatment_id": "TREATMENT_11038",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2539",
        "submitter_treatment_id": "TREATMENT_11039",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2540",
        "submitter_treatment_id": "TREATMENT_11040",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2541",
        "submitter_treatment_id": "TREATMENT_11041",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2542",
        "submitter_treatment_id": "TREATMENT_11042",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2543",
        "submitter_treatment_id": "TREATMENT_11043",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2544",
        "submitter_treatment_id": "TREATMENT_11044",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2545",
        "submitter_treatment_id": "TREATMENT_11045",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2546",
        "submitter_treatment_id": "TREATMENT_11046",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2547",
        "submitter_treatment_id": "TREATMENT_11047",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2548",
        "submitter_treatment_id": "TREATMENT_11048",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2549",
        "submitter_treatment_id": "TREATMENT_11049",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2550",
        "submitter_treatment_id": "TREATMENT_11050",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2551",
        "submitter_treatment_id": "TREATMENT_11051",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2552",
        "submitter_treatment_id": "TREATMENT_11052",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2553",
        "submitter_treatment_id": "TREATMENT_11053",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2554",
        "submitter_treatment_id": "TREATMENT_11054",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2555",
        "submitter_treatment_id": "TREATMENT_11055",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2556",
        "submitter_treatment_id": "TREATMENT_11056",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2557",
        "submitter_treatment_id": "TREATMENT_11057",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2558",
        "submitter_treatment_id": "TREATMENT_11058",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2559",
        "submitter_treatment_id": "TREATMENT_11059",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2560",
        "submitter_treatment_id": "TREATMENT_11060",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2561",
        "submitter_treatment_id": "TREATMENT_11061",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2562",
        "submitter_treatment_id": "TREATMENT_11062",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2563",
        "submitter_treatment_id": "TREATMENT_11063",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2564",
        "submitter_treatment_id": "TREATMENT_11064",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2565",
        "submitter_treatment_id": "TREATMENT_11065",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2566",
        "submitter_treatment_id": "TREATMENT_11066",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2567",
        "submitter_treatment_id": "TREATMENT_11067",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2568",
        "submitter_treatment_id": "TREATMENT_11068",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2569",
        "submitter_treatment_id": "TREATMENT_11069",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2570",
        "submitter_treatment_id": "TREATMENT_11070",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2571",
        "submitter_treatment_id": "TREATMENT_11071",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2572",
        "submitter_treatment_id": "TREATMENT_11072",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2573",
        "submitter_treatment_id": "TREATMENT_11073",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2574",
        "submitter_treatment_id": "TREATMENT_11074",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2575",
        "submitter_treatment_id": "TREATMENT_11075",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2576",
        "submitter_treatment_id": "TREATMENT_11076",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2577",
        "submitter_treatment_id": "TREATMENT_11077",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2578",
        "submitter_treatment_id": "TREATMENT_11078",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2579",
        "submitter_treatment_id": "TREATMENT_11079",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2580",
        "submitter_treatment_id": "TREATMENT_11080",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2581",
        "submitter_treatment_id": "TREATMENT_11081",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2582",
        "submitter_treatment_id": "TREATMENT_11082",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2583",
        "submitter_treatment_id": "TREATMENT_11083",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2584",
        "submitter_treatment_id": "TREATMENT_11084",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2585",
        "submitter_treatment_id": "TREATMENT_11085",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2586",
        "submitter_treatment_id": "TREATMENT_11086",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2587",
        "submitter_treatment_id": "TREATMENT_11087",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2588",
        "submitter_treatment_id": "TREATMENT_11088",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2589",
        "submitter_treatment_id": "TREATMENT_11089",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2590",
        "submitter_treatment_id": "TREATMENT_11090",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2591",
        "submitter_treatment_id": "TREATMENT_11091",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2592",
        "submitter_treatment_id": "TREATMENT_11092",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2593",
        "submitter_treatment_id": "TREATMENT_11093",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2594",
        "submitter_treatment_id": "TREATMENT_11094",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2595",
        "submitter_treatment_id": "TREATMENT_11095",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2596",
        "submitter_treatment_id": "TREATMENT_11096",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2597",
        "submitter_treatment_id": "TREATMENT_11097",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2598",
        "submitter_treatment_id": "TREATMENT_11098",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2599",
        "submitter_treatment_id": "TREATMENT_11099",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2600",
        "submitter_treatment_id": "TREATMENT_11100",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2601",
        "submitter_treatment_id": "TREATMENT_11101",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2602",
        "submitter_treatment_id": "TREATMENT_11102",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2603",
        "submitter_treatment_id": "TREATMENT_11103",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2604",
        "submitter_treatment_id": "TREATMENT_11104",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2605",
        "submitter_treatment_id": "TREATMENT_11105",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2606",
        "submitter_treatment_id": "TREATMENT_11106",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2607",
        "submitter_treatment_id": "TREATMENT_11107",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2608",
        "submitter_treatment_id": "TREATMENT_11108",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2609",
        "submitter_treatment_id": "TREATMENT_11109",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2610",
        "submitter_treatment_id": "TREATMENT_11110",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2611",
        "submitter_treatment_id": "TREATMENT_11111",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2612",
        "submitter_treatment_id": "TREATMENT_11112",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2613",
        "submitter_treatment_id": "TREATMENT_11113",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2614",
        "submitter_treatment_id": "TREATMENT_11114",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2615",
        "submitter_treatment_id": "TREATMENT_11115",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2616",
        "submitter_treatment_id": "TREATMENT_11116",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2617",
        "submitter_treatment_id": "TREATMENT_11117",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2618",
        "submitter_treatment_id": "TREATMENT_11118",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2619",
        "submitter_treatment_id": "TREATMENT_11119",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2620",
        "submitter_treatment_id": "TREATMENT_11120",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2621",
        "submitter_treatment_id": "TREATMENT_11121",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2622",
        "submitter_treatment_id": "TREATMENT_11122",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2623",
        "submitter_treatment_id": "TREATMENT_11123",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2624",
        "submitter_treatment_id": "TREATMENT_11124",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2625",
        "submitter_treatment_id": "TREATMENT_11125",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2626",
        "submitter_treatment_id": "TREATMENT_11126",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2627",
        "submitter_treatment_id": "TREATMENT_11127",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2628",
        "submitter_treatment_id": "TREATMENT_11128",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2629",
        "submitter_treatment_id": "TREATMENT_11129",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2630",
        "submitter_treatment_id": "TREATMENT_11130",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2631",
        "submitter_treatment_id": "TREATMENT_11131",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2632",
        "submitter_treatment_id": "TREATMENT_11132",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2633",
        "submitter_treatment_id": "TREATMENT_11133",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2634",
        "submitter_treatment_id": "TREATMENT_11134",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2635",
        "submitter_treatment_id": "TREATMENT_11135",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2636",
        "submitter_treatment_id": "TREATMENT_11136",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2637",
        "submitter_treatment_id": "TREATMENT_11137",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2638",
        "submitter_treatment_id": "TREATMENT_11138",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2639",
        "submitter_treatment_id": "TREATMENT_11139",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2640",
        "submitter_treatment_id": "TREATMENT_11140",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2641",
        "submitter_treatment_id": "TREATMENT_11141",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2642",
        "submitter_treatment_id": "TREATMENT_11142",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2643",
        "submitter_treatment_id": "TREATMENT_11143",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2644",
        "submitter_treatment_id": "TREATMENT_11144",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2645",
        "submitter_treatment_id": "TREATMENT_11145",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2646",
        "submitter_treatment_id": "TREATMENT_11146",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2647",
        "submitter_treatment_id": "TREATMENT_11147",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2648",
        "submitter_treatment_id": "TREATMENT_11148",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2649",
        "submitter_treatment_id": "TREATMENT_11149",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2650",
        "submitter_treatment_id": "TREATMENT_11150",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2651",
        "submitter_treatment_id": "TREATMENT_11151",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2652",
        "submitter_treatment_id": "TREATMENT_11152",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2653",
        "submitter_treatment_id": "TREATMENT_11153",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2654",
        "submitter_treatment_id": "TREATMENT_11154",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2655",
        "submitter_treatment_id": "TREATMENT_11155",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2656",
        "submitter_treatment_id": "TREATMENT_11156",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2657",
        "submitter_treatment_id": "TREATMENT_11157",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2658",
        "submitter_treatment_id": "TREATMENT_11158",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2659",
        "submitter_treatment_id": "TREATMENT_11159",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2660",
        "submitter_treatment_id": "TREATMENT_11160",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2661",
        "submitter_treatment_id": "TREATMENT_11161",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2662",
        "submitter_treatment_id": "TREATMENT_11162",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2663",
        "submitter_treatment_id": "TREATMENT_11163",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2664",
        "submitter_treatment_id": "TREATMENT_11164",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2665",
        "submitter_treatment_id": "TREATMENT_11165",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2666",
        "submitter_treatment_id": "TREATMENT_11166",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2667",
        "submitter_treatment_id": "TREATMENT_11167",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2668",
        "submitter_treatment_id": "TREATMENT_11168",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2669",
        "submitter_treatment_id": "TREATMENT_11169",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2670",
        "submitter_treatment_id": "TREATMENT_11170",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2671",
        "submitter_treatment_id": "TREATMENT_11171",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2672",
        "submitter_treatment_id": "TREATMENT_11172",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2673",
        "submitter_treatment_id": "TREATMENT_11173",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2674",
        "submitter_treatment_id": "TREATMENT_11174",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2675",
        "submitter_treatment_id": "TREATMENT_11175",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2676",
        "submitter_treatment_id": "TREATMENT_11176",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2677",
        "submitter_treatment_id": "TREATMENT_11177",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2678",
        "submitter_treatment_id": "TREATMENT_11178",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2679",
        "submitter_treatment_id": "TREATMENT_11179",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2680",
        "submitter_treatment_id": "TREATMENT_11180",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2681",
        "submitter_treatment_id": "TREATMENT_11181",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2682",
        "submitter_treatment_id": "TREATMENT_11182",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2683",
        "submitter_treatment_id": "TREATMENT_11183",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2684",
        "submitter_treatment_id": "TREATMENT_11184",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2685",
        "submitter_treatment_id": "TREATMENT_11185",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2686",
        "submitter_treatment_id": "TREATMENT_11186",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2687",
        "submitter_treatment_id": "TREATMENT_11187",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2688",
        "submitter_treatment_id": "TREATMENT_11188",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2689",
        "submitter_treatment_id": "TREATMENT_11189",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2690",
        "submitter_treatment_id": "TREATMENT_11190",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2691",
        "submitter_treatment_id": "TREATMENT_11191",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2692",
        "submitter_treatment_id": "TREATMENT_11192",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2693",
        "submitter_treatment_id": "TREATMENT_11193",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2694",
        "submitter_treatment_id": "TREATMENT_11194",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2695",
        "submitter_treatment_id": "TREATMENT_11195",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2696",
        "submitter_treatment_id": "TREATMENT_11196",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2697",
        "submitter_treatment_id": "TREATMENT_11197",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2698",
        "submitter_treatment_id": "TREATMENT_11198",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2699",
        "submitter_treatment_id": "TREATMENT_11199",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2700",
        "submitter_treatment_id": "TREATMENT_11200",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2701",
        "submitter_treatment_id": "TREATMENT_11201",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2702",
        "submitter_treatment_id": "TREATMENT_11202",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2703",
        "submitter_treatment_id": "TREATMENT_11203",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2704",
        "submitter_treatment_id": "TREATMENT_11204",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2705",
        "submitter_treatment_id": "TREATMENT_11205",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2706",
        "submitter_treatment_id": "TREATMENT_11206",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2707",
        "submitter_treatment_id": "TREATMENT_11207",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2708",
        "submitter_treatment_id": "TREATMENT_11208",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2709",
        "submitter_treatment_id": "TREATMENT_11209",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2710",
        "submitter_treatment_id": "TREATMENT_11210",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2711",
        "submitter_treatment_id": "TREATMENT_11211",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2712",
        "submitter_treatment_id": "TREATMENT_11212",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2713",
        "submitter_treatment_id": "TREATMENT_11213",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2714",
        "submitter_treatment_id": "TREATMENT_11214",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2715",
        "submitter_treatment_id": "TREATMENT_11215",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2716",
        "submitter_treatment_id": "TREATMENT_11216",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2717",
        "submitter_treatment_id": "TREATMENT_11217",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2718",
        "submitter_treatment_id": "TREATMENT_11218",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2719",
        "submitter_treatment_id": "TREATMENT_11219",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2720",
        "submitter_treatment_id": "TREATMENT_11220",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2721",
        "submitter_treatment_id": "TREATMENT_11221",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2722",
        "submitter_treatment_id": "TREATMENT_11222",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2723",
        "submitter_treatment_id": "TREATMENT_11223",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2724",
        "submitter_treatment_id": "TREATMENT_11224",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2725",
        "submitter_treatment_id": "TREATMENT_11225",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2726",
        "submitter_treatment_id": "TREATMENT_11226",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2727",
        "submitter_treatment_id": "TREATMENT_11227",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2728",
        "submitter_treatment_id": "TREATMENT_11228",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2729",
        "submitter_treatment_id": "TREATMENT_11229",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2730",
        "submitter_treatment_id": "TREATMENT_11230",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2731",
        "submitter_treatment_id": "TREATMENT_11231",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2732",
        "submitter_treatment_id": "TREATMENT_11232",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2733",
        "submitter_treatment_id": "TREATMENT_11233",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2734",
        "submitter_treatment_id": "TREATMENT_11234",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2735",
        "submitter_treatment_id": "TREATMENT_11235",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2736",
        "submitter_treatment_id": "TREATMENT_11236",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2737",
        "submitter_treatment_id": "TREATMENT_11237",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2738",
        "submitter_treatment_id": "TREATMENT_11238",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2739",
        "submitter_treatment_id": "TREATMENT_11239",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2740",
        "submitter_treatment_id": "TREATMENT_11240",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2741",
        "submitter_treatment_id": "TREATMENT_11241",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2742",
        "submitter_treatment_id": "TREATMENT_11242",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2743",
        "submitter_treatment_id": "TREATMENT_11243",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2744",
        "submitter_treatment_id": "TREATMENT_11244",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2745",
        "submitter_treatment_id": "TREATMENT_11245",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2746",
        "submitter_treatment_id": "TREATMENT_11246",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2747",
        "submitter_treatment_id": "TREATMENT_11247",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2748",
        "submitter_treatment_id": "TREATMENT_11248",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2749",
        "submitter_treatment_id": "TREATMENT_11249",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2750",
        "submitter_treatment_id": "TREATMENT_11250",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2751",
        "submitter_treatment_id": "TREATMENT_11251",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2752",
        "submitter_treatment_id": "TREATMENT_11252",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2753",
        "submitter_treatment_id": "TREATMENT_11253",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2754",
        "submitter_treatment_id": "TREATMENT_11254",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2755",
        "submitter_treatment_id": "TREATMENT_11255",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2756",
        "submitter_treatment_id": "TREATMENT_11256",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2757",
        "submitter_treatment_id": "TREATMENT_11257",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2758",
        "submitter_treatment_id": "TREATMENT_11258",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2759",
        "submitter_treatment_id": "TREATMENT_11259",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2760",
        "submitter_treatment_id": "TREATMENT_11260",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2761",
        "submitter_treatment_id": "TREATMENT_11261",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2762",
        "submitter_treatment_id": "TREATMENT_11262",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2763",
        "submitter_treatment_id": "TREATMENT_11263",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2764",
        "submitter_treatment_id": "TREATMENT_11264",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2765",
        "submitter_treatment_id": "TREATMENT_11265",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2766",
        "submitter_treatment_id": "TREATMENT_11266",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2767",
        "submitter_treatment_id": "TREATMENT_11267",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2768",
        "submitter_treatment_id": "TREATMENT_11268",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2769",
        "submitter_treatment_id": "TREATMENT_11269",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2770",
        "submitter_treatment_id": "TREATMENT_11270",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2771",
        "submitter_treatment_id": "TREATMENT_11271",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2772",
        "submitter_treatment_id": "TREATMENT_11272",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2773",
        "submitter_treatment_id": "TREATMENT_11273",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2774",
        "submitter_treatment_id": "TREATMENT_11274",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2775",
        "submitter_treatment_id": "TREATMENT_11275",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2776",
        "submitter_treatment_id": "TREATMENT_11276",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2777",
        "submitter_treatment_id": "TREATMENT_11277",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2778",
        "submitter_treatment_id": "TREATMENT_11278",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2779",
        "submitter_treatment_id": "TREATMENT_11279",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2780",
        "submitter_treatment_id": "TREATMENT_11280",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2781",
        "submitter_treatment_id": "TREATMENT_11281",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2782",
        "submitter_treatment_id": "TREATMENT_11282",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2783",
        "submitter_treatment_id": "TREATMENT_11283",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2784",
        "submitter_treatment_id": "TREATMENT_11284",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2785",
        "submitter_treatment_id": "TREATMENT_11285",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2786",
        "submitter_treatment_id": "TREATMENT_11286",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2787",
        "submitter_treatment_id": "TREATMENT_11287",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2788",
        "submitter_treatment_id": "TREATMENT_11288",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2789",
        "submitter_treatment_id": "TREATMENT_11289",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2790",
        "submitter_treatment_id": "TREATMENT_11290",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2791",
        "submitter_treatment_id": "TREATMENT_11291",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2792",
        "submitter_treatment_id": "TREATMENT_11292",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2793",
        "submitter_treatment_id": "TREATMENT_11293",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2794",
        "submitter_treatment_id": "TREATMENT_11294",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2795",
        "submitter_treatment_id": "TREATMENT_11295",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2796",
        "submitter_treatment_id": "TREATMENT_11296",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2797",
        "submitter_treatment_id": "TREATMENT_11297",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2798",
        "submitter_treatment_id": "TREATMENT_11298",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2799",
        "submitter_treatment_id": "TREATMENT_11299",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2800",
        "submitter_treatment_id": "TREATMENT_11300",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2801",
        "submitter_treatment_id": "TREATMENT_11301",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2802",
        "submitter_treatment_id": "TREATMENT_11302",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2803",
        "submitter_treatment_id": "TREATMENT_11303",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2804",
        "submitter_treatment_id": "TREATMENT_11304",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2805",
        "submitter_treatment_id": "TREATMENT_11305",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2806",
        "submitter_treatment_id": "TREATMENT_11306",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2807",
        "submitter_treatment_id": "TREATMENT_11307",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2808",
        "submitter_treatment_id": "TREATMENT_11308",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2809",
        "submitter_treatment_id": "TREATMENT_11309",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2810",
        "submitter_treatment_id": "TREATMENT_11310",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2811",
        "submitter_treatment_id": "TREATMENT_11311",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2812",
        "submitter_treatment_id": "TREATMENT_11312",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2813",
        "submitter_treatment_id": "TREATMENT_11313",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2814",
        "submitter_treatment_id": "TREATMENT_11314",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2815",
        "submitter_treatment_id": "TREATMENT_11315",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2816",
        "submitter_treatment_id": "TREATMENT_11316",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2817",
        "submitter_treatment_id": "TREATMENT_11317",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2818",
        "submitter_treatment_id": "TREATMENT_11318",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2819",
        "submitter_treatment_id": "TREATMENT_11319",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2820",
        "submitter_treatment_id": "TREATMENT_11320",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2821",
        "submitter_treatment_id": "TREATMENT_11321",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2822",
        "submitter_treatment_id": "TREATMENT_11322",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2823",
        "submitter_treatment_id": "TREATMENT_11323",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2824",
        "submitter_treatment_id": "TREATMENT_11324",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2825",
        "submitter_treatment_id": "TREATMENT_11325",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2826",
        "submitter_treatment_id": "TREATMENT_11326",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2827",
        "submitter_treatment_id": "TREATMENT_11327",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2828",
        "submitter_treatment_id": "TREATMENT_11328",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2829",
        "submitter_treatment_id": "TREATMENT_11329",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2830",
        "submitter_treatment_id": "TREATMENT_11330",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2831",
        "submitter_treatment_id": "TREATMENT_11331",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2832",
        "submitter_treatment_id": "TREATMENT_11332",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2833",
        "submitter_treatment_id": "TREATMENT_11333",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2834",
        "submitter_treatment_id": "TREATMENT_11334",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2835",
        "submitter_treatment_id": "TREATMENT_11335",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2836",
        "submitter_treatment_id": "TREATMENT_11336",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2837",
        "submitter_treatment_id": "TREATMENT_11337",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2838",
        "submitter_treatment_id": "TREATMENT_11338",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2839",
        "submitter_treatment_id": "TREATMENT_11339",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2840",
        "submitter_treatment_id": "TREATMENT_11340",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2841",
        "submitter_treatment_id": "TREATMENT_11341",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2842",
        "submitter_treatment_id": "TREATMENT_11342",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2843",
        "submitter_treatment_id": "TREATMENT_11343",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2844",
        "submitter_treatment_id": "TREATMENT_11344",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2845",
        "submitter_treatment_id": "TREATMENT_11345",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2846",
        "submitter_treatment_id": "TREATMENT_11346",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2847",
        "submitter_treatment_id": "TREATMENT_11347",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2848",
        "submitter_treatment_id": "TREATMENT_11348",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2849",
        "submitter_treatment_id": "TREATMENT_11349",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2850",
        "submitter_treatment_id": "TREATMENT_11350",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2851",
        "submitter_treatment_id": "TREATMENT_11351",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2852",
        "submitter_treatment_id": "TREATMENT_11352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2853",
        "submitter_treatment_id": "TREATMENT_11353",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2854",
        "submitter_treatment_id": "TREATMENT_11354",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2855",
        "submitter_treatment_id": "TREATMENT_11355",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2856",
        "submitter_treatment_id": "TREATMENT_11356",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2857",
        "submitter_treatment_id": "TREATMENT_11357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2858",
        "submitter_treatment_id": "TREATMENT_11358",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2859",
        "submitter_treatment_id": "TREATMENT_11359",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2860",
        "submitter_treatment_id": "TREATMENT_11360",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2861",
        "submitter_treatment_id": "TREATMENT_11361",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2862",
        "submitter_treatment_id": "TREATMENT_11362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2863",
        "submitter_treatment_id": "TREATMENT_11363",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2864",
        "submitter_treatment_id": "TREATMENT_11364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2865",
        "submitter_treatment_id": "TREATMENT_11365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2866",
        "submitter_treatment_id": "TREATMENT_11366",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2867",
        "submitter_treatment_id": "TREATMENT_11367",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2868",
        "submitter_treatment_id": "TREATMENT_11368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2869",
        "submitter_treatment_id": "TREATMENT_11369",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2870",
        "submitter_treatment_id": "TREATMENT_11370",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2871",
        "submitter_treatment_id": "TREATMENT_11371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2872",
        "submitter_treatment_id": "TREATMENT_11372",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2873",
        "submitter_treatment_id": "TREATMENT_11373",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2874",
        "submitter_treatment_id": "TREATMENT_11374",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2875",
        "submitter_treatment_id": "TREATMENT_11375",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2876",
        "submitter_treatment_id": "TREATMENT_11376",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2877",
        "submitter_treatment_id": "TREATMENT_11377",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2878",
        "submitter_treatment_id": "TREATMENT_11378",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2879",
        "submitter_treatment_id": "TREATMENT_11379",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2880",
        "submitter_treatment_id": "TREATMENT_11380",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2881",
        "submitter_treatment_id": "TREATMENT_11381",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2882",
        "submitter_treatment_id": "TREATMENT_11382",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2883",
        "submitter_treatment_id": "TREATMENT_11383",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2884",
        "submitter_treatment_id": "TREATMENT_11384",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2885",
        "submitter_treatment_id": "TREATMENT_11385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2886",
        "submitter_treatment_id": "TREATMENT_11386",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2887",
        "submitter_treatment_id": "TREATMENT_11387",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2888",
        "submitter_treatment_id": "TREATMENT_11388",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2889",
        "submitter_treatment_id": "TREATMENT_11389",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2890",
        "submitter_treatment_id": "TREATMENT_11390",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2891",
        "submitter_treatment_id": "TREATMENT_11391",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2892",
        "submitter_treatment_id": "TREATMENT_11392",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2893",
        "submitter_treatment_id": "TREATMENT_11393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2894",
        "submitter_treatment_id": "TREATMENT_11394",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2895",
        "submitter_treatment_id": "TREATMENT_11395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2896",
        "submitter_treatment_id": "TREATMENT_11396",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2897",
        "submitter_treatment_id": "TREATMENT_11397",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2898",
        "submitter_treatment_id": "TREATMENT_11398",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2899",
        "submitter_treatment_id": "TREATMENT_11399",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2900",
        "submitter_treatment_id": "TREATMENT_11400",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2901",
        "submitter_treatment_id": "TREATMENT_11401",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2902",
        "submitter_treatment_id": "TREATMENT_11402",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2903",
        "submitter_treatment_id": "TREATMENT_11403",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2904",
        "submitter_treatment_id": "TREATMENT_11404",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2905",
        "submitter_treatment_id": "TREATMENT_11405",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2906",
        "submitter_treatment_id": "TREATMENT_11406",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2907",
        "submitter_treatment_id": "TREATMENT_11407",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2908",
        "submitter_treatment_id": "TREATMENT_11408",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2909",
        "submitter_treatment_id": "TREATMENT_11409",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2910",
        "submitter_treatment_id": "TREATMENT_11410",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2911",
        "submitter_treatment_id": "TREATMENT_11411",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2912",
        "submitter_treatment_id": "TREATMENT_11412",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2913",
        "submitter_treatment_id": "TREATMENT_11413",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2914",
        "submitter_treatment_id": "TREATMENT_11414",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2915",
        "submitter_treatment_id": "TREATMENT_11415",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2916",
        "submitter_treatment_id": "TREATMENT_11416",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2917",
        "submitter_treatment_id": "TREATMENT_11417",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2918",
        "submitter_treatment_id": "TREATMENT_11418",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2919",
        "submitter_treatment_id": "TREATMENT_11419",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2920",
        "submitter_treatment_id": "TREATMENT_11420",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2921",
        "submitter_treatment_id": "TREATMENT_11421",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2922",
        "submitter_treatment_id": "TREATMENT_11422",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2923",
        "submitter_treatment_id": "TREATMENT_11423",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2924",
        "submitter_treatment_id": "TREATMENT_11424",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2925",
        "submitter_treatment_id": "TREATMENT_11425",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2926",
        "submitter_treatment_id": "TREATMENT_11426",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2927",
        "submitter_treatment_id": "TREATMENT_11427",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2928",
        "submitter_treatment_id": "TREATMENT_11428",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2929",
        "submitter_treatment_id": "TREATMENT_11429",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2930",
        "submitter_treatment_id": "TREATMENT_11430",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2931",
        "submitter_treatment_id": "TREATMENT_11431",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2932",
        "submitter_treatment_id": "TREATMENT_11432",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2933",
        "submitter_treatment_id": "TREATMENT_11433",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2934",
        "submitter_treatment_id": "TREATMENT_11434",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2935",
        "submitter_treatment_id": "TREATMENT_11435",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2936",
        "submitter_treatment_id": "TREATMENT_11436",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2937",
        "submitter_treatment_id": "TREATMENT_11437",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2938",
        "submitter_treatment_id": "TREATMENT_11438",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2939",
        "submitter_treatment_id": "TREATMENT_11439",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2940",
        "submitter_treatment_id": "TREATMENT_11440",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2941",
        "submitter_treatment_id": "TREATMENT_11441",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2942",
        "submitter_treatment_id": "TREATMENT_11442",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2943",
        "submitter_treatment_id": "TREATMENT_11443",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2944",
        "submitter_treatment_id": "TREATMENT_11444",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2945",
        "submitter_treatment_id": "TREATMENT_11445",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2946",
        "submitter_treatment_id": "TREATMENT_11446",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2947",
        "submitter_treatment_id": "TREATMENT_11447",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2948",
        "submitter_treatment_id": "TREATMENT_11448",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2949",
        "submitter_treatment_id": "TREATMENT_11449",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2950",
        "submitter_treatment_id": "TREATMENT_11450",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2951",
        "submitter_treatment_id": "TREATMENT_11451",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2952",
        "submitter_treatment_id": "TREATMENT_11452",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2953",
        "submitter_treatment_id": "TREATMENT_11453",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2954",
        "submitter_treatment_id": "TREATMENT_11454",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2955",
        "submitter_treatment_id": "TREATMENT_11455",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2956",
        "submitter_treatment_id": "TREATMENT_11456",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2957",
        "submitter_treatment_id": "TREATMENT_11457",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2958",
        "submitter_treatment_id": "TREATMENT_11458",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2959",
        "submitter_treatment_id": "TREATMENT_11459",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2960",
        "submitter_treatment_id": "TREATMENT_11460",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2961",
        "submitter_treatment_id": "TREATMENT_11461",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2962",
        "submitter_treatment_id": "TREATMENT_11462",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2963",
        "submitter_treatment_id": "TREATMENT_11463",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2964",
        "submitter_treatment_id": "TREATMENT_11464",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2965",
        "submitter_treatment_id": "TREATMENT_11465",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2966",
        "submitter_treatment_id": "TREATMENT_11466",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2967",
        "submitter_treatment_id": "TREATMENT_11467",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2968",
        "submitter_treatment_id": "TREATMENT_11468",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2969",
        "submitter_treatment_id": "TREATMENT_11469",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2970",
        "submitter_treatment_id": "TREATMENT_11470",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2971",
        "submitter_treatment_id": "TREATMENT_11471",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2972",
        "submitter_treatment_id": "TREATMENT_11472",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2973",
        "submitter_treatment_id": "TREATMENT_11473",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2974",
        "submitter_treatment_id": "TREATMENT_11474",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2975",
        "submitter_treatment_id": "TREATMENT_11475",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2976",
        "submitter_treatment_id": "TREATMENT_11476",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2977",
        "submitter_treatment_id": "TREATMENT_11477",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2978",
        "submitter_treatment_id": "TREATMENT_11478",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2979",
        "submitter_treatment_id": "TREATMENT_11479",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2980",
        "submitter_treatment_id": "TREATMENT_11480",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2981",
        "submitter_treatment_id": "TREATMENT_11481",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2982",
        "submitter_treatment_id": "TREATMENT_11482",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2983",
        "submitter_treatment_id": "TREATMENT_11483",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2984",
        "submitter_treatment_id": "TREATMENT_11484",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2985",
        "submitter_treatment_id": "TREATMENT_11485",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2986",
        "submitter_treatment_id": "TREATMENT_11486",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2987",
        "submitter_treatment_id": "TREATMENT_11487",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2988",
        "submitter_treatment_id": "TREATMENT_11488",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2989",
        "submitter_treatment_id": "TREATMENT_11489",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2990",
        "submitter_treatment_id": "TREATMENT_11490",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2991",
        "submitter_treatment_id": "TREATMENT_11491",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2992",
        "submitter_treatment_id": "TREATMENT_11492",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2993",
        "submitter_treatment_id": "TREATMENT_11493",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2994",
        "submitter_treatment_id": "TREATMENT_11494",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2995",
        "submitter_treatment_id": "TREATMENT_11495",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2996",
        "submitter_treatment_id": "TREATMENT_11496",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2997",
        "submitter_treatment_id": "TREATMENT_11497",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2998",
        "submitter_treatment_id": "TREATMENT_11498",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2999",
        "submitter_treatment_id": "TREATMENT_11499",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_3000",
        "submitter_treatment_id": "TREATMENT_11500",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2501",
        "submitter_treatment_id": "TREATMENT_11501",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2502",
        "submitter_treatment_id": "TREATMENT_11502",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2503",
        "submitter_treatment_id": "TREATMENT_11503",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2504",
        "submitter_treatment_id": "TREATMENT_11504",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2505",
        "submitter_treatment_id": "TREATMENT_11505",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2506",
        "submitter_treatment_id": "TREATMENT_11506",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2507",
        "submitter_treatment_id": "TREATMENT_11507",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2508",
        "submitter_treatment_id": "TREATMENT_11508",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2509",
        "submitter_treatment_id": "TREATMENT_11509",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2510",
        "submitter_treatment_id": "TREATMENT_11510",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2511",
        "submitter_treatment_id": "TREATMENT_11511",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2512",
        "submitter_treatment_id": "TREATMENT_11512",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2513",
        "submitter_treatment_id": "TREATMENT_11513",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2514",
        "submitter_treatment_id": "TREATMENT_11514",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2515",
        "submitter_treatment_id": "TREATMENT_11515",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2516",
        "submitter_treatment_id": "TREATMENT_11516",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2517",
        "submitter_treatment_id": "TREATMENT_11517",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2518",
        "submitter_treatment_id": "TREATMENT_11518",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2519",
        "submitter_treatment_id": "TREATMENT_11519",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2520",
        "submitter_treatment_id": "TREATMENT_11520",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2521",
        "submitter_treatment_id": "TREATMENT_11521",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2522",
        "submitter_treatment_id": "TREATMENT_11522",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2523",
        "submitter_treatment_id": "TREATMENT_11523",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2524",
        "submitter_treatment_id": "TREATMENT_11524",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2525",
        "submitter_treatment_id": "TREATMENT_11525",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2526",
        "submitter_treatment_id": "TREATMENT_11526",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2527",
        "submitter_treatment_id": "TREATMENT_11527",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2528",
        "submitter_treatment_id": "TREATMENT_11528",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2529",
        "submitter_treatment_id": "TREATMENT_11529",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2530",
        "submitter_treatment_id": "TREATMENT_11530",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2531",
        "submitter_treatment_id": "TREATMENT_11531",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2532",
        "submitter_treatment_id": "TREATMENT_11532",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2533",
        "submitter_treatment_id": "TREATMENT_11533",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2534",
        "submitter_treatment_id": "TREATMENT_11534",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2535",
        "submitter_treatment_id": "TREATMENT_11535",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2536",
        "submitter_treatment_id": "TREATMENT_11536",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2537",
        "submitter_treatment_id": "TREATMENT_11537",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2538",
        "submitter_treatment_id": "TREATMENT_11538",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2539",
        "submitter_treatment_id": "TREATMENT_11539",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2540",
        "submitter_treatment_id": "TREATMENT_11540",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2541",
        "submitter_treatment_id": "TREATMENT_11541",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2542",
        "submitter_treatment_id": "TREATMENT_11542",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2543",
        "submitter_treatment_id": "TREATMENT_11543",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2544",
        "submitter_treatment_id": "TREATMENT_11544",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2545",
        "submitter_treatment_id": "TREATMENT_11545",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2546",
        "submitter_treatment_id": "TREATMENT_11546",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2547",
        "submitter_treatment_id": "TREATMENT_11547",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2548",
        "submitter_treatment_id": "TREATMENT_11548",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2549",
        "submitter_treatment_id": "TREATMENT_11549",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2550",
        "submitter_treatment_id": "TREATMENT_11550",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2551",
        "submitter_treatment_id": "TREATMENT_11551",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2552",
        "submitter_treatment_id": "TREATMENT_11552",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2553",
        "submitter_treatment_id": "TREATMENT_11553",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2554",
        "submitter_treatment_id": "TREATMENT_11554",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2555",
        "submitter_treatment_id": "TREATMENT_11555",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2556",
        "submitter_treatment_id": "TREATMENT_11556",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2557",
        "submitter_treatment_id": "TREATMENT_11557",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2558",
        "submitter_treatment_id": "TREATMENT_11558",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2559",
        "submitter_treatment_id": "TREATMENT_11559",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2560",
        "submitter_treatment_id": "TREATMENT_11560",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2561",
        "submitter_treatment_id": "TREATMENT_11561",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2562",
        "submitter_treatment_id": "TREATMENT_11562",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2563",
        "submitter_treatment_id": "TREATMENT_11563",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2564",
        "submitter_treatment_id": "TREATMENT_11564",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2565",
        "submitter_treatment_id": "TREATMENT_11565",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2566",
        "submitter_treatment_id": "TREATMENT_11566",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2567",
        "submitter_treatment_id": "TREATMENT_11567",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2568",
        "submitter_treatment_id": "TREATMENT_11568",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2569",
        "submitter_treatment_id": "TREATMENT_11569",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2570",
        "submitter_treatment_id": "TREATMENT_11570",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2571",
        "submitter_treatment_id": "TREATMENT_11571",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2572",
        "submitter_treatment_id": "TREATMENT_11572",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2573",
        "submitter_treatment_id": "TREATMENT_11573",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2574",
        "submitter_treatment_id": "TREATMENT_11574",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2575",
        "submitter_treatment_id": "TREATMENT_11575",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2576",
        "submitter_treatment_id": "TREATMENT_11576",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2577",
        "submitter_treatment_id": "TREATMENT_11577",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2578",
        "submitter_treatment_id": "TREATMENT_11578",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2579",
        "submitter_treatment_id": "TREATMENT_11579",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2580",
        "submitter_treatment_id": "TREATMENT_11580",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2581",
        "submitter_treatment_id": "TREATMENT_11581",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2582",
        "submitter_treatment_id": "TREATMENT_11582",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2583",
        "submitter_treatment_id": "TREATMENT_11583",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2584",
        "submitter_treatment_id": "TREATMENT_11584",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2585",
        "submitter_treatment_id": "TREATMENT_11585",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2586",
        "submitter_treatment_id": "TREATMENT_11586",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2587",
        "submitter_treatment_id": "TREATMENT_11587",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2588",
        "submitter_treatment_id": "TREATMENT_11588",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2589",
        "submitter_treatment_id": "TREATMENT_11589",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2590",
        "submitter_treatment_id": "TREATMENT_11590",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2591",
        "submitter_treatment_id": "TREATMENT_11591",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2592",
        "submitter_treatment_id": "TREATMENT_11592",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2593",
        "submitter_treatment_id": "TREATMENT_11593",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2594",
        "submitter_treatment_id": "TREATMENT_11594",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2595",
        "submitter_treatment_id": "TREATMENT_11595",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2596",
        "submitter_treatment_id": "TREATMENT_11596",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2597",
        "submitter_treatment_id": "TREATMENT_11597",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2598",
        "submitter_treatment_id": "TREATMENT_11598",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2599",
        "submitter_treatment_id": "TREATMENT_11599",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2600",
        "submitter_treatment_id": "TREATMENT_11600",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2601",
        "submitter_treatment_id": "TREATMENT_11601",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2602",
        "submitter_treatment_id": "TREATMENT_11602",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2603",
        "submitter_treatment_id": "TREATMENT_11603",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2604",
        "submitter_treatment_id": "TREATMENT_11604",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2605",
        "submitter_treatment_id": "TREATMENT_11605",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2606",
        "submitter_treatment_id": "TREATMENT_11606",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2607",
        "submitter_treatment_id": "TREATMENT_11607",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2608",
        "submitter_treatment_id": "TREATMENT_11608",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2609",
        "submitter_treatment_id": "TREATMENT_11609",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2610",
        "submitter_treatment_id": "TREATMENT_11610",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2611",
        "submitter_treatment_id": "TREATMENT_11611",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2612",
        "submitter_treatment_id": "TREATMENT_11612",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2613",
        "submitter_treatment_id": "TREATMENT_11613",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2614",
        "submitter_treatment_id": "TREATMENT_11614",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2615",
        "submitter_treatment_id": "TREATMENT_11615",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2616",
        "submitter_treatment_id": "TREATMENT_11616",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2617",
        "submitter_treatment_id": "TREATMENT_11617",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2618",
        "submitter_treatment_id": "TREATMENT_11618",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2619",
        "submitter_treatment_id": "TREATMENT_11619",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2620",
        "submitter_treatment_id": "TREATMENT_11620",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2621",
        "submitter_treatment_id": "TREATMENT_11621",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2622",
        "submitter_treatment_id": "TREATMENT_11622",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2623",
        "submitter_treatment_id": "TREATMENT_11623",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2624",
        "submitter_treatment_id": "TREATMENT_11624",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2625",
        "submitter_treatment_id": "TREATMENT_11625",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2626",
        "submitter_treatment_id": "TREATMENT_11626",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2627",
        "submitter_treatment_id": "TREATMENT_11627",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2628",
        "submitter_treatment_id": "TREATMENT_11628",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2629",
        "submitter_treatment_id": "TREATMENT_11629",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2630",
        "submitter_treatment_id": "TREATMENT_11630",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2631",
        "submitter_treatment_id": "TREATMENT_11631",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2632",
        "submitter_treatment_id": "TREATMENT_11632",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2633",
        "submitter_treatment_id": "TREATMENT_11633",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2634",
        "submitter_treatment_id": "TREATMENT_11634",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2635",
        "submitter_treatment_id": "TREATMENT_11635",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2636",
        "submitter_treatment_id": "TREATMENT_11636",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2637",
        "submitter_treatment_id": "TREATMENT_11637",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2638",
        "submitter_treatment_id": "TREATMENT_11638",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2639",
        "submitter_treatment_id": "TREATMENT_11639",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2640",
        "submitter_treatment_id": "TREATMENT_11640",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2641",
        "submitter_treatment_id": "TREATMENT_11641",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2642",
        "submitter_treatment_id": "TREATMENT_11642",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2643",
        "submitter_treatment_id": "TREATMENT_11643",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2644",
        "submitter_treatment_id": "TREATMENT_11644",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2645",
        "submitter_treatment_id": "TREATMENT_11645",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2646",
        "submitter_treatment_id": "TREATMENT_11646",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2647",
        "submitter_treatment_id": "TREATMENT_11647",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2648",
        "submitter_treatment_id": "TREATMENT_11648",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2649",
        "submitter_treatment_id": "TREATMENT_11649",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2650",
        "submitter_treatment_id": "TREATMENT_11650",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2651",
        "submitter_treatment_id": "TREATMENT_11651",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2652",
        "submitter_treatment_id": "TREATMENT_11652",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2653",
        "submitter_treatment_id": "TREATMENT_11653",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2654",
        "submitter_treatment_id": "TREATMENT_11654",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2655",
        "submitter_treatment_id": "TREATMENT_11655",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2656",
        "submitter_treatment_id": "TREATMENT_11656",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2657",
        "submitter_treatment_id": "TREATMENT_11657",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2658",
        "submitter_treatment_id": "TREATMENT_11658",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2659",
        "submitter_treatment_id": "TREATMENT_11659",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2660",
        "submitter_treatment_id": "TREATMENT_11660",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2661",
        "submitter_treatment_id": "TREATMENT_11661",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2662",
        "submitter_treatment_id": "TREATMENT_11662",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2663",
        "submitter_treatment_id": "TREATMENT_11663",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2664",
        "submitter_treatment_id": "TREATMENT_11664",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2665",
        "submitter_treatment_id": "TREATMENT_11665",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2666",
        "submitter_treatment_id": "TREATMENT_11666",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2667",
        "submitter_treatment_id": "TREATMENT_11667",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2668",
        "submitter_treatment_id": "TREATMENT_11668",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2669",
        "submitter_treatment_id": "TREATMENT_11669",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2670",
        "submitter_treatment_id": "TREATMENT_11670",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2671",
        "submitter_treatment_id": "TREATMENT_11671",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2672",
        "submitter_treatment_id": "TREATMENT_11672",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2673",
        "submitter_treatment_id": "TREATMENT_11673",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2674",
        "submitter_treatment_id": "TREATMENT_11674",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2675",
        "submitter_treatment_id": "TREATMENT_11675",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2676",
        "submitter_treatment_id": "TREATMENT_11676",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2677",
        "submitter_treatment_id": "TREATMENT_11677",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2678",
        "submitter_treatment_id": "TREATMENT_11678",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2679",
        "submitter_treatment_id": "TREATMENT_11679",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2680",
        "submitter_treatment_id": "TREATMENT_11680",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2681",
        "submitter_treatment_id": "TREATMENT_11681",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2682",
        "submitter_treatment_id": "TREATMENT_11682",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2683",
        "submitter_treatment_id": "TREATMENT_11683",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2684",
        "submitter_treatment_id": "TREATMENT_11684",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2685",
        "submitter_treatment_id": "TREATMENT_11685",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2686",
        "submitter_treatment_id": "TREATMENT_11686",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2687",
        "submitter_treatment_id": "TREATMENT_11687",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2688",
        "submitter_treatment_id": "TREATMENT_11688",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2689",
        "submitter_treatment_id": "TREATMENT_11689",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2690",
        "submitter_treatment_id": "TREATMENT_11690",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2691",
        "submitter_treatment_id": "TREATMENT_11691",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2692",
        "submitter_treatment_id": "TREATMENT_11692",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2693",
        "submitter_treatment_id": "TREATMENT_11693",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2694",
        "submitter_treatment_id": "TREATMENT_11694",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2695",
        "submitter_treatment_id": "TREATMENT_11695",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2696",
        "submitter_treatment_id": "TREATMENT_11696",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2697",
        "submitter_treatment_id": "TREATMENT_11697",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2698",
        "submitter_treatment_id": "TREATMENT_11698",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2699",
        "submitter_treatment_id": "TREATMENT_11699",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2700",
        "submitter_treatment_id": "TREATMENT_11700",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2701",
        "submitter_treatment_id": "TREATMENT_11701",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2702",
        "submitter_treatment_id": "TREATMENT_11702",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2703",
        "submitter_treatment_id": "TREATMENT_11703",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2704",
        "submitter_treatment_id": "TREATMENT_11704",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2705",
        "submitter_treatment_id": "TREATMENT_11705",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2706",
        "submitter_treatment_id": "TREATMENT_11706",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2707",
        "submitter_treatment_id": "TREATMENT_11707",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2708",
        "submitter_treatment_id": "TREATMENT_11708",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2709",
        "submitter_treatment_id": "TREATMENT_11709",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2710",
        "submitter_treatment_id": "TREATMENT_11710",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2711",
        "submitter_treatment_id": "TREATMENT_11711",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2712",
        "submitter_treatment_id": "TREATMENT_11712",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2713",
        "submitter_treatment_id": "TREATMENT_11713",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2714",
        "submitter_treatment_id": "TREATMENT_11714",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2715",
        "submitter_treatment_id": "TREATMENT_11715",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2716",
        "submitter_treatment_id": "TREATMENT_11716",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2717",
        "submitter_treatment_id": "TREATMENT_11717",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2718",
        "submitter_treatment_id": "TREATMENT_11718",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2719",
        "submitter_treatment_id": "TREATMENT_11719",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2720",
        "submitter_treatment_id": "TREATMENT_11720",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2721",
        "submitter_treatment_id": "TREATMENT_11721",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2722",
        "submitter_treatment_id": "TREATMENT_11722",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2723",
        "submitter_treatment_id": "TREATMENT_11723",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2724",
        "submitter_treatment_id": "TREATMENT_11724",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2725",
        "submitter_treatment_id": "TREATMENT_11725",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2726",
        "submitter_treatment_id": "TREATMENT_11726",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2727",
        "submitter_treatment_id": "TREATMENT_11727",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2728",
        "submitter_treatment_id": "TREATMENT_11728",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2729",
        "submitter_treatment_id": "TREATMENT_11729",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2730",
        "submitter_treatment_id": "TREATMENT_11730",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2731",
        "submitter_treatment_id": "TREATMENT_11731",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2732",
        "submitter_treatment_id": "TREATMENT_11732",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2733",
        "submitter_treatment_id": "TREATMENT_11733",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2734",
        "submitter_treatment_id": "TREATMENT_11734",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2735",
        "submitter_treatment_id": "TREATMENT_11735",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2736",
        "submitter_treatment_id": "TREATMENT_11736",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2737",
        "submitter_treatment_id": "TREATMENT_11737",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2738",
        "submitter_treatment_id": "TREATMENT_11738",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2739",
        "submitter_treatment_id": "TREATMENT_11739",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2740",
        "submitter_treatment_id": "TREATMENT_11740",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2741",
        "submitter_treatment_id": "TREATMENT_11741",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2742",
        "submitter_treatment_id": "TREATMENT_11742",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2743",
        "submitter_treatment_id": "TREATMENT_11743",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2744",
        "submitter_treatment_id": "TREATMENT_11744",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2745",
        "submitter_treatment_id": "TREATMENT_11745",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2746",
        "submitter_treatment_id": "TREATMENT_11746",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2747",
        "submitter_treatment_id": "TREATMENT_11747",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2748",
        "submitter_treatment_id": "TREATMENT_11748",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2749",
        "submitter_treatment_id": "TREATMENT_11749",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2750",
        "submitter_treatment_id": "TREATMENT_11750",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2751",
        "submitter_treatment_id": "TREATMENT_11751",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2752",
        "submitter_treatment_id": "TREATMENT_11752",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2753",
        "submitter_treatment_id": "TREATMENT_11753",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2754",
        "submitter_treatment_id": "TREATMENT_11754",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2755",
        "submitter_treatment_id": "TREATMENT_11755",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2756",
        "submitter_treatment_id": "TREATMENT_11756",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2757",
        "submitter_treatment_id": "TREATMENT_11757",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2758",
        "submitter_treatment_id": "TREATMENT_11758",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2759",
        "submitter_treatment_id": "TREATMENT_11759",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2760",
        "submitter_treatment_id": "TREATMENT_11760",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2761",
        "submitter_treatment_id": "TREATMENT_11761",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2762",
        "submitter_treatment_id": "TREATMENT_11762",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2763",
        "submitter_treatment_id": "TREATMENT_11763",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2764",
        "submitter_treatment_id": "TREATMENT_11764",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2765",
        "submitter_treatment_id": "TREATMENT_11765",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2766",
        "submitter_treatment_id": "TREATMENT_11766",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2767",
        "submitter_treatment_id": "TREATMENT_11767",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2768",
        "submitter_treatment_id": "TREATMENT_11768",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2769",
        "submitter_treatment_id": "TREATMENT_11769",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2770",
        "submitter_treatment_id": "TREATMENT_11770",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2771",
        "submitter_treatment_id": "TREATMENT_11771",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2772",
        "submitter_treatment_id": "TREATMENT_11772",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2773",
        "submitter_treatment_id": "TREATMENT_11773",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2774",
        "submitter_treatment_id": "TREATMENT_11774",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2775",
        "submitter_treatment_id": "TREATMENT_11775",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2776",
        "submitter_treatment_id": "TREATMENT_11776",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2777",
        "submitter_treatment_id": "TREATMENT_11777",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2778",
        "submitter_treatment_id": "TREATMENT_11778",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2779",
        "submitter_treatment_id": "TREATMENT_11779",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2780",
        "submitter_treatment_id": "TREATMENT_11780",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2781",
        "submitter_treatment_id": "TREATMENT_11781",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2782",
        "submitter_treatment_id": "TREATMENT_11782",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2783",
        "submitter_treatment_id": "TREATMENT_11783",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2784",
        "submitter_treatment_id": "TREATMENT_11784",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2785",
        "submitter_treatment_id": "TREATMENT_11785",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2786",
        "submitter_treatment_id": "TREATMENT_11786",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2787",
        "submitter_treatment_id": "TREATMENT_11787",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2788",
        "submitter_treatment_id": "TREATMENT_11788",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2789",
        "submitter_treatment_id": "TREATMENT_11789",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2790",
        "submitter_treatment_id": "TREATMENT_11790",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2791",
        "submitter_treatment_id": "TREATMENT_11791",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2792",
        "submitter_treatment_id": "TREATMENT_11792",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2793",
        "submitter_treatment_id": "TREATMENT_11793",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2794",
        "submitter_treatment_id": "TREATMENT_11794",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2795",
        "submitter_treatment_id": "TREATMENT_11795",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2796",
        "submitter_treatment_id": "TREATMENT_11796",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2797",
        "submitter_treatment_id": "TREATMENT_11797",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2798",
        "submitter_treatment_id": "TREATMENT_11798",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2799",
        "submitter_treatment_id": "TREATMENT_11799",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2800",
        "submitter_treatment_id": "TREATMENT_11800",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2801",
        "submitter_treatment_id": "TREATMENT_11801",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2802",
        "submitter_treatment_id": "TREATMENT_11802",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2803",
        "submitter_treatment_id": "TREATMENT_11803",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2804",
        "submitter_treatment_id": "TREATMENT_11804",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2805",
        "submitter_treatment_id": "TREATMENT_11805",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2806",
        "submitter_treatment_id": "TREATMENT_11806",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2807",
        "submitter_treatment_id": "TREATMENT_11807",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2808",
        "submitter_treatment_id": "TREATMENT_11808",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2809",
        "submitter_treatment_id": "TREATMENT_11809",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2810",
        "submitter_treatment_id": "TREATMENT_11810",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2811",
        "submitter_treatment_id": "TREATMENT_11811",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2812",
        "submitter_treatment_id": "TREATMENT_11812",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2813",
        "submitter_treatment_id": "TREATMENT_11813",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2814",
        "submitter_treatment_id": "TREATMENT_11814",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2815",
        "submitter_treatment_id": "TREATMENT_11815",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2816",
        "submitter_treatment_id": "TREATMENT_11816",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2817",
        "submitter_treatment_id": "TREATMENT_11817",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2818",
        "submitter_treatment_id": "TREATMENT_11818",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2819",
        "submitter_treatment_id": "TREATMENT_11819",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2820",
        "submitter_treatment_id": "TREATMENT_11820",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2821",
        "submitter_treatment_id": "TREATMENT_11821",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2822",
        "submitter_treatment_id": "TREATMENT_11822",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2823",
        "submitter_treatment_id": "TREATMENT_11823",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2824",
        "submitter_treatment_id": "TREATMENT_11824",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2825",
        "submitter_treatment_id": "TREATMENT_11825",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2826",
        "submitter_treatment_id": "TREATMENT_11826",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2827",
        "submitter_treatment_id": "TREATMENT_11827",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2828",
        "submitter_treatment_id": "TREATMENT_11828",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2829",
        "submitter_treatment_id": "TREATMENT_11829",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2830",
        "submitter_treatment_id": "TREATMENT_11830",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2831",
        "submitter_treatment_id": "TREATMENT_11831",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2832",
        "submitter_treatment_id": "TREATMENT_11832",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2833",
        "submitter_treatment_id": "TREATMENT_11833",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2834",
        "submitter_treatment_id": "TREATMENT_11834",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2835",
        "submitter_treatment_id": "TREATMENT_11835",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2836",
        "submitter_treatment_id": "TREATMENT_11836",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2837",
        "submitter_treatment_id": "TREATMENT_11837",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2838",
        "submitter_treatment_id": "TREATMENT_11838",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2839",
        "submitter_treatment_id": "TREATMENT_11839",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2840",
        "submitter_treatment_id": "TREATMENT_11840",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2841",
        "submitter_treatment_id": "TREATMENT_11841",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2842",
        "submitter_treatment_id": "TREATMENT_11842",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2843",
        "submitter_treatment_id": "TREATMENT_11843",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2844",
        "submitter_treatment_id": "TREATMENT_11844",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2845",
        "submitter_treatment_id": "TREATMENT_11845",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2846",
        "submitter_treatment_id": "TREATMENT_11846",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2847",
        "submitter_treatment_id": "TREATMENT_11847",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2848",
        "submitter_treatment_id": "TREATMENT_11848",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2849",
        "submitter_treatment_id": "TREATMENT_11849",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2850",
        "submitter_treatment_id": "TREATMENT_11850",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2851",
        "submitter_treatment_id": "TREATMENT_11851",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2852",
        "submitter_treatment_id": "TREATMENT_11852",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2853",
        "submitter_treatment_id": "TREATMENT_11853",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2854",
        "submitter_treatment_id": "TREATMENT_11854",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2855",
        "submitter_treatment_id": "TREATMENT_11855",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2856",
        "submitter_treatment_id": "TREATMENT_11856",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2857",
        "submitter_treatment_id": "TREATMENT_11857",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2858",
        "submitter_treatment_id": "TREATMENT_11858",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2859",
        "submitter_treatment_id": "TREATMENT_11859",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2860",
        "submitter_treatment_id": "TREATMENT_11860",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2861",
        "submitter_treatment_id": "TREATMENT_11861",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2862",
        "submitter_treatment_id": "TREATMENT_11862",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2863",
        "submitter_treatment_id": "TREATMENT_11863",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2864",
        "submitter_treatment_id": "TREATMENT_11864",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 78,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2865",
        "submitter_treatment_id": "TREATMENT_11865",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2866",
        "submitter_treatment_id": "TREATMENT_11866",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2867",
        "submitter_treatment_id": "TREATMENT_11867",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2868",
        "submitter_treatment_id": "TREATMENT_11868",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2869",
        "submitter_treatment_id": "TREATMENT_11869",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2870",
        "submitter_treatment_id": "TREATMENT_11870",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2871",
        "submitter_treatment_id": "TREATMENT_11871",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2872",
        "submitter_treatment_id": "TREATMENT_11872",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2873",
        "submitter_treatment_id": "TREATMENT_11873",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2874",
        "submitter_treatment_id": "TREATMENT_11874",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2875",
        "submitter_treatment_id": "TREATMENT_11875",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2876",
        "submitter_treatment_id": "TREATMENT_11876",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2877",
        "submitter_treatment_id": "TREATMENT_11877",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2878",
        "submitter_treatment_id": "TREATMENT_11878",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2879",
        "submitter_treatment_id": "TREATMENT_11879",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2880",
        "submitter_treatment_id": "TREATMENT_11880",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2881",
        "submitter_treatment_id": "TREATMENT_11881",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2882",
        "submitter_treatment_id": "TREATMENT_11882",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2883",
        "submitter_treatment_id": "TREATMENT_11883",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2884",
        "submitter_treatment_id": "TREATMENT_11884",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2885",
        "submitter_treatment_id": "TREATMENT_11885",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2886",
        "submitter_treatment_id": "TREATMENT_11886",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2887",
        "submitter_treatment_id": "TREATMENT_11887",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2888",
        "submitter_treatment_id": "TREATMENT_11888",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2889",
        "submitter_treatment_id": "TREATMENT_11889",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2890",
        "submitter_treatment_id": "TREATMENT_11890",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2891",
        "submitter_treatment_id": "TREATMENT_11891",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2892",
        "submitter_treatment_id": "TREATMENT_11892",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2893",
        "submitter_treatment_id": "TREATMENT_11893",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2894",
        "submitter_treatment_id": "TREATMENT_11894",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2895",
        "submitter_treatment_id": "TREATMENT_11895",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2896",
        "submitter_treatment_id": "TREATMENT_11896",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2897",
        "submitter_treatment_id": "TREATMENT_11897",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2898",
        "submitter_treatment_id": "TREATMENT_11898",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2899",
        "submitter_treatment_id": "TREATMENT_11899",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2900",
        "submitter_treatment_id": "TREATMENT_11900",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2901",
        "submitter_treatment_id": "TREATMENT_11901",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2902",
        "submitter_treatment_id": "TREATMENT_11902",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2903",
        "submitter_treatment_id": "TREATMENT_11903",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2904",
        "submitter_treatment_id": "TREATMENT_11904",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2905",
        "submitter_treatment_id": "TREATMENT_11905",
        "immunotherapy_type": null,
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2906",
        "submitter_treatment_id": "TREATMENT_11906",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2907",
        "submitter_treatment_id": "TREATMENT_11907",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2908",
        "submitter_treatment_id": "TREATMENT_11908",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2909",
        "submitter_treatment_id": "TREATMENT_11909",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2910",
        "submitter_treatment_id": "TREATMENT_11910",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2911",
        "submitter_treatment_id": "TREATMENT_11911",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2912",
        "submitter_treatment_id": "TREATMENT_11912",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2913",
        "submitter_treatment_id": "TREATMENT_11913",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2914",
        "submitter_treatment_id": "TREATMENT_11914",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2915",
        "submitter_treatment_id": "TREATMENT_11915",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2916",
        "submitter_treatment_id": "TREATMENT_11916",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2917",
        "submitter_treatment_id": "TREATMENT_11917",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2918",
        "submitter_treatment_id": "TREATMENT_11918",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2919",
        "submitter_treatment_id": "TREATMENT_11919",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2920",
        "submitter_treatment_id": "TREATMENT_11920",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2921",
        "submitter_treatment_id": "TREATMENT_11921",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2922",
        "submitter_treatment_id": "TREATMENT_11922",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2923",
        "submitter_treatment_id": "TREATMENT_11923",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2924",
        "submitter_treatment_id": "TREATMENT_11924",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2925",
        "submitter_treatment_id": "TREATMENT_11925",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2926",
        "submitter_treatment_id": "TREATMENT_11926",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2927",
        "submitter_treatment_id": "TREATMENT_11927",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2928",
        "submitter_treatment_id": "TREATMENT_11928",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2929",
        "submitter_treatment_id": "TREATMENT_11929",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2930",
        "submitter_treatment_id": "TREATMENT_11930",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2931",
        "submitter_treatment_id": "TREATMENT_11931",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2932",
        "submitter_treatment_id": "TREATMENT_11932",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2933",
        "submitter_treatment_id": "TREATMENT_11933",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2934",
        "submitter_treatment_id": "TREATMENT_11934",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2935",
        "submitter_treatment_id": "TREATMENT_11935",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2936",
        "submitter_treatment_id": "TREATMENT_11936",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2937",
        "submitter_treatment_id": "TREATMENT_11937",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2938",
        "submitter_treatment_id": "TREATMENT_11938",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2939",
        "submitter_treatment_id": "TREATMENT_11939",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2940",
        "submitter_treatment_id": "TREATMENT_11940",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2941",
        "submitter_treatment_id": "TREATMENT_11941",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2942",
        "submitter_treatment_id": "TREATMENT_11942",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2943",
        "submitter_treatment_id": "TREATMENT_11943",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2944",
        "submitter_treatment_id": "TREATMENT_11944",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2945",
        "submitter_treatment_id": "TREATMENT_11945",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2946",
        "submitter_treatment_id": "TREATMENT_11946",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2947",
        "submitter_treatment_id": "TREATMENT_11947",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2948",
        "submitter_treatment_id": "TREATMENT_11948",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2949",
        "submitter_treatment_id": "TREATMENT_11949",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2950",
        "submitter_treatment_id": "TREATMENT_11950",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2951",
        "submitter_treatment_id": "TREATMENT_11951",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2952",
        "submitter_treatment_id": "TREATMENT_11952",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2953",
        "submitter_treatment_id": "TREATMENT_11953",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2954",
        "submitter_treatment_id": "TREATMENT_11954",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2955",
        "submitter_treatment_id": "TREATMENT_11955",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2956",
        "submitter_treatment_id": "TREATMENT_11956",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2957",
        "submitter_treatment_id": "TREATMENT_11957",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2958",
        "submitter_treatment_id": "TREATMENT_11958",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2959",
        "submitter_treatment_id": "TREATMENT_11959",
        "immunotherapy_type": null,
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2960",
        "submitter_treatment_id": "TREATMENT_11960",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2961",
        "submitter_treatment_id": "TREATMENT_11961",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2962",
        "submitter_treatment_id": "TREATMENT_11962",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2963",
        "submitter_treatment_id": "TREATMENT_11963",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2964",
        "submitter_treatment_id": "TREATMENT_11964",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2965",
        "submitter_treatment_id": "TREATMENT_11965",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2966",
        "submitter_treatment_id": "TREATMENT_11966",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2967",
        "submitter_treatment_id": "TREATMENT_11967",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2968",
        "submitter_treatment_id": "TREATMENT_11968",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2969",
        "submitter_treatment_id": "TREATMENT_11969",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2970",
        "submitter_treatment_id": "TREATMENT_11970",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2971",
        "submitter_treatment_id": "TREATMENT_11971",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2972",
        "submitter_treatment_id": "TREATMENT_11972",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2973",
        "submitter_treatment_id": "TREATMENT_11973",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2974",
        "submitter_treatment_id": "TREATMENT_11974",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2975",
        "submitter_treatment_id": "TREATMENT_11975",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2976",
        "submitter_treatment_id": "TREATMENT_11976",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2977",
        "submitter_treatment_id": "TREATMENT_11977",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2978",
        "submitter_treatment_id": "TREATMENT_11978",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2979",
        "submitter_treatment_id": "TREATMENT_11979",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2980",
        "submitter_treatment_id": "TREATMENT_11980",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2981",
        "submitter_treatment_id": "TREATMENT_11981",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2982",
        "submitter_treatment_id": "TREATMENT_11982",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2983",
        "submitter_treatment_id": "TREATMENT_11983",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2984",
        "submitter_treatment_id": "TREATMENT_11984",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2985",
        "submitter_treatment_id": "TREATMENT_11985",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2986",
        "submitter_treatment_id": "TREATMENT_11986",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2987",
        "submitter_treatment_id": "TREATMENT_11987",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2988",
        "submitter_treatment_id": "TREATMENT_11988",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2989",
        "submitter_treatment_id": "TREATMENT_11989",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2990",
        "submitter_treatment_id": "TREATMENT_11990",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2991",
        "submitter_treatment_id": "TREATMENT_11991",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2992",
        "submitter_treatment_id": "TREATMENT_11992",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2993",
        "submitter_treatment_id": "TREATMENT_11993",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2994",
        "submitter_treatment_id": "TREATMENT_11994",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2995",
        "submitter_treatment_id": "TREATMENT_11995",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2996",
        "submitter_treatment_id": "TREATMENT_11996",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2997",
        "submitter_treatment_id": "TREATMENT_11997",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2998",
        "submitter_treatment_id": "TREATMENT_11998",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_2999",
        "submitter_treatment_id": "TREATMENT_11999",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-6",
        "submitter_donor_id": "DONOR_3000",
        "submitter_treatment_id": "TREATMENT_12000",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 105
    }
]